[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 116
1. Bach JR, Saltstein K, Sinquee D, Weaver B, Komaroff E: Long-term survival in Werdnig-Hoffmann disease. Am J Phys Med Rehabil; 2007 May;86(5):339-45 quiz 346-8, 379
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • DESIGN: A retrospective chart review of 106 consecutively referred SMA 1 patients, the 92 most severe of which were considered in three groups: untreated (group 1), tracheostomy managed (group 2), and noninvasively managed (group 3).
  • RESULTS: The untreated patients died at 9.6 +/- 4.0 mos of age.
  • The 47 patients who used noninvasive mechanical ventilation (NIV) (group 3) were extubated to it during episodes of acute respiratory failure.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17449977.001).
  • [ISSN] 0894-9115
  • [Journal-full-title] American journal of physical medicine & rehabilitation
  • [ISO-abbreviation] Am J Phys Med Rehabil
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


2. Wickström M, Johnsen JI, Ponthan F, Segerström L, Sveinbjörnsson B, Lindskog M, Lövborg H, Viktorsson K, Lewensohn R, Kogner P, Larsson R, Gullbo J: The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo. Mol Cancer Ther; 2007 Sep;6(9):2409-17
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Neuroblastoma is the most common extracranial solid tumor of childhood.
  • Tumor growth in vivo was significantly inhibited by J1 compared with untreated controls.

  • Genetic Alliance. consumer health - Neuroblastoma.
  • MedlinePlus Health Information. consumer health - Neuroblastoma.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. MELPHALAN .
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. ETOPOSIDE .
  • Hazardous Substances Data Bank. CARBOPLATIN .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17876040.001).
  • [ISSN] 1535-7163
  • [Journal-full-title] Molecular cancer therapeutics
  • [ISO-abbreviation] Mol. Cancer Ther.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Dipeptides; 0 / L-melphalanyl-p-L-fluorophenylalanine ethyl ester; 0 / Prodrugs; 5J49Q6B70F / Vincristine; 6PLQ3CP4P3 / Etoposide; 80168379AG / Doxorubicin; BG3F62OND5 / Carboplatin; Q41OR9510P / Melphalan
  •  go-up   go-down


3. Smith SD, Fischer G: Childhood onset vulvar lichen sclerosus does not resolve at puberty: a prospective case series. Pediatr Dermatol; 2009 Nov-Dec;26(6):725-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Childhood onset vulvar lichen sclerosus does not resolve at puberty: a prospective case series.
  • However when it occurs in adult women it is accepted that remission is unlikely and that in addition untreated or inadequately treated disease may be complicated by significant disturbance of vulvar architecture and less commonly squamous cell carcinoma.
  • Even when diagnosed early and treated effectively, childhood onset lichen sclerosus may be complicated by distortion of vulvar architecture.

  • MedlinePlus Health Information. consumer health - Puberty.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20199450.001).
  • [ISSN] 1525-1470
  • [Journal-full-title] Pediatric dermatology
  • [ISO-abbreviation] Pediatr Dermatol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


Advertisement
4. de Vries L, Bulvik S, Phillip M: Chronic autoimmune thyroiditis in children and adolescents: at presentation and during long-term follow-up. Arch Dis Child; 2009 Jan;94(1):33-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There was no change in thyroid status in the nine untreated patients.

  • MedlinePlus Health Information. consumer health - Hypothyroidism.
  • Hazardous Substances Data Bank. LEVOTHYROXINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18703546.001).
  • [ISSN] 1468-2044
  • [Journal-full-title] Archives of disease in childhood
  • [ISO-abbreviation] Arch. Dis. Child.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] Q51BO43MG4 / Thyroxine
  •  go-up   go-down


5. De Rosa G, Pardeo M, Rigante D: Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications. Eur Rev Med Pharmacol Sci; 2007 Sep-Oct;11(5):301-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Kawasaki syndrome is a potentially life-threatening disease of early childhood that untreated holds a risk of severe coronary involvement.

  • Genetic Alliance. consumer health - Kawasaki Disease.
  • MedlinePlus Health Information. consumer health - Kawasaki Disease.
  • Hazardous Substances Data Bank. ACETYLSALICYLIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18074939.001).
  • [ISSN] 1128-3602
  • [Journal-full-title] European review for medical and pharmacological sciences
  • [ISO-abbreviation] Eur Rev Med Pharmacol Sci
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents, Non-Steroidal; 0 / Fibrinolytic Agents; 0 / Immunoglobulins, Intravenous; 0 / Immunologic Factors; R16CO5Y76E / Aspirin
  • [Number-of-references] 54
  •  go-up   go-down


6. Webster J, Lines J, Bruce J, Armstrong Schellenberg JR, Hanson K: Which delivery systems reach the poor? A review of equity of coverage of ever-treated nets, never-treated nets, and immunisation to reduce child mortality in Africa. Lancet Infect Dis; 2005 Nov;5(11):709-17
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Insecticide-treated nets (ITNs) and childhood vaccination are two of the most powerful interventions available to prevent childhood mortality in Africa, but ITN coverage is still very low.
  • Here, we review data available on coverage and equity of coverage of three interventions to prevent childhood mortality.
  • We compiled and analysed data from nationally representative surveys in 26 African countries to compare equity of coverage of (1) the Expanded Programme on Immunisation (EPI), (2) any net, (3) ever-treated nets (ie, ITNs), and (4) never-treated nets (ie, untreated nets; UTNs).

  • MedlinePlus Health Information. consumer health - Immunization.
  • MedlinePlus Health Information. consumer health - Malaria.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16253888.001).
  • [ISSN] 1473-3099
  • [Journal-full-title] The Lancet. Infectious diseases
  • [ISO-abbreviation] Lancet Infect Dis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Number-of-references] 36
  •  go-up   go-down


7. Wanjau J, du Plessis JB: Prevalence of early childhood caries in 3- to 5-year-old children in Philadelphia district, Mpumalanga Province. SADJ; 2006 Oct;61(9):390-2, 394
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prevalence of early childhood caries in 3- to 5-year-old children in Philadelphia district, Mpumalanga Province.
  • INTRODUCTION: Early Childhood Caries (ECC) can be defined as dental caries in preschool children.
  • Virtually all caries in preschool children from this community is left untreated.

  • MedlinePlus Health Information. consumer health - Child Dental Health.
  • MedlinePlus Health Information. consumer health - Tooth Decay.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17201306.001).
  • [ISSN] 1029-4864
  • [Journal-full-title] SADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging
  • [ISO-abbreviation] SADJ
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] South Africa
  •  go-up   go-down


8. Centers for Disease Control and Prevention (CDC): Visual impairment and use of eye-care services and protective eyewear among children--United States, 2002. MMWR Morb Mortal Wkly Rep; 2005 May 6;54(17):425-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ocular conditions, if undetected or untreated, can have substantial long-term implications for the quality of life of the child and the family and can place a burden on public health resources.
  • To address all three childhood vision objectives, CDC analyzed data from the 2002 National Health Interview Survey (NHIS).
  • Collaborative efforts of all relevant agencies, health professionals, educators, and the public are needed to achieve the national childhood vision objectives for 2010.


9. Kumar G, Dagur PK, Singh M, Yadav VS, Dayal R, Singh HB, Katoch VM, Sengupta U, Joshi B: Diagnostic potential of Ag85C in comparison to various secretory antigens for childhood tuberculosis. Scand J Immunol; 2008 Aug;68(2):177-83
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnostic potential of Ag85C in comparison to various secretory antigens for childhood tuberculosis.
  • Childhood tuberculosis is difficult to diagnose.
  • Therefore, efficacy and diagnostic potential of different secretory antigens of Mycobacterium tuberculosis (CFP-10, Ag85complex, Ag85 A, B, C) and their combinations along with ESAT-6 in the detection of antibody profiles of childhood tuberculosis cases were evaluated using ELISA technique and reactivity was compared with the gold standards (smear, culture and IS6110 targeted PCR).
  • In the present study, 88 fresh, untreated childhood tuberculosis (TB) cases, 17 children undergoing anti-tubercular therapy, 17 children having disease other than TB and 25 healthy children were included.
  • Our finding demonstrates the potential of Ag85C in the detection of antibody in childhood TB cases and this antigen showed good concordance with PCR positivity.

  • Genetic Alliance. consumer health - Tuberculosis.
  • MedlinePlus Health Information. consumer health - Tuberculosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18702747.001).
  • [ISSN] 1365-3083
  • [Journal-full-title] Scandinavian journal of immunology
  • [ISO-abbreviation] Scand. J. Immunol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies, Bacterial; 0 / Antigens, Bacterial; 0 / Immunoglobulin G; EC 2.3.- / Acyltransferases; EC 2.3.1.- / antigen 85A, Mycobacterium tuberculosis
  •  go-up   go-down


10. Peet AC, Lateef S, MacPherson L, Natarajan K, Sgouros S, Grundy RG: Short echo time 1 H magnetic resonance spectroscopy of childhood brain tumours. Childs Nerv Syst; 2007 Feb;23(2):163-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Short echo time 1 H magnetic resonance spectroscopy of childhood brain tumours.
  • Inositol/Myoinositol (Inos)/Cho ratios were significantly (p<0.05) lower in untreated tumours (1.91) than in treated tumours (3.93) and in non-involved brain (3.32).
  • Inos/Cho levels differ between untreated and treated tumours and may be useful for treatment monitoring.

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • Hazardous Substances Data Bank. HYDROGEN .
  • Hazardous Substances Data Bank. (L)-ASPARTIC ACID .
  • Hazardous Substances Data Bank. CREATINE .
  • Hazardous Substances Data Bank. CHOLINE CHLORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJNR Am J Neuroradiol. 2000 Jan;21(1):84-93 [10669230.001]
  • [Cites] Cancer. 2004 Mar 15;100(6):1246-56 [15022293.001]
  • [Cites] Br J Cancer. 2003 Feb 10;88(3):478-85 [12569394.001]
  • [Cites] Magn Reson Med. 2003 Apr;49(4):632-7 [12652533.001]
  • [Cites] Magn Reson Imaging. 2001 Oct;19(8):1081-9 [11711232.001]
  • [Cites] Neuroradiology. 2003 Jan;45(1):1-10 [12525947.001]
  • [Cites] AJNR Am J Neuroradiol. 2002 Feb;23(2):322-33 [11847064.001]
  • [Cites] Neuroradiology. 1998 Feb;40(2):121-5 [9541923.001]
  • [Cites] NMR Biomed. 1998 Jun-Aug;11(4-5):192-200 [9719573.001]
  • [Cites] Childs Nerv Syst. 2007 Feb;23(2):163-9 [17106750.001]
  • [Cites] Pediatr Blood Cancer. 2005 Feb;44(2):103-13 [15495214.001]
  • [Cites] Magn Reson Med. 1993 Dec;30(6):672-9 [8139448.001]
  • [Cites] Acta Radiol. 2001 Jan;42(1):39-42 [11167330.001]
  • [Cites] Nat Med. 1996 Mar;2(3):323-5 [8612232.001]
  • [Cites] NMR Biomed. 2003 May;16(3):123-31 [12884355.001]
  • [Cites] Clin Cancer Res. 2004 Dec 15;10(24):8220-8 [15623597.001]
  • [Cites] Eur J Cancer. 2003 Apr;39(6):728-35 [12651196.001]
  • (PMID = 17106750.001).
  • [ISSN] 0256-7040
  • [Journal-full-title] Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
  • [ISO-abbreviation] Childs Nerv Syst
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 30KYC7MIAI / Aspartic Acid; 7YNJ3PO35Z / Hydrogen; 997-55-7 / N-acetylaspartate; MU72812GK0 / Creatine; N91BDP6H0X / Choline
  •  go-up   go-down


11. Melamud A, Palekar R, Singh A: Retinoblastoma. Am Fam Physician; 2006 Mar 15;73(6):1039-44
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Retinoblastoma, a neuroblastic tumor, is the most common primary intraocular malignancy of childhood.
  • If untreated, almost all patients die of intracranial extension and disseminated disease within two years.

  • Genetic Alliance. consumer health - Retinoblastoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Am Fam Physician. 2007 Apr 1;75(7):980
  • (PMID = 16570739.001).
  • [ISSN] 0002-838X
  • [Journal-full-title] American family physician
  • [ISO-abbreviation] Am Fam Physician
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 21
  •  go-up   go-down


12. Pähkla ER, Jõgi E, Nurk A, Pisarev H, Koppel T, Naaber P, Saag M, Lõivukene K: Periodontal disease in mothers indicates risk in their children. Int J Paediatr Dent; 2010 Jan;20(1):24-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Four study groups were included: (I) 20 female patients with untreated generalized severe chronic periodontitis, (II) their children (34), (III) 13 periodontally healthy mothers and (IV) their children (13).
  • CONCLUSION: Maternal indicators, such as periodontitis, hygiene habits, and periodontal microflora are risk factors for childhood periodontal diseases, and might be predictive of future childhood and adolescent periodontitis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20059590.001).
  • [ISSN] 1365-263X
  • [Journal-full-title] International journal of paediatric dentistry
  • [ISO-abbreviation] Int J Paediatr Dent
  • [Language] ENG
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


13. Kovács M, Pák P, Pák G, Fehér J: [Small intestine capsule endoscopy in the diagnostics of coeliac disease]. Orv Hetil; 2008 Oct 12;149(41):1951-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It had for long been considered a childhood condition as clinical symptoms manifested when gluten was introduced into the diet.
  • Macroscopic signs of villous atrophy (reduction in the number or loss of Kerking's folds, vascular pattern visible through the mucosa, "mosaic or micronodular" pattern, "scalloped" folds) are clearly visible in untreated patients.

  • MedlinePlus Health Information. consumer health - Celiac Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18842513.001).
  • [ISSN] 0030-6002
  • [Journal-full-title] Orvosi hetilap
  • [ISO-abbreviation] Orv Hetil
  • [Language] hun
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Hungary
  • [Number-of-references] 34
  •  go-up   go-down


14. Labate A, Briellmann RS, Abbott DF, Waites AB, Jackson GD: Typical childhood absence seizures are associated with thalamic activation. Epileptic Disord; 2005 Dec;7(4):373-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Typical childhood absence seizures are associated with thalamic activation.
  • This study demonstrates thalamic activation in typical, untreated childhood absence epilepsy.

  • Genetic Alliance. consumer health - Seizures.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16338682.001).
  • [ISSN] 1294-9361
  • [Journal-full-title] Epileptic disorders : international epilepsy journal with videotape
  • [ISO-abbreviation] Epileptic Disord
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] France
  •  go-up   go-down


15. Mittal R, Khalifa NM, Khalifa SO, Ragheb AM, Ali J: Outcome of children with Hodgkin's disease. A 10-year experience from a single institution in Kuwait. Saudi Med J; 2010 Jan;31(1):69-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Sixty-three children with previously untreated Hodgkin's disease, who were diagnosed at the Pediatric Oncology Unit of Kuwait Cancer Control Centre, Shuwaikh, Kuwait from January 1998 to December 2007 were included in the study.
  • CONCLUSION: With moderate toxicity, combined modality therapy is effective in the treatment of childhood Hodgkin's disease.

  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20062903.001).
  • [ISSN] 0379-5284
  • [Journal-full-title] Saudi medical journal
  • [ISO-abbreviation] Saudi Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Saudi Arabia
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


16. Eng CM, Fletcher J, Wilcox WR, Waldek S, Scott CR, Sillence DO, Breunig F, Charrow J, Germain DP, Nicholls K, Banikazemi M: Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry. J Inherit Metab Dis; 2007 Apr;30(2):184-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This paper demonstrates that in spite of the considerable burden of disease in both sexes that begins to manifest in childhood or adolescence, the recognition of the underlying diagnosis is delayed by 14 years in males and 19 years in females.
  • The Fabry Registry provides data that can increase awareness of common symptoms in all age groups, as well as insight into treated and untreated disease course, leading to improved recognition and earlier treatment, and possibly to improved outcomes for affected individuals.


17. Thuo N, Ohuma E, Karisa J, Talbert A, Berkley JA, Maitland K: The prognostic value of dipstick urinalysis in children admitted to hospital with severe malnutrition. Arch Dis Child; 2010 Jun;95(6):422-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Prospective studies to determine the role of untreated UTI in these deaths are needed before any treatment recommendations can be made.

  • MedlinePlus Health Information. consumer health - Malnutrition.
  • MedlinePlus Health Information. consumer health - Urinary Tract Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20371590.001).
  • [ISSN] 1468-2044
  • [Journal-full-title] Archives of disease in childhood
  • [ISO-abbreviation] Arch. Dis. Child.
  • [Language] eng
  • [Grant] United Kingdom / Wellcome Trust / /
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Nitrites; 0 / Reagent Strips; EC 3.1.- / leukocyte esterase; EC 3.1.1.- / Carboxylic Ester Hydrolases
  •  go-up   go-down


18. Gurney JG, Ness KK, Sibley SD, O'Leary M, Dengel DR, Lee JM, Youngren NM, Glasser SP, Baker KS: Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer; 2006 Sep 15;107(6):1303-12
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia.
  • BACKGROUND: The purpose of the study was to determine the prevalence of metabolic syndrome, growth hormone deficiency, and cardiovascular risk factors among adult survivors of childhood acute lymphoblastic leukemia (ALL) treated with or without cranial irradiation.
  • METHODS: Follow-up was undertaken of 75 randomly selected long-term childhood ALL survivors.
  • Untreated abnormally low GH was present in 64% of subjects overall and 85% of those who received past cranial irradiation.
  • CONCLUSIONS: Hematologists who treat childhood ALL patients, and particularly those who provide primary care to adult survivors, should be aware of the potential for long-term GH deficiency and adverse cardiovascular and diabetes risk profiles as a consequence of leukemia treatment.
  • [MeSH-major] Cranial Irradiation / adverse effects. Growth Hormone / deficiency. Metabolic Syndrome X / blood. Precursor Cell Lymphoblastic Leukemia-Lymphoma / radiotherapy


19. Halbower AC, Degaonkar M, Barker PB, Earley CJ, Marcus CL, Smith PL, Prahme MC, Mahone EM: Childhood obstructive sleep apnea associates with neuropsychological deficits and neuronal brain injury. PLoS Med; 2006 Aug;3(8):e301
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Childhood obstructive sleep apnea associates with neuropsychological deficits and neuronal brain injury.
  • BACKGROUND: Childhood obstructive sleep apnea (OSA) is associated with neuropsychological deficits of memory, learning, and executive function.
  • We hypothesized that childhood OSA is associated with neuropsychological performance dysfunction, and with neuronal metabolite alterations in the brain, indicative of neuronal injury in areas corresponding to neuropsychological function.
  • CONCLUSIONS: Childhood OSA is associated with deficits of IQ and executive function and also with possible neuronal injury in the hippocampus and frontal cortex.
  • We speculate that untreated childhood OSA could permanently alter a developing child's cognitive potential.

  • Genetic Alliance. consumer health - Sleep Apnea.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. (L)-ASPARTIC ACID .
  • Hazardous Substances Data Bank. CHOLINE CHLORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Pediatr Adolesc Med. 2003 Dec;157(12):1206-11 [14662577.001]
  • [Cites] J Int Neuropsychol Soc. 2003 Nov;9(7):1016-26 [14738283.001]
  • [Cites] Pediatrics. 2002 Jul;110(1 Pt 1):68-72 [12093948.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2002 Jul;128(7):770-5 [12117332.001]
  • [Cites] Pediatr Radiol. 2002 Nov;32(11):787-92 [12389106.001]
  • [Cites] Am J Respir Crit Care Med. 2002 Nov 15;166(10):1382-7 [12421746.001]
  • [Cites] J Neuropsychiatry Clin Neurosci. 2002 Fall;14(4):377-405 [12426407.001]
  • [Cites] Child Neuropsychol. 2002 Mar;8(1):52-65 [12610776.001]
  • [Cites] Sleep. 2003 May 1;26(3):298-307 [12749549.001]
  • [Cites] Brain Res Bull. 2003 Jun 30;61(1):87-92 [12788211.001]
  • [Cites] Ment Retard Dev Disabil Res Rev. 2003;9(3):184-95 [12953298.001]
  • [Cites] Pediatrics. 2003 Oct;112(4):870-7 [14523179.001]
  • [Cites] Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1527-32 [10228121.001]
  • [Cites] Eur J Radiol. 1999 May;30(2):142-53 [10401595.001]
  • [Cites] Sleep. 2003 Dec 15;26(8):999-1005 [14746381.001]
  • [Cites] Chest. 2004 Mar;125(3):872-8 [15006944.001]
  • [Cites] Pediatr Pulmonol. 2004 Apr;37(4):330-7 [15022130.001]
  • [Cites] Brain Dev. 2004 Mar;26(2):73-80 [15036425.001]
  • [Cites] J Sleep Res. 2004 Jun;13(2):165-72 [15175097.001]
  • [Cites] Eur J Neurosci. 2004 Jun;19(11):3121-4 [15182321.001]
  • [Cites] Neuroscience. 2004;126(2):313-23 [15207349.001]
  • [Cites] Pediatrics. 2004 Jul;114(1):44-9 [15231906.001]
  • [Cites] Pediatr Res. 1999 Oct;46(4):474-85 [10509371.001]
  • [Cites] J Pediatr. 2004 Oct;145(4):458-64 [15480367.001]
  • [Cites] Curr Opin Pulm Med. 2004 Nov;10(6):461-7 [15510051.001]
  • [Cites] Sleep Med. 2004 Nov;5(6):593-6 [15511707.001]
  • [Cites] Act Nerv Super (Praha). 1969;11(3):2095 [5798781.001]
  • [Cites] Bull Eur Physiopathol Respir. 1981;17(3):341-9 [7248557.001]
  • [Cites] J Pediatr. 1982 Jan;100(1):31-40 [7057314.001]
  • [Cites] Eur J Pediatr. 1982 Nov;139(3):165-71 [7160405.001]
  • [Cites] Lancet. 1990 Feb 3;335(8684):249-53 [1967719.001]
  • [Cites] Radiology. 1990 Aug;176(2):509-15 [2164237.001]
  • [Cites] Crit Rev Neurobiol. 1991;6(3):149-82 [1773451.001]
  • [Cites] J Clin Exp Neuropsychol. 1991 Nov;13(6):950-64 [1779033.001]
  • [Cites] Magn Reson Med. 1991 Nov;22(1):23-31 [1798392.001]
  • [Cites] Clin Chest Med. 1992 Sep;13(3):437-58 [1521412.001]
  • [Cites] Am Rev Respir Dis. 1992 Nov;146(5 Pt 1):1235-9 [1443877.001]
  • [Cites] Lancet. 1993 Mar 6;341(8845):630-1 [8094854.001]
  • [Cites] Arch Dis Child. 1993 Mar;68(3):360-6 [8280201.001]
  • [Cites] AJNR Am J Neuroradiol. 1993 Jul-Aug;14(4):963-70 [8352171.001]
  • [Cites] Brain. 1994 Feb;117 ( Pt 1):49-58 [8149214.001]
  • [Cites] Ann Neurol. 1994 Jul;36(1):40-7 [8024260.001]
  • [Cites] Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 1):1587-91 [7952619.001]
  • [Cites] Sleep. 1995 Jan;18(1):43-52 [7761742.001]
  • [Cites] J Pediatr. 1995 Nov;127(5):741-4 [7472827.001]
  • [Cites] Physiol Behav. 1996 Jan;59(1):93-7 [8848497.001]
  • [Cites] Eur J Pediatr. 1996 Jan;155(1):56-62 [8750813.001]
  • [Cites] Stroke. 1998 Jan;29(1):87-93 [9445334.001]
  • [Cites] Sleep. 1998 Jun 15;21(4):392-7 [9646384.001]
  • [Cites] Pediatrics. 1998 Sep;102(3 Pt 1):616-20 [9738185.001]
  • [Cites] Pediatrics. 1998 Nov;102(5):1178-84 [9794951.001]
  • [Cites] Biochem Soc Symp. 1999;66:123-40 [10989663.001]
  • [Cites] Sleep. 1992 Apr;15(2):173-84 [11032543.001]
  • [Cites] Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1512-7 [11029370.001]
  • [Cites] J Clin Exp Neuropsychol. 2000 Oct;22(5):554-68 [11094391.001]
  • [Cites] Ann Neurol. 2001 Apr;49(4):423-4 [11310618.001]
  • [Cites] Am J Respir Crit Care Med. 2001 Jun;163(7):1626-31 [11401885.001]
  • [Cites] AJNR Am J Neuroradiol. 2001 Jun-Jul;22(6):1125-30 [11415908.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2001 Sep;71(3):334-9 [11511706.001]
  • [Cites] J Pediatr. 2002 Jan;140(1):97-102 [11815771.001]
  • [Cites] J Magn Reson Imaging. 2002 Feb;15(2):137-43 [11836768.001]
  • [Cites] J Clin Exp Neuropsychol. 2002 Feb;24(1):93-100 [11935427.001]
  • [Cites] Behav Sleep Med. 2005;3(1):4-17 [15639754.001]
  • [Cites] Eur Respir J. 2005 Feb;25(2):336-42 [15684300.001]
  • [Cites] J Appl Physiol (1985). 2005 Mar;98(3):958-69 [15531561.001]
  • [Cites] Minerva Pediatr. 2004 Dec;56(6):585-601 [15765021.001]
  • [Cites] J Int Neuropsychol Soc. 2004 Nov;10(7):962-75 [15803560.001]
  • [Cites] Pediatr Pulmonol. 2005 Jul;40(1):22-30 [15858805.001]
  • [Cites] Child Neuropsychol. 2005 Apr;11(2):153-73 [16036442.001]
  • [Cites] Pediatr Res. 2005 Sep;58(3):594-9 [16148079.001]
  • [Cites] J Appl Physiol (1985). 2005 Nov;99(5):1998-2007 [16227461.001]
  • [Cites] Psychol Methods. 2003 Dec;8(4):434-47 [14664681.001]
  • [Cites] J Neurosci. 2003 Oct 22;23(29):9687-95 [14573548.001]
  • [Cites] Sleep Med. 2003 Sep;4(5):451-4 [14592287.001]
  • [Cites] Exp Neurol. 2003 Nov;184 Suppl 1:S37-41 [14597324.001]
  • [Cites] Eur J Neurosci. 2003 Oct;18(8):2335-42 [14622195.001]
  • (PMID = 16933960.001).
  • [ISSN] 1549-1676
  • [Journal-full-title] PLoS medicine
  • [ISO-abbreviation] PLoS Med.
  • [Language] ENG
  • [Grant] United States / NHLBI NIH HHS / HL / HL58585; United States / NHLBI NIH HHS / HL / R01 HL037379; United States / NCRR NIH HHS / RR / P41 RR15241; United States / NCRR NIH HHS / RR / M01-RR00052; United States / NCRR NIH HHS / RR / M01 RR000052; United States / NCRR NIH HHS / RR / P41 RR015241; United States / NHLBI NIH HHS / HL / R01 HL058585; United States / NHLBI NIH HHS / HL / HL 37379-19; United States / NHLBI NIH HHS / HL / R56 HL058585
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 30KYC7MIAI / Aspartic Acid; N91BDP6H0X / Choline
  • [Other-IDs] NLM/ PMC1551912
  •  go-up   go-down


20. Sadleir LG, Scheffer IE, Smith S, Carstensen B, Farrell K, Connolly MB: EEG features of absence seizures in idiopathic generalized epilepsy: impact of syndrome, age, and state. Epilepsia; 2009 Jun;50(6):1572-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Children with untreated absence seizures were studied using video-EEG recording.
  • RESULTS: Five hundred nine seizures were evaluated in 70 children with the following syndromes: childhood absence epilepsy (CAE) 37, CAE+ photoparoxysmal response (PPR) 10, juvenile absence epilepsy (JAE) 8, juvenile myoclonic epilepsy (JME) 6, and unclassified 9.


21. Ferrand RA, Bandason T, Musvaire P, Larke N, Nathoo K, Mujuru H, Ndhlovu CE, Munyati S, Cowan FM, Gibb DM, Corbett EL: Causes of acute hospitalization in adolescence: burden and spectrum of HIV-related morbidity in a country with an early-onset and severe HIV epidemic: a prospective survey. PLoS Med; 2010 Feb 02;7(2):e1000178
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Causes of acute hospitalization in adolescence: burden and spectrum of HIV-related morbidity in a country with an early-onset and severe HIV epidemic: a prospective survey.
  • BACKGROUND: Survival to older childhood with untreated, vertically acquired HIV infection, which was previously considered extremely unusual, is increasingly well described.
  • METHODS AND FINDINGS: Adolescents (aged 10-18 y) systematically recruited from acute admissions to the two public hospitals in Harare, Zimbabwe, answered a questionnaire and underwent standard investigations including HIV testing, with consent.

  • Genetic Alliance. consumer health - HIV.
  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • MedlinePlus Health Information. consumer health - HIV/AIDS and Infections.
  • MedlinePlus Health Information. consumer health - HIV/AIDS in Women.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Microbiol. 2000 Aug;38(8):2994-7 [10921966.001]
  • [Cites] Bull World Health Organ. 2010 Jun;88(6):428-34 [20539856.001]
  • [Cites] Arch Pediatr. 2000 Jul;7(7):732-7 [10941488.001]
  • [Cites] J Acquir Immune Defic Syndr. 2000 Oct 1;25 Suppl 1:S37-42 [11126424.001]
  • [Cites] Trop Med Int Health. 2001 Jul;6(7):517-25 [11469944.001]
  • [Cites] J Acquir Immune Defic Syndr. 2001 Sep 1;28(1):35-42 [11579275.001]
  • [Cites] AIDS. 2001 Aug;15 Suppl 4:S97-108 [11686471.001]
  • [Cites] Clin Infect Dis. 2002 May 1;34(9):1251-8 [11941552.001]
  • [Cites] Lancet. 2002 Jun 1;359(9321):1896-903 [12057552.001]
  • [Cites] J Acquir Immune Defic Syndr. 2003 May 1;33(1):56-65 [12792356.001]
  • [Cites] Lancet. 2003 Dec 20;362(9401):2045-51 [14697803.001]
  • [Cites] AIDS. 2004 Sep 24;18(14):1915-24 [15353977.001]
  • [Cites] Lancet. 2004 Oct 2-8;364(9441):1236-43 [15464184.001]
  • [Cites] S Afr Med J. 1988 Mar 19;73(6):337-9 [3353804.001]
  • [Cites] Int J Epidemiol. 1992 Oct;21(5):981-8 [1468863.001]
  • [Cites] Am J Public Health. 1996 Apr;86(4):513-9 [8604781.001]
  • [Cites] Arch Dis Child. 1997 Jan;76(1):47-9 [9059161.001]
  • [Cites] Int J Epidemiol. 1997 Feb;26(1):224-7 [9126524.001]
  • [Cites] AIDS. 1997 Sep;11(11):1357-64 [9302446.001]
  • [Cites] AIDS. 1998 Jul 9;12(10):1185-93 [9677168.001]
  • [Cites] Int J Tuberc Lung Dis. 1998 Nov;2(11):926-34 [9848615.001]
  • [Cites] S Afr Med J. 1999 Jun;89(6):646-8 [10443216.001]
  • [Cites] J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):219-27 [15671809.001]
  • [Cites] PLoS Med. 2005 Feb;2(2):e37 [15736994.001]
  • [Cites] J Trop Pediatr. 2005 Oct;51(5):300-3 [15980027.001]
  • [Cites] J Infect Dis. 2006 Apr 1;193(7):954-62 [16518757.001]
  • [Cites] Sex Transm Infect. 2006 Jun;82 Suppl 3:iii45-50 [16735293.001]
  • [Cites] J Acquir Immune Defic Syndr. 2006 Aug 15;42(5):637-45 [16868501.001]
  • [Cites] AIDS Behav. 2006 Jul;10(4 Suppl):S85-93 [16791525.001]
  • [Cites] Clin Infect Dis. 2007 Mar 15;44(6):874-8 [17304463.001]
  • [Cites] J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):384-92 [18931630.001]
  • [Cites] AIDS. 2009 Sep 24;23(15):2039-46 [19684508.001]
  • [CommentIn] PLoS Med. 2010 Feb;7(2):e1000227 [20161804.001]
  • (PMID = 20126383.001).
  • [ISSN] 1549-1676
  • [Journal-full-title] PLoS medicine
  • [ISO-abbreviation] PLoS Med.
  • [Language] eng
  • [Grant] United Kingdom / Wellcome Trust / / ; United Kingdom / Medical Research Council / / G0700837; United Kingdom / Medical Research Council / / MC/ U122886353
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2814826
  •  go-up   go-down


22. Paclt I, Koudelová J, Pacltova D, Kopeckova M: Dopamine beta hydroxylase (DBH) plasma activity in childhood mental disorders. Neuro Endocrinol Lett; 2009;30(5):604-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dopamine beta hydroxylase (DBH) plasma activity in childhood mental disorders.
  • OBJECTIVES: The main aim of the present study was to measure DBH activity at the onset of acute schizophrenia and depressive disorder in children and adolescents without pharmacological treatment and to compare these values with DBH activity in healthy controls.
  • The authors also investigated untreated ADHD children.
  • METHODS: We examined 42 control healthy children, 15 children non-treated with acute schizophrenia, 15 non-treated children with acute depressive disorders and 30 non-treated ADHD children, all in age 7-14.

  • MedlinePlus Health Information. consumer health - Child Mental Health.
  • MedlinePlus Health Information. consumer health - Mental Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20035263.001).
  • [ISSN] 0172-780X
  • [Journal-full-title] Neuro endocrinology letters
  • [ISO-abbreviation] Neuro Endocrinol. Lett.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Sweden
  • [Chemical-registry-number] 0 / Biomarkers; EC 1.14.17.1 / Dopamine beta-Hydroxylase
  •  go-up   go-down


23. Lan ZJ, Tang YM, Shen HQ, Qian BQ, Ning BT, Chen YH: [Evaluation of the P-gp pump function on leukemic cell membrane and proper application of its reversal agents with Calcein-AM and flow cytometry]. Zhonghua Er Ke Za Zhi; 2007 May;45(5):334-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: Leukemia is the most common malignancy in children.
  • During the past decade, very high cure rates of childhood acute lymphoblastic leukemia (ALL) have been reported both at home and abroad.
  • However, the cure rates of children with acute myeloid leukemia (AML) remain low due to the multiple-drug resistance (MDR).
  • P-glycoprotein (P-gp) is one of the most important mechanisms of MDR for leukemia cells.
  • The present study aimed to evaluate the P-gp pump function on leukemia cell membrane and the effects of the combined administration of the reversal agents cyclosporin A (CSA) and verapamil (VER) through the observation of Calcein-AM (C-AM) metabolism in the cell line K562 and its multi-drug resistant subline K562/VCR.
  • The events of K562 and K562/VCR cells treated and untreated with CSA, VER and CSA + VER were acquired at time points 0, 30, 60, 90 and 120 minutes, respectively, and the data obtained were analyzed with CellQuest software.

  • Hazardous Substances Data Bank. VERAPAMIL HYDROCHLORIDE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17697617.001).
  • [ISSN] 0578-1310
  • [Journal-full-title] Zhonghua er ke za zhi = Chinese journal of pediatrics
  • [ISO-abbreviation] Zhonghua Er Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Fluoresceins; 0 / P-Glycoprotein; 148504-34-1 / calcein AM; 5J49Q6B70F / Vincristine; CJ0O37KU29 / Verapamil; V0YM2B16TS / fluorexon
  •  go-up   go-down


24. Sadleir LG, Farrell K, Smith S, Connolly MB, Scheffer IE: Electroclinical features of absence seizures in childhood absence epilepsy. Neurology; 2006 Aug 8;67(3):413-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Electroclinical features of absence seizures in childhood absence epilepsy.
  • OBJECTIVE: To accurately define the electroclinical features of absence seizures in children with newly diagnosed, untreated childhood absence epilepsy (CAE).
  • METHODS: The authors searched an EEG database for absence seizures in normal children with new onset untreated absence epilepsy.
  • CONCLUSION: The heterogeneous nature of each clinical and EEG feature of untreated absence seizures is of critical importance when determining criteria for childhood absence epilepsy.


25. Chen F, Wang D: Novel technologies for the prevention and treatment of dental caries: a patent survey. Expert Opin Ther Pat; 2010 May;20(5):681-94
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • IMPORTANCE OF THE FIELD: Dental caries is one of the most common preventable childhood diseases; people are susceptible to this ailment throughout their lifetime.
  • In the US, 90% of late adolescents and young adults have dental caries, while 94% of all dentate adults had evidence of treated or untreated coronal caries.

  • MedlinePlus Health Information. consumer health - Tooth Decay.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Odontol Scand. 1977;35(5):257-63 [21508.001]
  • [Cites] Arch Oral Biol. 1978;23(6):445-51 [30434.001]
  • [Cites] Pediatr Dent. 2006 Mar-Apr;28(2):154-63; discussion 192-8 [16708791.001]
  • [Cites] Cell Mol Life Sci. 2006 Jun;63(11):1294-313 [16710608.001]
  • [Cites] Nat Rev Immunol. 2006 Jul;6(7):555-63 [16729013.001]
  • [Cites] Int Dent J. 2006 Jun;56(3):119-30 [16826877.001]
  • [Cites] J Dent Res. 2006 Aug;85(8):722-7 [16861289.001]
  • [Cites] Acta Odontol Scand. 2006 Oct;64(5):314-8 [16945898.001]
  • [Cites] Curr Opin Pharmacol. 2006 Oct;6(5):468-72 [16890021.001]
  • [Cites] J Oral Sci. 2006 Sep;48(3):117-23 [17023743.001]
  • [Cites] Antimicrob Agents Chemother. 2006 Nov;50(11):3651-7 [17060534.001]
  • [Cites] Eur Arch Paediatr Dent. 2006 Dec;7(4):258-61 [17164072.001]
  • [Cites] Lancet. 2007 Jan 6;369(9555):51-9 [17208642.001]
  • [Cites] J Agric Food Chem. 2007 Jan 24;55(2):278-84 [17227054.001]
  • [Cites] Mol Microbiol. 2007 Feb;63(3):872-80 [17302806.001]
  • [Cites] J Dent Res. 2007 Apr;86(4):378-83 [17384036.001]
  • [Cites] J Ethnopharmacol. 2007 May 4;111(2):413-7 [17234374.001]
  • [Cites] Curr Pharm Des. 2007;13(8):793-800 [17430181.001]
  • [Cites] Am J Chin Med. 2007;35(3):497-505 [17597508.001]
  • [Cites] Antimicrob Agents Chemother. 2007 Nov;51(11):4125-32 [17785509.001]
  • [Cites] Med Sci Monit. 2007 Nov;13(11):RA196-203 [17968308.001]
  • [Cites] Caries Res. 2008;42(2):148-54 [18367836.001]
  • [Cites] J Am Dent Assoc. 2008 May;139(5):553-63 [18451371.001]
  • [Cites] J Am Dent Assoc. 2008 May;139 Suppl:25S-34S [18460677.001]
  • [Cites] Caries Res. 2008;42(3):171-84 [18446025.001]
  • [Cites] Biomaterials. 2008 Nov;29(32):4261-7 [18708252.001]
  • [Cites] Aust Dent J. 2008 Sep;53(3):286-91 [18782377.001]
  • [Cites] J Am Dent Assoc. 2008 Dec;139(12):1602-14 [19047666.001]
  • [Cites] Int J Antimicrob Agents. 2009 Jan;33(1):8-13 [18804350.001]
  • [Cites] J Appl Oral Sci. 2008 Jul-Aug;16(4):238-46 [19089254.001]
  • [Cites] J Clin Dent. 2008;19(3):81-4 [19301513.001]
  • [Cites] J Clin Dent. 2008;19(3):106-10 [19301517.001]
  • [Cites] Indian J Dent Res. 2009 Jan-Mar;20(1):99-106 [19336869.001]
  • [Cites] J Dent. 2009 Jun;37(6):413-23 [19303186.001]
  • [Cites] J Clin Dent. 2009;20(2):62-5 [19591339.001]
  • [Cites] Adv Dent Res. 2009;21(1):53-6 [19710082.001]
  • [Cites] Adv Dent Res. 2009;21(1):4-7 [19717404.001]
  • [Cites] Antimicrob Agents Chemother. 2009 Nov;53(11):4898-902 [19704121.001]
  • [Cites] J Dent Res. 2009 Dec;88(12):1148-53 [19887683.001]
  • [Cites] Chem Biol Drug Des. 2010 Jan;75(1):127-32 [19878192.001]
  • [Cites] Caries Res. 2009;43(6):430-5 [19864905.001]
  • [Cites] Acta Odontol Scand. 2009;67(6):321-32 [19701818.001]
  • [Cites] Oral Health Prev Dent. 2007;5(3):229-33 [17977295.001]
  • [Cites] Antonie Van Leeuwenhoek. 2002 Aug;82(1-4):361-6 [12369203.001]
  • [Cites] J Calif Dent Assoc. 2003 Mar;31(3):211-4 [12693819.001]
  • [Cites] Int J Pharm. 2003 Aug 11;261(1-2):153-8 [12878404.001]
  • [Cites] Oral Microbiol Immunol. 2004 Feb;19(1):61-4 [14678476.001]
  • [Cites] Acta Odontol Scand. 2003 Dec;61(6):331-40 [14960004.001]
  • [Cites] Acta Odontol Scand. 2003 Dec;61(6):367-70 [14960009.001]
  • [Cites] J Biol Chem. 2004 Feb 27;279(9):7856-66 [14660678.001]
  • [Cites] J Dent Res. 2004;83 Spec No C:C35-8 [15286119.001]
  • [Cites] J Dent Res. 2004;83 Spec No C:C39-42 [15286120.001]
  • [Cites] J Immunol. 2004 Sep 1;173(5):2909-12 [15322146.001]
  • [Cites] Eur J Oral Sci. 2005 Jun;113(3):188-96 [15953242.001]
  • [Cites] J Ind Microbiol Biotechnol. 2005 Jul;32(7):296-300 [15959729.001]
  • [Cites] Acta Odontol Scand. 2005 Jun;63(3):136-42 [16191906.001]
  • [Cites] Caries Res. 2006;40(1):20-7 [16352876.001]
  • [Cites] J Dent Res. 2006 Feb;85(2):177-81 [16434738.001]
  • [Cites] Caries Res. 2006;40(2):163-71 [16508276.001]
  • [Cites] Acta Odontol Scand. 2005 Nov;63(6):317-20 [16512103.001]
  • [Cites] Caries Res. 2006;40(3):265-70 [16707877.001]
  • [Cites] Arch Oral Biol. 1968 Jan;13(1):13-26 [5237553.001]
  • [Cites] Caries Res. 1967;1(3):222-38 [4384379.001]
  • [Cites] J Dent Res. 2001 Jan;80(1):363-70 [11269730.001]
  • [Cites] J Med Microbiol. 2001 Apr;50(4):299-302 [11289514.001]
  • [Cites] Infect Immun. 2001 Jul;69(7):4210-6 [11401956.001]
  • [Cites] Caries Res. 2001 Nov-Dec;35(6):412-20 [11799281.001]
  • [Cites] Nature. 2002 Jan 24;415(6870):389-95 [11807545.001]
  • [Cites] Biosci Biotechnol Biochem. 2002 Apr;66(4):921-4 [12036078.001]
  • [Cites] Caries Res. 2002 Mar-Apr;36(2):93-100 [12037365.001]
  • [Cites] J West Soc Periodontol Periodontal Abstr. 2002;50(1):5-9 [12049062.001]
  • [Cites] J Clin Periodontol. 2002 May;29(5):411-20 [12060423.001]
  • [Cites] Infect Immun. 2000 Feb;68(2):543-9 [10639415.001]
  • [Cites] J Dent Res. 2000 Mar;79(3):882-7 [10765964.001]
  • [Cites] J Am Dent Assoc. 2000 Jul;131(7):887-99 [10916327.001]
  • [Cites] Aust Dent J. 2000 Dec;45(4):235-45 [11225524.001]
  • [Cites] Basic Life Sci. 1982;19:371-81 [7066010.001]
  • [Cites] Helv Odontol Acta. 1966 Oct;10(2):94-101 [5957240.001]
  • [Cites] J Dent Res. 1983 Aug;62(8):882-4 [6575035.001]
  • [Cites] Scand J Dent Res. 1983 Aug;91(4):256-9 [6579603.001]
  • [Cites] J Bacteriol. 1984 Oct;160(1):211-5 [6090413.001]
  • [Cites] Swed Dent J. 1984;8(3):147-54 [6592773.001]
  • [Cites] Caries Res. 1985;19(1):53-63 [3856485.001]
  • [Cites] Br Med J (Clin Res Ed). 1985 Nov 9;291(6505):1297-8 [3933640.001]
  • [Cites] Acta Pathol Microbiol Immunol Scand B. 1986 Apr;94(2):97-102 [3728029.001]
  • [Cites] Br J Clin Pharmacol. 1987 May;23(5):579-83 [3593627.001]
  • [Cites] J Dent Res. 1987 Jun;66(6):1120-7 [3476583.001]
  • [Cites] J Am Dent Assoc. 1988 Aug;117(2):315-20 [3166474.001]
  • [Cites] J Dent Res. 1990 Feb;69 Spec No:620-5; discussion 634-6 [2312892.001]
  • [Cites] Am J Dent. 1989 Sep;2 Spec No:197-206 [2561629.001]
  • [Cites] Infect Immun. 1990 Oct;58(10):3407-14 [2401569.001]
  • [Cites] J Can Dent Assoc. 1990;56(7 Suppl):13-30 [2207850.001]
  • [Cites] J Dent Res. 1990 Nov;69(11):1771-5 [2229617.001]
  • [Cites] J Periodontol. 1990 Nov;61(11):674-9 [2254833.001]
  • [Cites] J Immunol. 1991 Jan 1;146(1):332-6 [1984447.001]
  • [Cites] Am J Dent. 1990 Sep;3 Spec No:S7-14 [2083048.001]
  • [Cites] Dis Colon Rectum. 1991 Jun;34(6):464-8 [2036926.001]
  • [Cites] Crit Rev Oral Biol Med. 1991;2(3):283-96 [1892991.001]
  • [Cites] J Dent Res. 1992 Apr;71 Spec No:804-10 [1592963.001]
  • [Cites] Infect Immun. 1992 Dec;60(12):5057-64 [1333448.001]
  • [Cites] J Dent Res. 1993 Feb;72(2):529-37 [8423251.001]
  • [Cites] J Clin Periodontol. 1993 Feb;20(2):130-8 [8436632.001]
  • [Cites] Int Dent J. 1993 Aug;43(4 Suppl 1):399-406 [8282422.001]
  • [Cites] Int Dent J. 1993 Aug;43(4 Suppl 1):441-52 [8282427.001]
  • [Cites] Caries Res. 1994;28(1):48-54 [8124697.001]
  • [Cites] Int Dent J. 1993 Dec;43(6 Suppl 1):529-39 [8138324.001]
  • [Cites] Science. 1994 Apr 15;264(5157):375-82 [8153624.001]
  • [Cites] J Dent Res. 1994 Mar;73(3):682-91 [8163738.001]
  • [Cites] Int Dent J. 1994 Feb;44(1 Suppl 1):63-70 [8021038.001]
  • [Cites] Infection. 1994 Jul-Aug;22(4):233-7 [8002081.001]
  • [Cites] Infect Immun. 1995 Aug;63(8):3088-93 [7622235.001]
  • [Cites] J Ind Microbiol. 1995 Sep;15(3):169-75 [8519474.001]
  • [Cites] Infect Immun. 1996 Aug;64(8):3069-73 [8757835.001]
  • [Cites] J Clin Periodontol. 1996 May;23(5):444-51 [8783049.001]
  • [Cites] Eur J Oral Sci. 1997 Oct;105(5 Pt 2):502-7 [9395116.001]
  • [Cites] Pediatr Dent. 1998 Jan-Feb;20(1):17-24 [9524968.001]
  • [Cites] Infect Immun. 1998 Apr;66(4):1740-3 [9529105.001]
  • [Cites] Community Dent Oral Epidemiol. 1998;26(1 Suppl):8-27 [9671196.001]
  • [Cites] Spec Care Dentist. 1998 Jan-Feb;18(1):8-16 [9791302.001]
  • [Cites] Caries Res. 1999;33(1):4-15 [9831775.001]
  • [Cites] Community Dent Oral Epidemiol. 1999 Feb;27(1):31-40 [10086924.001]
  • [Cites] Acta Odontol Scand. 1954 Sep;11(3-4):232-64 [13196991.001]
  • [Cites] Community Dent Oral Epidemiol. 2004 Dec;32(6):462-9 [15541162.001]
  • [Cites] Oral Health Prev Dent. 2003;1(1):53-7 [15643749.001]
  • [Cites] Nat Rev Microbiol. 2005 Mar;3(3):238-50 [15703760.001]
  • [Cites] Caries Res. 2005 May-Jun;39(3):195-200 [15914981.001]
  • [Cites] J Dent Res. 1974 Jan-Feb;53(1):115-20 [4520429.001]
  • (PMID = 20230309.001).
  • [ISSN] 1744-7674
  • [Journal-full-title] Expert opinion on therapeutic patents
  • [ISO-abbreviation] Expert Opin Ther Pat
  • [Language] ENG
  • [Grant] United States / NIAMS NIH HHS / AR / R01 AR053325; United States / NIAMS NIH HHS / AR / R01 AR053325-03; United States / NIAMS NIH HHS / AR / AR053325
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Number-of-references] 174
  • [Other-IDs] NLM/ NIHMS181703; NLM/ PMC2857592
  •  go-up   go-down


26. Yong MH, Hwang WS, Knight LA, Fung W, Chan MY, Seow WT, Chui CH: Comparing histopathological classification with MYCN, 1p36 and 17q status detected by fluorescence in situ hybridisation from 14 untreated primary neuroblastomas in Singapore. Singapore Med J; 2009 Nov;50(11):1090-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparing histopathological classification with MYCN, 1p36 and 17q status detected by fluorescence in situ hybridisation from 14 untreated primary neuroblastomas in Singapore.
  • INTRODUCTION: Neuroblastoma is the most common extracranial solid tumour in children, accounting for about 5.3 percent of all childhood cancers in Singapore.
  • METHODS: 14 untreated primary neuroblastoma tumours, diagnosed consecutively in our hospital between 2003 and 2007, were included for this study.

  • MedlinePlus Health Information. consumer health - Neuroblastoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19960166.001).
  • [ISSN] 0037-5675
  • [Journal-full-title] Singapore medical journal
  • [ISO-abbreviation] Singapore Med J
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Singapore
  •  go-up   go-down


27. Cruz AT, Ong LT, Starke JR: Childhood pleural tuberculosis: a review of 45 cases. Pediatr Infect Dis J; 2009 Nov;28(11):981-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Childhood pleural tuberculosis: a review of 45 cases.
  • BACKGROUND: Pleural tuberculosis (TB) can be seen in isolation or complicate untreated pulmonary disease in children.

  • Genetic Alliance. consumer health - Tuberculosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19672211.001).
  • [ISSN] 1532-0987
  • [Journal-full-title] The Pediatric infectious disease journal
  • [ISO-abbreviation] Pediatr. Infect. Dis. J.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antitubercular Agents
  •  go-up   go-down


28. Stark Z, Savarirayan R: Osteopetrosis. Orphanet J Rare Dis; 2009;4:5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The presence of primary neurodegeneration, mental retardation, skin and immune system involvement, or renal tubular acidosis may point to rarer osteopetrosis variants, whereas onset of primarily skeletal manifestations such as fractures and osteomyelitis in late childhood or adolescence is typical of ADO.
  • The severe infantile forms of osteopetrosis are associated with diminished life expectancy, with most untreated children dying in the first decade as a complication of bone marrow suppression.

  • Genetics Home Reference. consumer health - osteopetrosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurosurg Pediatr. 2008 Jan;1(1):103-6 [18352814.001]
  • [Cites] Am J Hum Genet. 2008 Jul;83(1):64-76 [18606301.001]
  • [Cites] Blood. 2008 Sep 15;112(6):2591 [18779414.001]
  • [Cites] Nat Genet. 2009 Jan;41(1):95-100 [19079258.001]
  • [Cites] Calcif Tissue Int. 2009 Jan;84(1):1-12 [19082854.001]
  • [Cites] J Clin Immunol. 2009 Jan;29(1):117-22 [18709451.001]
  • [Cites] Nat Genet. 1999 Dec;23(4):447-51 [10581033.001]
  • [Cites] Bone. 2000 Jan;26(1):87-93 [10617161.001]
  • [Cites] Endocr Rev. 2000 Apr;21(2):115-37 [10782361.001]
  • [Cites] Nat Genet. 2000 Jul;25(3):343-6 [10888887.001]
  • [Cites] Neuropathol Appl Neurobiol. 2003 Apr;29(2):87-97 [12662317.001]
  • [Cites] Clin Imaging. 2003 May-Jun;27(3):203-5 [12727061.001]
  • [Cites] Am J Med Genet A. 2003 Jun 1;119A(2):188-93 [12749062.001]
  • [Cites] Am J Orthop (Belle Mead NJ). 2003 May;32(5):222-8 [12772872.001]
  • [Cites] Bone Marrow Transplant. 2003 Oct;32(7):657-63 [13130312.001]
  • [Cites] Br J Haematol. 2004 Jan;124(1):63-71 [14675409.001]
  • [Cites] J Bone Miner Res. 2004 Feb;19(2):183-9 [14969387.001]
  • [Cites] Clin Chem. 2004 May;50(5):883-90 [15016726.001]
  • [Cites] Hum Mutat. 2004 May;23(5):471-6 [15108279.001]
  • [Cites] Nat Genet. 2004 Nov;36(11):1213-8 [15489854.001]
  • [Cites] Fortschr Geb Rontgenstr Nuklearmed. 1968 Oct;109(4):504-12 [5750745.001]
  • [Cites] J Clin Endocrinol Metab. 1973 Jul;37(1):46-55 [4715295.001]
  • [Cites] J Pediatr. 1977 Jul;91(1):43-7 [874663.001]
  • [Cites] Clin Orthop Relat Res. 1982 Jan-Feb;(162):2-3 [7039911.001]
  • [Cites] Proc Natl Acad Sci U S A. 1983 May;80(9):2752-6 [6405388.001]
  • [Cites] N Engl J Med. 1984 Feb 16;310(7):409-15 [6546410.001]
  • [Cites] Bone. 1988;9(1):7-13 [3377922.001]
  • [Cites] Br Dent J. 1988 Apr 9;164(7):218-20 [3288260.001]
  • [Cites] Nature. 1990 May 31;345(6274):442-4 [2188141.001]
  • [Cites] Hum Mol Genet. 2000 Aug 12;9(13):2059-63 [10942435.001]
  • [Cites] Pediatr Neurosurg. 2000 Dec;33(6):328-32 [11182645.001]
  • [Cites] Cell. 2001 Jan 26;104(2):205-15 [11207362.001]
  • [Cites] Nat Genet. 2001 Mar;27(3):277-85 [11242109.001]
  • [Cites] Metabolism. 2001 Aug;50(8):905-11 [11474477.001]
  • [Cites] Hum Mol Genet. 2001 Aug 15;10(17):1767-73 [11532986.001]
  • [Cites] Mamm Genome. 2001 Dec;12(12):887-92 [11707774.001]
  • [Cites] Hum Mol Genet. 2001 Dec 1;10(25):2861-7 [11741829.001]
  • [Cites] J Clin Endocrinol Metab. 2002 May;87(5):2212-7 [11994366.001]
  • [Cites] J Med Genet. 2002 Aug;39(8):603-7 [12161605.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1991 Oct;72(4):449-55 [1923445.001]
  • [Cites] Clin Orthop Relat Res. 1992 Jul;(280):263-76 [1611757.001]
  • [Cites] J Pediatr. 1992 Jul;121(1):119-24 [1320672.001]
  • [Cites] Clin Orthop Relat Res. 1993 Sep;(294):52-63 [8358947.001]
  • [Cites] N Engl J Med. 1995 Jun 15;332(24):1594-9 [7753137.001]
  • [Cites] Prenat Diagn. 1995 May;15(5):477-81 [7644439.001]
  • [Cites] J Biol Chem. 1996 May 24;271(21):12517-24 [8647860.001]
  • [Cites] Science. 1996 Aug 30;273(5279):1236-8 [8703060.001]
  • [Cites] Genome Res. 1996 Nov;6(11):1050-5 [8938428.001]
  • [Cites] J Bone Miner Res. 1997 Sep;12(9):1396-406 [9286755.001]
  • [Cites] Am J Med Genet. 1997 Oct 3;72(1):43-6 [9295073.001]
  • [Cites] Clin Genet. 1997 Oct;52(4):199-205 [9383023.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13453-8 [9811821.001]
  • [Cites] Neuroradiology. 1998 Oct;40(10):662-3 [9833897.001]
  • [Cites] Am J Med Genet. 1999 Feb 19;82(5):409-14 [10069713.001]
  • [Cites] J Bone Miner Res. 1999 Oct;14(10):1654-63 [10491212.001]
  • [Cites] JAMA. 1965 Mar 1;191:715-7 [14245511.001]
  • [Cites] Presse Med. 1962 Apr 25;70:999-1002 [14470123.001]
  • [Cites] EMBO J. 2005 Mar 9;24(5):1079-91 [15706348.001]
  • [Cites] Otol Neurotol. 2005 Jul;26(4):762-6 [16015181.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14629-34 [16195375.001]
  • [Cites] Hum Mutat. 2006 Mar;27(3):290 [16470551.001]
  • [Cites] Nature. 2006 Mar 9;440(7081):220-3 [16525474.001]
  • [Cites] J Med Genet. 2006 Apr;43(4):315-25 [16118345.001]
  • [Cites] Ann N Y Acad Sci. 2006 Apr;1068:165-72 [16831915.001]
  • [Cites] J Bone Miner Res. 2006 Sep;21(9):1399-408 [16939398.001]
  • [Cites] Am J Med Genet A. 2007 Jan 1;143A(1):1-18 [17120245.001]
  • [Cites] J Clin Invest. 2007 Apr;117(4):919-30 [17404618.001]
  • [Cites] Nat Genet. 2007 Jul;39(7):836-8 [17546030.001]
  • [Cites] Nat Genet. 2007 Jul;39(7):833-5 [17546031.001]
  • [Cites] Nat Genet. 2007 Aug;39(8):960-2 [17632511.001]
  • [Cites] Ultrastruct Pathol. 2007 Sep-Oct;31(5):333-8 [17963182.001]
  • [Cites] J Am Acad Orthop Surg. 2007 Nov;15(11):654-62 [17989416.001]
  • [Cites] Bone. 2008 Jan;42(1):19-29 [17936098.001]
  • [Cites] J Bone Miner Res. 2008 Feb;23(2):296-300 [17922613.001]
  • (PMID = 19232111.001).
  • [ISSN] 1750-1172
  • [Journal-full-title] Orphanet journal of rare diseases
  • [ISO-abbreviation] Orphanet J Rare Dis
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 77
  • [Other-IDs] NLM/ PMC2654865
  •  go-up   go-down


29. Uong EC, Jeffe DB, Gozal D, Arens R, Holbrook CR, Palmer J, Cleveland C, Schotland HM: Development of a measure of knowledge and attitudes about obstructive sleep apnea in children (OSAKA-KIDS). Arch Pediatr Adolesc Med; 2005 Feb;159(2):181-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Primary care physicians play an important role in screening for childhood obstructive sleep apnea syndrome (OSAS) that, if untreated, can result in serious complications.
  • OBJECTIVE: To describe the development of the Obstructive Sleep Apnea Knowledge and Attitudes in Children (OSAKA-KIDS) questionnaire for use in measuring physicians' knowledge and attitudes about childhood OSAS and its treatment.
  • CONCLUSIONS: Deficits in basic knowledge about childhood OSAS were observed regardless of physician practice setting and specialty training.
  • More education focusing on the diagnosis and treatment of childhood OSAS and identifying children at risk for OSAS is recommended.

  • Genetic Alliance. consumer health - Sleep Apnea.
  • MedlinePlus Health Information. consumer health - Children's Health.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15699313.001).
  • [ISSN] 1072-4710
  • [Journal-full-title] Archives of pediatrics & adolescent medicine
  • [ISO-abbreviation] Arch Pediatr Adolesc Med
  • [Language] eng
  • [Grant] United States / NHLBI NIH HHS / HL / HL-65270; United States / AHRQ HHS / HS / HS13145
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


30. Horo I, Rao PS, Nanda NK, Abraham S: Childhood leprosy: profiles from a leprosy referral hospital in West Bengal, India. Indian J Lepr; 2010 Jan-Mar;82(1):33-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Childhood leprosy: profiles from a leprosy referral hospital in West Bengal, India.
  • Monitoring childhood leprosy in terms of incidence and occurrence of deformities are crucial for better control and understanding the transmission of the disease.
  • In this paper, a profile of all new untreated leprosy patients below 15 years of age who reported at a Leprosy Referral Centre in West Bengal during 2004-2006 are described.

  • MedlinePlus Health Information. consumer health - Mycobacterial Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21229845.001).
  • [ISSN] 0254-9395
  • [Journal-full-title] Indian journal of leprosy
  • [ISO-abbreviation] Indian J Lepr
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  •  go-up   go-down


31. Restuccia D, Valeriani M, Della Marca G: Giant subcortical high-frequency SEPs in idiopathic generalized epilepsy: a protective mechanism against seizures? Clin Neurophysiol; 2007 Jan;118(1):60-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here, we aimed at verifying whether similar HF-SEP abnormalities were significantly correlated to the clinical outcome in a larger population of untreated IGE patients.
  • METHODS: Patients were classified as Juvenile Myoclonic epilepsy (JME; six patients) and Childhood or Juvenile Absence epilepsy (CAE and JAE, six patients).
  • They were untreated because newly diagnosed, or because seizure-free.


32. Zheng XQ, Li CC, Xu DP, Lin A, Bao WG, Yang GS, Yan WH: Analysis of the plasma soluble human leukocyte antigen-G and interleukin-10 levels in childhood atopic asthma. Hum Immunol; 2010 Oct;71(10):982-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Analysis of the plasma soluble human leukocyte antigen-G and interleukin-10 levels in childhood atopic asthma.
  • In this study, the 14-bp polymorphism in exon 8 of the HLA-G gene, plasma soluble HLA-G, and interleukin-10 (IL-10) levels in untreated atopic asthmatic children, and in a group of age-, gender-, and ethnicity-matched normal controls were analyzed.

  • Genetic Alliance. consumer health - Asthma.
  • MedlinePlus Health Information. consumer health - Asthma.
  • MedlinePlus Health Information. consumer health - Asthma in Children.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2010 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
  • (PMID = 20600443.001).
  • [ISSN] 1879-1166
  • [Journal-full-title] Human immunology
  • [ISO-abbreviation] Hum. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers; 0 / HLA Antigens; 0 / HLA-G Antigens; 0 / Histocompatibility Antigens Class I; 130068-27-8 / Interleukin-10
  •  go-up   go-down


33. Pansy J, Minkov M, Dengg R, Quehenberger F, Lackner H, Nebl A, Sovinz P, Schwinger W, Urban C, Benesch M: Evaluating bleeding severity in children with newly diagnosed immune thrombocytopenia: a pilot study. Klin Padiatr; 2010 Nov;222(6):374-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Childhood immune thrombocytopenia (ITP) is a bleeding disorder characterized by decreased platelet counts.
  • RESULTS: Median platelet counts at the 3 different time points were 13, 19, 32×10 (9)/L (untreated patients) and 2, 7, 37×10 (9)/L (treated patients).
  • Corresponding median cumulative bleeding scores were 5, 2, 0 (untreated patients) and 7, 6, 2 (treated patients).
  • Cumulative median bleeding scores and platelet counts were inversely correlated in treated and untreated patients at all 3 time points.

  • Genetic Alliance. consumer health - Immune thrombocytopenia.
  • MedlinePlus Health Information. consumer health - Bleeding.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © Georg Thieme Verlag KG Stuttgart · New York.
  • (PMID = 21058224.001).
  • [ISSN] 1439-3824
  • [Journal-full-title] Klinische Pädiatrie
  • [ISO-abbreviation] Klin Padiatr
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Adrenal Cortex Hormones
  •  go-up   go-down


34. Modesto-Lowe V, Danforth JS, Brooks D: ADHD: does parenting style matter? Clin Pediatr (Phila); 2008 Nov;47(9):865-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Attention deficit hyperactivity disorder (ADHD) is a condition typically arising in childhood, which untreated, can have consequences reaching into adolescence and beyond.

  • MedlinePlus Health Information. consumer health - Attention Deficit Hyperactivity Disorder.
  • MedlinePlus Health Information. consumer health - Parenting.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18559885.001).
  • [ISSN] 0009-9228
  • [Journal-full-title] Clinical pediatrics
  • [ISO-abbreviation] Clin Pediatr (Phila)
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 56
  •  go-up   go-down


35. Magiakou MA, Manousaki D, Papadaki M, Hadjidakis D, Levidou G, Vakaki M, Papaefstathiou A, Lalioti N, Kanaka-Gantenbein C, Piaditis G, Chrousos GP, Dacou-Voutetakis C: The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study. J Clin Endocrinol Metab; 2010 Jan;95(1):109-17
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study.
  • The prevalence of polycystic ovary syndrome in treated and untreated girls with ICPP was comparable, whereas in the entire cohort, it was 11.1% in GnRHa treated and 32.1% in the untreated (P = 0.02).
  • CONCLUSIONS: Girls treated in childhood with GnRHa have normal BMI, BMD, body composition, and ovarian function in early adulthood.

  • MedlinePlus Health Information. consumer health - Growth Disorders.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19897682.001).
  • [ISSN] 1945-7197
  • [Journal-full-title] The Journal of clinical endocrinology and metabolism
  • [ISO-abbreviation] J. Clin. Endocrinol. Metab.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Drug Combinations; 0 / Luteolytic Agents; 12629-01-5 / Human Growth Hormone; 33515-09-2 / Gonadotropin-Releasing Hormone; 57773-63-4 / Triptorelin Pamoate
  •  go-up   go-down


36. Feinstein J, Arroyo R: Successful treatment of childhood onset refractory polyarteritis nodosa with tumor necrosis factor alpha blockade. J Clin Rheumatol; 2005 Aug;11(4):219-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Successful treatment of childhood onset refractory polyarteritis nodosa with tumor necrosis factor alpha blockade.
  • The 5-year survival rate is 13% in untreated patients and 77.6% with modern therapy.

  • Genetic Alliance. consumer health - Polyarteritis nodosa.
  • Hazardous Substances Data Bank. Etanercept .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16357761.001).
  • [ISSN] 1076-1608
  • [Journal-full-title] Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
  • [ISO-abbreviation] J Clin Rheumatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Immunoglobulin G; 0 / Receptors, Tumor Necrosis Factor; 0 / Tumor Necrosis Factor-alpha; OP401G7OJC / Etanercept
  •  go-up   go-down


37. Hussain K: Ketotic hypoglycaemia in children with diazoxide responsive hyperinsulinism of infancy. Eur J Pediatr; 2005 Jun;164(6):387-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Hyperinsulinism of infancy (HI) is a cause of persistent and recurrent hypoglycaemia in infancy and childhood, which if untreated can cause significant brain damage and mental retardation.

  • MedlinePlus Health Information. consumer health - Hypoglycemia.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Dis Child Fetal Neonatal Ed. 2000 Mar;82(2):F87-97 [10685980.001]
  • [Cites] Endocrinology. 1993 Aug;133(2):705-12 [8344209.001]
  • [Cites] J Clin Endocrinol Metab. 2003 Aug;88(8):3715-23 [12915660.001]
  • [Cites] J Emerg Med. 2003 Jul;25(1):39-43 [12865107.001]
  • [Cites] Pediatrics. 2001 Aug;108(2):495-7 [11483824.001]
  • [Cites] Nat Med. 1996 Dec;2(12):1344-7 [8946833.001]
  • [Cites] Acta Paediatr Scand. 1979 Sep;68(5):649-56 [393061.001]
  • [Cites] FASEB J. 2000 Mar;14(3):455-60 [10698960.001]
  • [Cites] Eur J Pediatr. 2002 Jan;161(1):6-20 [11808881.001]
  • [Cites] Metabolism. 1996 Mar;45(3):334-41 [8606640.001]
  • [Cites] Pediatr Res. 1987 Feb;21(2):211-3 [2881245.001]
  • [Cites] Physiol Rev. 2004 Jan;84(1):239-75 [14715916.001]
  • [Cites] J Clin Invest. 1972 Jun;51(6):1440-9 [5024041.001]
  • [Cites] Arch Dis Child Fetal Neonatal Ed. 2000 Mar;82(2):F98-F107 [10685981.001]
  • [Cites] Eur J Endocrinol. 2002 Jun;146(6):871-9 [12039709.001]
  • (PMID = 15772812.001).
  • [ISSN] 0340-6199
  • [Journal-full-title] European journal of pediatrics
  • [ISO-abbreviation] Eur. J. Pediatr.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Insulin Antagonists; O5CB12L4FN / Diazoxide
  •  go-up   go-down


38. Bannink EM, van Pareren YK, Theunissen NC, Raat H, Mulder PG, Hokken-Koelega AC: Quality of life in adolescents born small for gestational age: does growth hormone make a difference? Horm Res; 2005;64(4):166-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Additionally, to assess whether GH treatment has a positive effect on QoL, besides improving adult height and height SDS during childhood.
  • METHODS: Two groups of adolescents born SGA without spontaneous catch-up growth participated in the QoL evaluation; a GH-treated group (n = 44, mean GH duration: 8.8 (1.7) years) and an untreated group (n = 28), both mean age 15.8 (2.1) years.
  • On all TACQOL-S scales the GH group scored better QoL than the untreated group, with effect sizes of moderate to large, not all differences reaching statistical significance.
  • The generic CHQ did not reveal significant differences in QoL between the GH group and the untreated group.
  • CONCLUSIONS: Firstly, adolescents born SGA, with a GH-induced improved height, had in many aspects a better QoL than untreated adolescents born SGA, according to the disorder-specific questionnaire.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2005 S. Karger AG, Basel.
  • (PMID = 16205095.001).
  • [ISSN] 0301-0163
  • [Journal-full-title] Hormone research
  • [ISO-abbreviation] Horm. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Randomized Controlled Trial
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 12629-01-5 / Human Growth Hormone
  •  go-up   go-down


39. Baranwal AK, Ravi RN, Singh R: Exchange transfusion: a low-cost alternative for severe childhood Guillain-Barré syndrome. J Child Neurol; 2006 Nov;21(11):960-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Exchange transfusion: a low-cost alternative for severe childhood Guillain-Barré syndrome.
  • Two untreated ones had died.

  • Genetic Alliance. consumer health - Guillain-Barre Syndrome.
  • MedlinePlus Health Information. consumer health - Guillain-Barre Syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17092462.001).
  • [ISSN] 0883-0738
  • [Journal-full-title] Journal of child neurology
  • [ISO-abbreviation] J. Child Neurol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


40. Gerotto M, Resti M, Dal Pero F, Migliorato I, Alberti A, Bortolotti F: Evolution of hepatitis C virus quasispecies in children with chronic hepatitis C. Infection; 2006 Apr;34(2):62-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Since little is known on the behavior of HCV quasispecies in children and adolescents with chronic hepatitis C, we analyzed the virus population in six untreated children during a 5-year follow-up.
  • CONCLUSIONS: HCV quasispecies diversification is a common event during chronic hepatitis C in childhood.

  • Genetic Alliance. consumer health - Hepatitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16703294.001).
  • [ISSN] 0300-8126
  • [Journal-full-title] Infection
  • [ISO-abbreviation] Infection
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / HVR1 protein, Hepatitis C virus; 0 / RNA, Viral; 0 / Viral Proteins
  •  go-up   go-down


41. Masola V, Maran C, Tassone E, Zin A, Rosolen A, Onisto M: Heparanase activity in alveolar and embryonal rhabdomyosarcoma: implications for tumor invasion. BMC Cancer; 2009;9:304
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Rhabdomyosarcoma (RMS) is a malignant soft tissue sarcoma of childhood including two major histological subtypes, alveolar (ARMS) and embryonal (ERMS) RMS.
  • Stable HPSE silencing by shRNA technique determined a significant knockdown of gene expression equal to 76% and 58% in RH30 and RD cell lines respectively and induced a less invasive behaviour compared to untreated cells.

  • Genetic Alliance. consumer health - Rhabdomyosarcoma alveolar.
  • Genetic Alliance. consumer health - Rhabdomyosarcoma embryonal.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Biochemistry. 2000 Dec 26;39(51):15659-67 [11123890.001]
  • [Cites] PLoS One. 2009;4(4):e5181 [19360105.001]
  • [Cites] Semin Cancer Biol. 2001 Apr;11(2):143-52 [11322833.001]
  • [Cites] Nature. 2001 May 17;411(6835):375-9 [11357145.001]
  • [Cites] Biochimie. 2001 Aug;83(8):831-9 [11530216.001]
  • [Cites] J Cell Sci. 2002 May 15;115(Pt 10):2179-87 [11973358.001]
  • [Cites] Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5968-79 [14676122.001]
  • [Cites] J Cell Sci. 2004 May 1;117(Pt 11):2249-58 [15126626.001]
  • [Cites] Cancer Sci. 2004 Jul;95(7):553-8 [15245589.001]
  • [Cites] Cancer Res. 1987 Jun 15;47(12):3239-45 [2438036.001]
  • [Cites] Hum Pathol. 1994 Sep;25(9):900-7 [8088765.001]
  • [Cites] Nat Med. 1999 Jul;5(7):793-802 [10395325.001]
  • [Cites] Oncogene. 1999 Sep 20;18(38):5340-8 [10498887.001]
  • [Cites] Int J Oncol. 2005 Sep;27(3):791-8 [16077930.001]
  • [Cites] Oncologist. 2005 Aug;10(7):518-27 [16079319.001]
  • [Cites] J Cell Biochem. 2005 Dec 1;96(5):897-905 [16149080.001]
  • [Cites] Cancer. 2006 Feb 1;106(3):532-40 [16388520.001]
  • [Cites] Mol Aspects Med. 2006 Apr-Jun;27(2-3):95-125 [16460794.001]
  • [Cites] Curr Med Chem. 2006;13(18):2101-11 [16918340.001]
  • [Cites] Int J Biochem Cell Biol. 2006;38(12):2018-39 [16901744.001]
  • [Cites] Br J Pharmacol. 2007 May;151(1):1-14 [17339837.001]
  • [Cites] Perit Dial Int. 2007 Jun;27 Suppl 2:S104-9 [17556287.001]
  • [Cites] Curr Pharm Des. 2007;13(20):2057-73 [17627539.001]
  • [Cites] Neoplasia. 2007 Nov;9(11):909-16 [18030359.001]
  • [Cites] J Pathol. 2008 Feb;214(3):283-93 [18095256.001]
  • [Cites] Biochim Biophys Acta. 2001 Mar 21;1471(3):M99-108 [11250066.001]
  • (PMID = 19715595.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] EC 3.2.1.- / heparanase; EC 3.2.1.31 / Glucuronidase
  • [Other-IDs] NLM/ PMC2743710
  •  go-up   go-down


42. Hsu HY, Tsai HY, Wu TC, Chiang CL, Ni YH, Chen PJ, Chang MH: Interferon-alpha treatment in children and young adults with chronic hepatitis B: a long-term follow-up study in Taiwan. Liver Int; 2008 Nov;28(9):1288-97
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND/AIMS: The short- and long-term benefits of interferon (IFN)-alpha therapy in young patients with chronic hepatitis B (CHB) acquiring infection perinatally or during early childhood have been questioned.
  • A control group included untreated 21 CHB patients closely matched for gender, age, duration of ALT >80 IU/L and HBeAg status.
  • CONCLUSION: For young CHB patients in Taiwan with infection occurring perinatally or in early childhood, the real advantage of IFN-alpha therapy was not observed.

  • Genetic Alliance. consumer health - Hepatitis.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18397229.001).
  • [ISSN] 1478-3231
  • [Journal-full-title] Liver international : official journal of the International Association for the Study of the Liver
  • [ISO-abbreviation] Liver Int.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antiviral Agents; 0 / Codon, Nonsense; 0 / DNA, Viral; 0 / Hepatitis B Surface Antigens; 0 / Interferon-alpha; 0 / Recombinant Proteins; 99210-65-8 / interferon alfa-2b
  •  go-up   go-down


43. Hatch SL, Harvey SB, Maughan B: A developmental-contextual approach to understanding mental health and well-being in early adulthood. Soc Sci Med; 2010 Jan;70(2):261-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There is an increasing awareness of the social and economic burden of untreated mental illness.
  • Information was collected on the cohort members from childhood to age 33 years.
  • Multinomial (polytomous) logistic regression models were used to examine the effects of individual characteristics and social contextual factors from childhood through adolescence on cross categorisations of psychological distress and well-being.

  • MedlinePlus Health Information. consumer health - Child Mental Health.
  • MedlinePlus Health Information. consumer health - Mental Disorders.
  • MedlinePlus Health Information. consumer health - Mental Health.
  • MedlinePlus Health Information. consumer health - Stress.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 Elsevier Ltd. All rights reserved.
  • (PMID = 19853983.001).
  • [ISSN] 1873-5347
  • [Journal-full-title] Social science & medicine (1982)
  • [ISO-abbreviation] Soc Sci Med
  • [Language] eng
  • [Grant] United Kingdom / Medical Research Council / / G0500953; United Kingdom / Medical Research Council / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


44. Allen VM, Wilson RD, Cheung A, GENETICS COMMITTEE, REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY COMMITTEE: Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can; 2006 Mar;28(3):220-233
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OUTCOMES: This guideline discusses the adverse outcomes that have been recorded in association with ART, including obstetrical complications, adverse perinatal outcomes, multiple gestations, structural congenital abnormalities, chromosomal abnormalities, imprinting disorders, and childhood cancer.
  • Spontaneous pregnancies in untreated infertile women may be at higher risk for obstetrical complications and perinatal mortality than spontaneous pregnancies in fertile women.
  • Further epidemiologic and basic science research is needed to help determine the etiology and extent of the increased risks to childhood and long-term growth and development associated with ART. (II-2A) 13.
  • The precise risks of imprinting and childhood cancer from ART remain unclear but cannot be ignored.

  • Genetic Alliance. consumer health - Pregnancy.
  • MedlinePlus Health Information. consumer health - Assisted Reproductive Technology.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16650361.001).
  • [ISSN] 1701-2163
  • [Journal-full-title] Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
  • [ISO-abbreviation] J Obstet Gynaecol Can
  • [Language] eng; fre
  • [Publication-type] Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Investigator] Wilson RD; Allen VM; Blight C; Désilets VA; Gagnon A; Langlois SF; Summers A; Wyatt P; Claman P; Cheung A; Goodrow G; Graves G; Min J
  •  go-up   go-down


45. Oguz A, Karadeniz C, Okur FV, Citak EC, Pinarli FG, Bora H, Akyurek N: Prognostic factors and treatment outcome in childhood Hodgkin disease. Pediatr Blood Cancer; 2005 Oct 15;45(5):670-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic factors and treatment outcome in childhood Hodgkin disease.
  • PROCEDURE: From 1991 to 2003, 69 children with newly diagnosed, untreated biopsy-proven stage I-IV HD were treated with chemotherapy (CT) and low-dose involved field radiotherapy (LD-IFRT).
  • CONCLUSION: Our study confirms that excellent results are achievable with combined modality therapy in childhood HD.

  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16007600.001).
  • [ISSN] 1545-5009
  • [Journal-full-title] Pediatric blood & cancer
  • [ISO-abbreviation] Pediatr Blood Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Hemoglobins
  •  go-up   go-down


46. Sadleir LG, Scheffer IE, Smith S, Connolly MB, Farrell K: Automatisms in absence seizures in children with idiopathic generalized epilepsy. Arch Neurol; 2009 Jun;66(6):729-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PATIENTS: Seventy consecutive children with new-onset untreated absence seizures in idiopathic generalized epilepsy recruited between January 1, 1992, and June 30, 1997.
  • CONCLUSIONS: Automatisms are frequently seen during childhood absence seizures.


47. Yin X, Wu T, Yan Y, Zhang H, Bu H: Treatment for leiomyosarcoma and leiomyoma in children with HIV infection. Cochrane Database Syst Rev; 2010;(5):CD007665
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although leiomyosarcoma accounts for only 2% to 4% of childhood soft tissue sarcomas, the prognosis is poor in HIV-infected compared with non-infected patients.
  • OBJECTIVES: To assess the effectiveness of current therapeutic interventions for previously untreated children with AIDS-associated leiomyoma and leiomyosarcoma SEARCH STRATEGY: We searched the following electronic databases by subject headings and text words:Cochrane HIV/AIDS Group trials register (November 2009); Cochrane Central Register of Controlled Trials on Cochrane Library (Issue 4, 2009); MEDLINE (January 1966 to November 2009); EMBASE (January 1985 to November 2009); NLMGateway database and AEGIS; Chinese Biomedical Disc (CBMDisc 1978 to November 2009); VIP (1989 to present); and China National Knowledge Infrastructure (CNKI 1994 to 2009).

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • Genetic Alliance. consumer health - HIV.
  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20464756.001).
  • [ISSN] 1469-493X
  • [Journal-full-title] The Cochrane database of systematic reviews
  • [ISO-abbreviation] Cochrane Database Syst Rev
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 43
  •  go-up   go-down


48. Gadient P, Bolton J, Puri V: Juvenile myasthenia gravis: three case reports and a literature review. J Child Neurol; 2009 May;24(5):584-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Juvenile myasthenia gravis is a rare disorder acquired in childhood, representing 10% to 15% of all cases of myasthenia gravis.
  • Left untreated, the disease may progress to paralysis of the respiratory muscles.

  • Genetic Alliance. consumer health - Myasthenia gravis.
  • MedlinePlus Health Information. consumer health - Myasthenia Gravis.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19406758.001).
  • [ISSN] 1708-8283
  • [Journal-full-title] Journal of child neurology
  • [ISO-abbreviation] J. Child Neurol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 34
  •  go-up   go-down


49. Shohat M, Mimouni D, Ben-Amitai D, Sredni B, Sredni D, Shohat B, David M: In vitro cytokine profile in childhood alopecia areata and the immunomodulatory effects of AS-101. Clin Exp Dermatol; 2005 Jul;30(4):432-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] In vitro cytokine profile in childhood alopecia areata and the immunomodulatory effects of AS-101.
  • Ten previously untreated children with PAA were compared to 10 healthy age- and sex-matched controls.

  • Genetic Alliance. consumer health - Alopecia Areata.
  • MedlinePlus Health Information. consumer health - Autoimmune Diseases.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15953089.001).
  • [ISSN] 0307-6938
  • [Journal-full-title] Clinical and experimental dermatology
  • [ISO-abbreviation] Clin. Exp. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cytokines; 0 / Ethylenes; 0 / Immunosuppressive Agents; 0 / Phytohemagglutinins; 0 / ammonium trichloro(dioxoethylene-O,O'-)tellurate
  •  go-up   go-down


50. Hubeek I, Peters GJ, Broekhuizen R, Zwaan CM, Kaaijk P, van Wering ES, Gibson BE, Creutzig U, Janka-Schaub GE, den Boer ML, Pieters R, Kaspers GJ: In vitro sensitivity and cross-resistance to deoxynucleoside analogs in childhood acute leukemia. Haematologica; 2006 Jan;91(1):17-23
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] In vitro sensitivity and cross-resistance to deoxynucleoside analogs in childhood acute leukemia.
  • BACKGROUND AND OBJECTIVES: Cytarabine (ara-C) is a key drug in the treatment of acute leukemia.
  • DESIGN AND METHODS: Using the MTT assay, we determined in vitro sensitivity and cross-resistance to deoxynucleoside analogs in 362 acute leukemia samples from untreated children and 32 normal bone marrow mononuclear cell samples.
  • RESULTS: Normal bone marrow samples were significantly more resistant to ara-C, cladribine and fludarabine than were acute myeloid leukemia (AML) samples and significantly more resistant to ara-C and fludarabine than were acute lymphoblastic leukemia (ALL) samples.
  • We observed cross-resistance between ara-C and other deoxynucleoside analogs, as well as between ara-C and drugs with different modes of action in childhood acute leukemia.
  • [MeSH-major] Drug Resistance, Multiple. Leukemia / drug therapy. Nucleosides / therapeutic use
  • [MeSH-minor] Acute Disease. Child. Cytarabine / therapeutic use. Drug Screening Assays, Antitumor. Humans

  • MedlinePlus Health Information. consumer health - Leukemia.
  • Hazardous Substances Data Bank. CYTARABINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16434366.001).
  • [ISSN] 1592-8721
  • [Journal-full-title] Haematologica
  • [ISO-abbreviation] Haematologica
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Nucleosides; 04079A1RDZ / Cytarabine
  •  go-up   go-down


51. Porco TC, Gebre T, Ayele B, House J, Keenan J, Zhou Z, Hong KC, Stoller N, Ray KJ, Emerson P, Gaynor BD, Lietman TM: Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial. JAMA; 2009 Sep 2;302(9):962-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Antibiotics are provided to target the ocular strains of chlamydia that cause trachoma, but may also be efficacious against respiratory disease, diarrhea, and malaria--frequent causes of childhood mortality in trachoma-endemic areas.
  • OBJECTIVE: To compare mortality rates of participants aged 1 to 9 years in treated communities with those in untreated communities.
  • RESULTS: The odds ratio for childhood mortality in the intervention communities was 0.51 (95% confidence interval, 0.29-0.90; P = .02; clustered logistic regression) compared with the control group.
  • In the treated communities, the estimated overall mortality rate during this period for children aged 1 to 9 years in the untreated group was 8.3 per 1000 person-years (95% confidence interval, 5.3-13.1), while among the treated communities, the estimated overall mortality rate was 4.1 per 1000 person-years (95% confidence interval, 3.0-5.7) for children aged 1 to 9 years.


52. Bach JR: The use of mechanical ventilation is appropriate in children with genetically proven spinal muscular atrophy type 1: the motion for. Paediatr Respir Rev; 2008 Mar;9(1):45-50; quiz 50; discussion 55-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ninety per cent of typical untreated SMA 1 patients die before 12 months of age and 100% by 24 months of age.
  • [MeSH-major] Respiration, Artificial. Spinal Muscular Atrophies of Childhood / therapy

  • Genetic Alliance. consumer health - Spinal muscular atrophy.
  • Genetic Alliance. consumer health - Spinal muscular atrophy 1.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Paediatr Respir Rev. 2008 Mar;9(1):51-4; discussion 55-6 [18280980.001]
  • (PMID = 18280979.001).
  • [ISSN] 1526-0542
  • [Journal-full-title] Paediatric respiratory reviews
  • [ISO-abbreviation] Paediatr Respir Rev
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 15
  •  go-up   go-down


53. Antoniewicz J, Litwin M, Daszkoska J, Niemirska A, Sladowska J, Wierzbicka A, Wawer Z, Grenda R: [Target organ damage in children with newly diagnosed and untreated essential hypertension]. Przegl Lek; 2006;63 Suppl 3:101-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Target organ damage in children with newly diagnosed and untreated essential hypertension].
  • Target organ damage in the course of essential hypertension (EH) may develop already in childhood.
  • The aim of the study was to determine the prevalence of left ventricular hypertrophy (LVH) and arterial damage and its main determinants in children with newly diagnosed, untreated EH.


54. Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG: Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients. Growth Horm IGF Res; 2008 Aug;18(4):318-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
  • OBJECTIVE: To evaluate the long-term evolution of cardiovascular parameters, lipid metabolism, body composition and bone mass in untreated and treated adult growth hormone deficient patients (AGHD) comparing the differences between the two groups and within each group.
  • In the TG, 22 were childhood-onset (CO) GH-deficient patients, 18-44 years (12 males) and 26 were adult-onset (AO) GH-deficient patients, 27-66 years (10 males).

  • MedlinePlus Health Information. consumer health - Bone Density.
  • MedlinePlus Health Information. consumer health - Growth Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18289903.001).
  • [ISSN] 1096-6374
  • [Journal-full-title] Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
  • [ISO-abbreviation] Growth Horm. IGF Res.
  • [Language] eng
  • [Publication-type] Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Scotland
  • [Chemical-registry-number] 12629-01-5 / Human Growth Hormone; 67763-96-6 / Insulin-Like Growth Factor I
  •  go-up   go-down


55. Mantadakis E, Cole PD, Kamen BA: High-dose methotrexate in acute lymphoblastic leukemia: where is the evidence for its continued use? Pharmacotherapy; 2005 May;25(5):748-55
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High-dose methotrexate in acute lymphoblastic leukemia: where is the evidence for its continued use?
  • High-dose intravenous methotrexate is an important component of many effective chemotherapeutic regimens for childhood acute lymphoblastic leukemia (ALL).
  • The implied superiority of intravenous methotrexate mainly stems from studies that used identical leucovorin rescue with low-dose methotrexate or from studies of upfront window therapy in untreated children with ALL in which single standard doses of oral methotrexate were compared with high-dose intravenous methotrexate with leucovorin rescue.
  • [MeSH-major] Antimetabolites, Antineoplastic / administration & dosage. Folic Acid Antagonists / administration & dosage. Methotrexate / administration & dosage. Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy

  • Genetic Alliance. consumer health - Acute Lymphoblastic Leukemia.
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • Hazardous Substances Data Bank. METHOTREXATE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15899736.001).
  • [ISSN] 0277-0008
  • [Journal-full-title] Pharmacotherapy
  • [ISO-abbreviation] Pharmacotherapy
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Folic Acid Antagonists; Q573I9DVLP / Leucovorin; YL5FZ2Y5U1 / Methotrexate
  • [Number-of-references] 58
  •  go-up   go-down


56. Udayakumar AM, Bashir WA, Pathare AV, Wali YA, Zacharia M, Khan AA, Soliman H, Al-Lamki Z, Raeburn JA: Cytogenetic profile of childhood acute lymphoblastic leukemia in Oman. Arch Med Res; 2007 Apr;38(3):305-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cytogenetic profile of childhood acute lymphoblastic leukemia in Oman.
  • BACKGROUND: Chromosomal abnormalities have important diagnostic and prognostic significance in acute lymphoblastic leukemia (ALL).
  • METHODS: Bone marrow chromosomal studies with GTG banding were performed in untreated ALL pediatric patients aged from 7 days to 14 years.
  • To our knowledge, this is the first report from the Middle East of a cytogenetic study on childhood ALL.
  • [MeSH-major] Chromosome Aberrations. Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics


57. Van Howe RS, Kusnier LP 2nd: Diagnosis and management of pharyngitis in a pediatric population based on cost-effectiveness and projected health outcomes. Pediatrics; 2006 Mar;117(3):609-19
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnosis and management of pharyngitis in a pediatric population based on cost-effectiveness and projected health outcomes.
  • BACKGROUND: Pharyngitis is a common childhood complaint.
  • The sequelae of untreated group A hemolytic streptococcal (GAS) pharyngitis are rare, whereas antibiotic treatment may result in side effects ranging from rash to death.
  • The model was most sensitive to the incidence of acute rheumatic fever and peritonsillar abscess after untreated GAS pharyngitis.
  • Before recommending observation rather than treatment of GAS pharyngitis, accurate estimates of the risk of developing acute rheumatic fever and peritonsillar abscess after GAS pharyngitis are needed.

  • MedlinePlus Health Information. consumer health - Sore Throat.
  • MedlinePlus Health Information. consumer health - Streptococcal Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16510638.001).
  • [ISSN] 1098-4275
  • [Journal-full-title] Pediatrics
  • [ISO-abbreviation] Pediatrics
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


58. Balansky R, Ganchev G, Iltcheva M, Steele VE, D'Agostini F, De Flora S: Potent carcinogenicity of cigarette smoke in mice exposed early in life. Carcinogenesis; 2007 Oct;28(10):2236-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A total of 98 newborn Swiss albino mice were either untreated (controls) or received a subcutaneous injection of benzo(a)pyrene [B(a)P] (positive control) or were exposed whole-body to mainstream cigarette smoke (MCS) for 120 days, starting within 12 h after birth.
  • In conclusion, MCS is a potent and broad spectrum carcinogen in mice when exposure starts early in life, covering stages of life corresponding to neonatal, childhood and adolescence periods in humans.

  • MedlinePlus Health Information. consumer health - Secondhand Smoke.
  • MedlinePlus Health Information. consumer health - Smoking.
  • Hazardous Substances Data Bank. Benzo(a)pyrene .
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17522065.001).
  • [ISSN] 1460-2180
  • [Journal-full-title] Carcinogenesis
  • [ISO-abbreviation] Carcinogenesis
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CN / N01-CN53301
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Carcinogens; 0 / Tobacco Smoke Pollution; 3417WMA06D / Benzo(a)pyrene
  •  go-up   go-down


59. Aksglaede L, Molgaard C, Skakkebaek NE, Juul A: Normal bone mineral content but unfavourable muscle/fat ratio in Klinefelter syndrome. Arch Dis Child; 2008 Jan;93(1):30-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PATIENTS: Eighteen untreated boys with KS and six boys with KS receiving androgen substitution with a median age of 11.0 years (range 4.3-18.6) participated in the study.
  • MAIN OUTCOME MEASURES: Lumbar and whole body BMC, lean body mass (LBM), body fat mass (BFM), body fat percentage (BF%), height and body mass index (BMI) were compared between treated and untreated boys with KS and compared to normal age-matched boys.
  • RESULTS: LBM (untreated -0.3 (-2.4 to +2.1) and treated +1.1 (-1.6 to +2.1)) was normal, while BFM (untreated +0.5 (-1.0 to +2.3), p = 0.02 and treated +1.6 (-0.2 to +2.4), p = 0.01) was significantly increased, all expressed as standard deviation scores.
  • Lumbar bone mineral density (BMD; untreated -0.4 (-3.1 to +0.9) and treated +1.0 (-1.4 to +3.0)) and whole body BMC (untreated +0.1 (-1.8 to +3.3) and treated +1.5 (-1.1 to +2.5)) were normal.
  • These findings suggest that the unfavourable metabolic profile seen in adult KS may already be present in childhood as evidenced by the increased fat mass, whereas the reported low BMD seems to develop after puberty.

  • Genetic Alliance. consumer health - Klinefelter syndrome.
  • MedlinePlus Health Information. consumer health - Bone Density.
  • MedlinePlus Health Information. consumer health - Klinefelter's Syndrome.
  • Hazardous Substances Data Bank. ESTRADIOL .
  • Hazardous Substances Data Bank. TESTOSTERONE .
  • Hazardous Substances Data Bank. MENOTROPINS .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17916585.001).
  • [ISSN] 1468-2044
  • [Journal-full-title] Archives of disease in childhood
  • [ISO-abbreviation] Arch. Dis. Child.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Androgens; 0 / Sex Hormone-Binding Globulin; 3XMK78S47O / Testosterone; 4TI98Z838E / Estradiol; 9002-67-9 / Luteinizing Hormone; 9002-68-0 / Follicle Stimulating Hormone; H16A5VCT9C / testosterone undecanoate
  •  go-up   go-down


60. Wirrell E, Sherman EM, Vanmastrigt R, Hamiwka L: Deterioration in cognitive function in children with benign epilepsy of childhood with central temporal spikes treated with sulthiame. J Child Neurol; 2008 Jan;23(1):14-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Deterioration in cognitive function in children with benign epilepsy of childhood with central temporal spikes treated with sulthiame.
  • The purpose of this study was to determine if reduction in spike frequency in children with benign epilepsy of childhood with centrotemporal spikes treated with sulthiame correlates with improved neuropsychologic function.
  • Six untreated children (5 boys, 1 girl) with a mean (standard deviation) age of 9.1 years (1.5 years) underwent overnight ambulatory electroencephalograph recording and neuropsychologic evaluation at baseline and after 6 months of sulthiame monotherapy.

  • Genetic Alliance. consumer health - Epilepsy.
  • MedlinePlus Health Information. consumer health - Developmental Disabilities.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Child Neurol. 2010 Jan;25(1):127-8 [20032519.001]
  • (PMID = 18184938.001).
  • [ISSN] 0883-0738
  • [Journal-full-title] Journal of child neurology
  • [ISO-abbreviation] J. Child Neurol.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Anticonvulsants; 0 / Thiazines; 61-56-3 / sulthiame
  •  go-up   go-down


61. Pacifico L, Anania C, Osborn JF, Ferraro F, Chiesa C: Consequences of Helicobacter pylori infection in children. World J Gastroenterol; 2010 Nov 7;16(41):5181-94
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • If untreated, H. pylori infection is lifelong.
  • There is evidence of the role of H. pylori in childhood iron deficiency anemia, but the results are not conclusive.
  • The possibility of an inverse relationship between H. pylori and gastroesophageal reflux disease, as well as childhood asthma, remains a controversial question.
  • A better understanding of the H. pylori disease spectrum in childhood should lead to clearer recommendations about testing for and treating H. pylori infection in children who are more likely to develop clinical sequelae.

  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] JAMA. 2004 Jan 14;291(2):187-94 [14722144.001]
  • [Cites] J Infect Dis. 1998 Aug;178(2):460-5 [9697727.001]
  • [Cites] BMJ. 1998 Aug 22;317(7157):514-5 [9712599.001]
  • [Cites] Lancet. 1998 Sep 12;352(9131):878 [9742983.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1999 Jan;28(1):116-9 [9890483.001]
  • [Cites] Dig Dis Sci. 1999 Feb;44(2):229-36 [10063905.001]
  • [Cites] Arch Dis Child. 1998 Dec;79(6):502-5 [10210995.001]
  • [Cites] Helicobacter. 1999 Jun;4(2):135-9 [10382128.001]
  • [Cites] Ann Intern Med. 1999 Jul 20;131(2):88-95 [10419446.001]
  • [Cites] Gut. 1999 Jul;45 Suppl 1:I36-9 [10457035.001]
  • [Cites] Am J Trop Med Hyg. 1999 Sep;61(3):395-8 [10497978.001]
  • [Cites] N Engl J Med. 1999 Oct 7;341(15):1106-11 [10511608.001]
  • [Cites] Arch Dis Child. 2004 Dec;89(12):1149-54 [15557054.001]
  • [Cites] Am J Gastroenterol. 2005 Feb;100(2):453-9 [15667507.001]
  • [Cites] Am J Hematol. 2005 Feb;78(2):142-50 [15682423.001]
  • [Cites] Arch Pediatr Adolesc Med. 2005 May;159(5):415-21 [15867113.001]
  • [Cites] Pediatr Int. 2005 Jun;47(3):292-5 [15910453.001]
  • [Cites] Haematologica. 2005 May;90(5):585-95 [15921373.001]
  • [Cites] Can J Gastroenterol. 2005 Jul;19(7):425-7 [16010305.001]
  • [Cites] Mod Pathol. 2005 Aug;18(8):1134-44 [15803187.001]
  • [Cites] Infect Immun. 2005 Sep;73(9):5612-9 [16113278.001]
  • [Cites] Arch Dis Child. 2005 Oct;90(10):1025-8 [15956048.001]
  • [Cites] J Clin Pathol. 2005 Nov;58(11):1189-93 [16254110.001]
  • [Cites] Dig Dis Sci. 2006 Jan;51(1):99-104 [16416219.001]
  • [Cites] J Infect Dis. 2006 Feb 15;193(4):537-46 [16425133.001]
  • [Cites] Pediatrics. 2006 Mar;117(3):e396-404 [16452320.001]
  • [Cites] Int J Immunopathol Pharmacol. 2010 Apr-Jun;23(2):405-16 [20646336.001]
  • [Cites] Dig Dis Sci. 2010 Oct;55(10):2878-86 [20112067.001]
  • [Cites] Int J Hematol. 2003 Dec;78(5):429-31 [14704035.001]
  • [Cites] Aliment Pharmacol Ther. 2000 Jan;14(1):45-51 [10632644.001]
  • [Cites] Am J Gastroenterol. 2000 Jan;95(1):101-5 [10638566.001]
  • [Cites] Arch Dis Child. 2000 Feb;82(2):136-40 [10648367.001]
  • [Cites] Hum Pathol. 1999 Dec;30(12):1431-4 [10667420.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2000 Mar;30(3):265-8 [10749409.001]
  • [Cites] Aliment Pharmacol Ther. 2000 Apr;14(4):427-32 [10759622.001]
  • [Cites] Am J Gastroenterol. 2000 Apr;95(4):914-20 [10763937.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2000 Jul;31(1):52-6 [10896071.001]
  • [Cites] Lancet. 2000 May 13;355(9216):1665-9 [10905240.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2000 Oct;31(4):424-7 [11045841.001]
  • [Cites] Ann Diagn Pathol. 2000 Oct;4(5):279-85 [11073332.001]
  • [Cites] Blood. 2001 Feb 1;97(3):812-4 [11157503.001]
  • [Cites] Lancet. 2001 Jun 2;357(9270):1738-42 [11403809.001]
  • [Cites] Scand J Gastroenterol. 2001 Jul;36(7):701-5 [11444468.001]
  • [Cites] J Pediatr. 2001 Jul;139(1):100-4 [11445801.001]
  • [Cites] Aliment Pharmacol Ther. 2001 Jun;15 Suppl 1:16-21 [11488657.001]
  • [Cites] Gut. 2001 Sep;49(3):347-53 [11511555.001]
  • [Cites] Curr Probl Pediatr Adolesc Health Care. 2001 Sep;31(8):247-66 [11595896.001]
  • [Cites] Gastroenterology. 2001 Nov;121(5):1120-6 [11677204.001]
  • [Cites] Aliment Pharmacol Ther. 2001 Nov;15(11):1753-61 [11683689.001]
  • [Cites] Helicobacter. 2001 Sep;6(3):234-8 [11683926.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2001 Oct;33(4):472-5 [11698766.001]
  • [Cites] Gut. 2004 Feb;53(2):310-1 [14724170.001]
  • [Cites] Gut. 2004 Feb;53(2):312-3 [14724171.001]
  • [Cites] Blood. 2004 Feb 1;103(3):890-6 [12920031.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2004 Feb;38(2):146-51 [14734875.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):4-10 [14744726.001]
  • [Cites] J Gastroenterol. 2004;39(3):231-7 [15064999.001]
  • [Cites] Eur J Haematol. 2004 Apr;72(4):304-5 [15089773.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2004 May;38(5):548 [15097448.001]
  • [Cites] Eur J Gastroenterol Hepatol. 2004 Aug;16(8):779-83 [15256980.001]
  • [Cites] Helicobacter. 2004 Aug;9(4):342-6 [15270749.001]
  • [Cites] Gut. 2004 Sep;53(9):1244-9 [15306578.001]
  • [Cites] J Clin Gastroenterol. 2004 Sep;38(8):646-50 [15319645.001]
  • [Cites] J Gastroenterol. 2004 Aug;39(8):734-8 [15338366.001]
  • [Cites] Arch Intern Med. 2004 Sep 27;164(17):1904-7 [15451766.001]
  • [Cites] Am J Med. 2004 Sep 6;117 Suppl 5A:30S-35S [15478850.001]
  • [Cites] Annu Rev Med. 1983;34:55-68 [6344777.001]
  • [Cites] Cancer Res. 1990 Aug 1;50(15):4731-6 [2369747.001]
  • [Cites] Dig Dis Sci. 1991 Apr;36(4):417-23 [2007358.001]
  • [Cites] Lancet. 1991 Nov 9;338(8776):1175-6 [1682595.001]
  • [Cites] Eur J Pediatr. 1991 Jun;150(8):560-1 [1954961.001]
  • [Cites] J Bacteriol. 1993 Jan;175(2):557-60 [8419304.001]
  • [Cites] Am J Gastroenterol. 1993 Apr;88(4):510-3 [8470630.001]
  • [Cites] J Infect Dis. 1993 Jul;168(1):219-21 [8515114.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1993 Aug;17(2):225-7 [8229554.001]
  • [Cites] Scand J Gastroenterol. 1993 Nov;28(11):939-42 [8284627.001]
  • [Cites] J Clin Pathol. 1994 May;47(5):436-9 [8027397.001]
  • [Cites] JAMA. 1995 Mar 1;273(9):729-34 [7853632.001]
  • [Cites] Gastroenterology. 1995 Sep;109(3):973-7 [7657127.001]
  • [Cites] Vaccine. 1995 May;13(7):691-4 [7668039.001]
  • [Cites] Hum Pathol. 1996 Jan;27(1):35-41 [8543308.001]
  • [Cites] Blood. 1996 Jul 1;88(1):3-40 [8704187.001]
  • [Cites] Am J Surg Pathol. 1996 Oct;20(10):1161-81 [8827022.001]
  • [Cites] Gastroenterology. 1997 May;112(5):1442-7 [9136820.001]
  • [Cites] Gut. 1997 Apr;40(4):435-9 [9176066.001]
  • [Cites] South Med J. 1997 Jun;90(6):570-6; quiz 577 [9191731.001]
  • [Cites] Arch Dis Child. 1997 Jul;77(1):46-9 [9279151.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 1997 Oct;25(4):441 [9327380.001]
  • [Cites] Gastroenterology. 1997 Dec;113(6 Suppl):S61-4 [9394762.001]
  • [Cites] Am J Gastroenterol. 1998 Jul;93(7):1080-4 [9672334.001]
  • [Cites] Ann Epidemiol. 2006 May;16(5):347-51 [16246582.001]
  • [Cites] World J Gastroenterol. 2006 Apr 28;12(16):2625-8 [16688815.001]
  • [Cites] Immunol Rev. 2006 Aug;212:238-55 [16903918.001]
  • [Cites] World J Gastroenterol. 2006 Oct 21;12(39):6274-9 [17072948.001]
  • [Cites] N Engl J Med. 2006 Nov 23;355(21):2226-35 [17124020.001]
  • [Cites] Helicobacter. 2007 Apr;12(2):150-6 [17309752.001]
  • [Cites] Haematologica. 2007 Apr;92(4):576 [17488677.001]
  • [Cites] Gut. 2007 Jun;56(6):772-81 [17170018.001]
  • [Cites] Acta Paediatr. 2007 Jul;96(7):1047-9 [17524023.001]
  • [Cites] Eur J Pediatr. 2007 Oct;166(10):1067-8 [17136353.001]
  • [Cites] Blood. 2007 Dec 1;110(12):3833-41 [17652264.001]
  • [Cites] Annu Rev Pathol. 2006;1:63-96 [18039108.001]
  • [Cites] Pediatr Int. 2007 Dec;49(6):858-63 [18045286.001]
  • [Cites] J Pediatr Hematol Oncol. 2008 Jan;30(1):2-3 [18176171.001]
  • [Cites] J Pediatr Hematol Oncol. 2008 Jan;30(1):53-7 [18176181.001]
  • [Cites] J Pediatr Hematol Oncol. 2008 Jan;30(1):96-7 [18176194.001]
  • [Cites] J Clin Gastroenterol. 2008 Feb;42(2):215-6 [18209597.001]
  • [Cites] Public Health Nutr. 2008 Mar;11(3):230-6 [17666124.001]
  • [Cites] Eur J Pediatr. 2008 May;167(5):557-62 [17618457.001]
  • [Cites] Curr Gastroenterol Rep. 2007 Dec;9(6):447-55 [18377794.001]
  • [Cites] J Infect Dis. 2008 Aug 15;198(4):553-60 [18598192.001]
  • [Cites] Gut. 2008 Oct;57(10):1375-85 [18467372.001]
  • [Cites] Gastroenterology. 2008 Nov;135(5):1534-42 [18775429.001]
  • [Cites] Dig Dis Sci. 2009 Jan;54(1):111-7 [18594977.001]
  • [Cites] Blood. 2009 Feb 5;113(6):1231-40 [18945961.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2009 Mar;48(3):268-70 [19274778.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2009 Mar;48(3):299-305 [19274785.001]
  • [Cites] J Infect Dis. 2009 Mar 1;199(5):652-60 [19125674.001]
  • [Cites] Acta Paediatr. 2009 May;98(5):860-4 [19191761.001]
  • [Cites] J Infect Dis. 2009 Mar 15;199(6):914-5; author reply 915-6 [19434934.001]
  • [Cites] Pediatr Blood Cancer. 2009 Jul;53(1):72-7 [19301380.001]
  • [Cites] Gastroenterology. 2009 May;136(6):1863-73 [19457415.001]
  • [Cites] Dig Dis Sci. 2009 Sep;54(9):1958-65 [19003529.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2009 Sep;49(3):283-8 [19525872.001]
  • [Cites] Helicobacter. 2009 Sep;14 Suppl 1:52-7 [19712169.001]
  • [Cites] Helicobacter. 2009 Sep;14 Suppl 1:58-68 [19712170.001]
  • [Cites] Acta Paediatr. 2010 Jan;99(1):121-5 [19785631.001]
  • [Cites] Pediatrics. 2010 Mar;125(3):e651-69 [20156901.001]
  • [Cites] Am J Gastroenterol. 2010 May;105(5):1007-13; quiz 1006, 1014 [20087334.001]
  • [Cites] Gut. 2002 Mar;50(3):295-8 [11839704.001]
  • [Cites] Br J Haematol. 2001 Dec;115(4):1002-3 [11843840.001]
  • [Cites] Helicobacter. 2001 Dec;6(4):263-7 [11843957.001]
  • [Cites] Acta Paediatr. 2002;91(1):39-44 [11883816.001]
  • [Cites] Gut. 2002 May;50 Suppl 3:III19-24 [11953328.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2002 Mar;34(3):281-5 [11964952.001]
  • [Cites] Helicobacter. 2002 Apr;7(2):71-5 [11966864.001]
  • [Cites] Br J Haematol. 2002 Aug;118(2):584-8 [12139750.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2002 Aug;35(2):232-3 [12187306.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2002;35 Suppl 2:S128-33 [12192181.001]
  • [Cites] N Engl J Med. 2002 Oct 10;347(15):1175-86 [12374879.001]
  • [Cites] Helicobacter. 2002 Oct;7(5):328-9 [12390215.001]
  • [Cites] Haematologica. 2002 Nov;87(11):1177-9 [12414347.001]
  • [Cites] Am J Gastroenterol. 2002 Dec;97(12):2992-7 [12492181.001]
  • [Cites] Arch Dis Child. 2003 Feb;88(2):178 [12538339.001]
  • [Cites] Ann Hematol. 2003 Jan;82(1):30-2 [12574961.001]
  • [Cites] Eur J Pediatr. 2003 Mar;162(3):177-9 [12655422.001]
  • [Cites] Int J Hematol. 2003 Apr;77(3):239-44 [12731666.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2003 Jul;37(1):96-7; author reply 97-8 [12827016.001]
  • [Cites] J Gastroenterol Hepatol. 2003 Aug;18(8):980-5 [12859729.001]
  • [Cites] Gastroenterology. 2003 Aug;125(2):364-71 [12891537.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2003 Sep;37(3):309-14 [12960654.001]
  • [Cites] Helicobacter. 2003;8(5):554-60 [14536002.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2003 Nov;37(5):614-9 [14581807.001]
  • [Cites] Acta Paediatr. 2003 Oct;92(10):1153-7 [14632330.001]
  • [Cites] J Pediatr Hematol Oncol. 2003 Dec;25 Suppl 1:S28-33 [14668636.001]
  • [Cites] Br J Haematol. 2004 Jan;124(1):91-6 [14675413.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2004 Jan;38(1):70-4 [14676598.001]
  • [Cites] Gut. 2004 Jan;53(1):34-7 [14684573.001]
  • [Cites] J Pediatr Gastroenterol Nutr. 2003 Nov-Dec;37 Suppl 1:S33-9 [14685076.001]
  • [Cites] Pediatrics. 2004 Jan;113(1 Pt 1):54-8 [14702447.001]
  • (PMID = 21049552.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC2975089
  •  go-up   go-down


62. Ippolito E, De Maio F, Mancini F, Bellini D, Orefice A: Leg muscle atrophy in idiopathic congenital clubfoot: is it primitive or acquired? J Child Orthop; 2009 Jun;3(3):171-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Magnetic resonance imaging (MRI) of both legs was taken in three cohorts of patients with unilateral congenital clubfoot (UCCF): eight untreated newborns (age range 10 days to 2 weeks); eight children who had been treated with the Ponseti method (age range 2-4 years); eight adults whose deformity had been corrected by manipulation and casting according to Ponseti, followed by a limited posterior release performed at age 2-3 months (age range 19-23 years).
  • RESULTS: Marked atrophy of the leg muscles on the clubfoot side was found in both fetuses and untreated newborns, with a percentage ratio of MTV between the normal and the affected leg of 1.3 and 1.5, respectively.
  • As a result, the difference in TLV tended to increase from childhood to adulthood.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Bone Joint Surg Am. 1992 Mar;74(3):448-54 [1548277.001]
  • [Cites] J Pediatr Orthop. 2006 Jan-Feb;26(1):91-3 [16439910.001]
  • [Cites] J Pediatr Orthop. 1990 Jan-Feb;10(1):109-19 [2137134.001]
  • [Cites] J Pediatr Orthop. 1990 Jul-Aug;10(4):477-82 [2358485.001]
  • [Cites] Pathol Res Pract. 1989 Nov;185(5):790-4 [2626390.001]
  • [Cites] J Bone Joint Surg Br. 1985 Nov;67(5):791-9 [4055883.001]
  • [Cites] J Bone Joint Surg Br. 1973 Nov;55(4):796-801 [4766184.001]
  • [Cites] J Pediatr Orthop. 1981;1(1):23-32 [7341648.001]
  • [Cites] J Bone Joint Surg Am. 1980 Jan;62(1):23-31 [7351412.001]
  • [Cites] J Bone Joint Surg Br. 1995 Jul;77(4):596-601 [7615605.001]
  • [Cites] Orthopedics. 1998 Jun;21(6):669-74 [9642705.001]
  • [Cites] Eur J Radiol. 2001 Feb;37(2):123-9 [11223479.001]
  • [Cites] J Bone Joint Surg Br. 2001 Jul;83(5):726-30 [11476314.001]
  • [Cites] Clin Orthop Relat Res. 2002 Oct;(403 Suppl):S133-45 [12394462.001]
  • [Cites] Clin Orthop Relat Res. 2002 Oct;(403 Suppl):S252-61 [12394475.001]
  • [Cites] Am J Clin Nutr. 2002 Nov;76(5):1096-100 [12399284.001]
  • [Cites] J Bone Joint Surg Am. 1953 Jan;35-A(1):111-4 [13022712.001]
  • [Cites] J Bone Joint Surg Am. 1950 Oct;32 A(4):827-38 [14784492.001]
  • [Cites] Clin Orthop Relat Res. 2007 Sep;462:32-7 [17534194.001]
  • [Cites] Z Orthop Ihre Grenzgeb. 1969 Jan;105(4):595-615 [4240753.001]
  • [Cites] J Bone Joint Surg Br. 1981;63-B(3):417-23 [7263758.001]
  • [Cites] J Bone Joint Surg Am. 1980 Jan;62(1):8-22 [7351421.001]
  • [Cites] Pediatr Nephrol. 1996 Jun;10(3):340-2 [8792401.001]
  • [Cites] J Pediatr Orthop. 1998 Nov-Dec;18(6):765-9 [9821133.001]
  • [Cites] J Pediatr Orthop. 2001 Nov-Dec;21(6):719-26 [11675543.001]
  • [Cites] Clin Orthop Relat Res. 2002 Oct;(403 Suppl):S146-52 [12394463.001]
  • [Cites] J Bone Joint Surg Am. 2003 Jul;85-A(7):1286-94 [12851354.001]
  • [Cites] Aust N Z J Surg. 1963 Aug;33:1-11 [14058872.001]
  • [Cites] Foot Ankle. 1992 Feb;13(2):80-4 [1572590.001]
  • (PMID = 19418086.001).
  • [ISSN] 1863-2521
  • [Journal-full-title] Journal of children's orthopaedics
  • [ISO-abbreviation] J Child Orthop
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2686819
  •  go-up   go-down


63. Germain DP: Fabry disease. Orphanet J Rare Dis; 2010;5:30
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In childhood, other possible causes of pain such as rheumatoid arthritis and 'growing pains' must be ruled out.
  • End-stage renal disease and life-threatening cardiovascular or cerebrovascular complications limit life-expectancy of untreated males and females with reductions of 20 and 10 years, respectively, as compared to the general population.

  • Genetic Alliance. consumer health - BabysFirstTest - Fabry Disease.
  • Genetic Alliance. consumer health - Fabry Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dement Geriatr Cogn Disord. 1997 Jul-Aug;8(4):252-7 [9213072.001]
  • [Cites] J Inherit Metab Dis. 1997 Sep;20(5):643-57 [9323559.001]
  • [Cites] FEBS Lett. 1997 Nov 3;417(1):89-91 [9395081.001]
  • [Cites] Hum Mutat. 1998;Suppl 1:S288-90 [9452111.001]
  • [Cites] Brain Pathol. 1998 Jan;8(1):195-215 [9458176.001]
  • [Cites] Can J Cardiol. 1998 Jan;14(1):81-4 [9487277.001]
  • [Cites] Neurology. 1998 Jun;50(6):1746-9 [9633721.001]
  • [Cites] Am J Hum Genet. 1998 Aug;63(2):415-27 [9683600.001]
  • [Cites] Nat Med. 1999 Jan;5(1):112-5 [9883849.001]
  • [Cites] JAMA. 1999 Jan 20;281(3):249-54 [9918480.001]
  • [Cites] Biochem Biophys Res Commun. 1999 Apr 21;257(3):708-13 [10208848.001]
  • [Cites] Neurology. 1999 May 12;52(8):1663-7 [10331696.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 May 25;96(11):6423-7 [10339603.001]
  • [Cites] Hum Genet. 1999 Jul-Aug;105(1-2):151-6 [10480370.001]
  • [Cites] Nature. 1961 Apr 22;190:372-3 [13764598.001]
  • [Cites] J Biol Chem. 1963 Sep;238:3148-50 [14081947.001]
  • [Cites] Gastroenterology. 1965 May;48:625-33 [14280390.001]
  • [Cites] Lancet Neurol. 2004 Dec;3(12):752-6 [15556808.001]
  • [Cites] Psychiatr Genet. 2004 Dec;14(4):199-201 [15564893.001]
  • [Cites] Eur J Clin Invest. 2004 Dec;34(12):838-44 [15606727.001]
  • [Cites] J Inherit Metab Dis. 2004;27(6):791-3 [15617195.001]
  • [Cites] Muscle Nerve. 2005 Jan;31(1):102-7 [15389653.001]
  • [Cites] Am J Med Genet A. 2004 Aug 30;129A(2):136-43 [15316978.001]
  • [Cites] Clin Exp Immunol. 2004 Sep;137(3):496-502 [15320898.001]
  • [Cites] Kidney Int. 2004 Sep;66(3):978-82 [15327390.001]
  • [Cites] Kidney Int. 2004 Sep;66(3):1279-82 [15327428.001]
  • [Cites] Circulation. 2001 Sep 25;104(13):1506-12 [11571244.001]
  • [Cites] Mutat Res. 2001 Nov 1;483(1-2):89-94 [11600137.001]
  • [Cites] Hum Mutat. 2001 Nov;18(5):459 [11668641.001]
  • [Cites] Contrib Nephrol. 2001;(136):234-40 [11688386.001]
  • [Cites] Contrib Nephrol. 2001;(136):241-4 [11688387.001]
  • [Cites] Contrib Nephrol. 2001;(136):245-50 [11688388.001]
  • [Cites] J Med Genet. 2001 Nov;38(11):750-60 [11694547.001]
  • [Cites] J Med Genet. 2001 Nov;38(11):769-75 [11732485.001]
  • [Cites] J Inherit Metab Dis. 2001;24 Suppl 2:66-70; discussion 65 [11758681.001]
  • [Cites] Kidney Int. 2002 Jan;61(1):249-55 [11786107.001]
  • [Cites] J Inherit Metab Dis. 2001 Dec;24(7):715-24 [11804208.001]
  • [Cites] Stroke. 2002 Feb;33(2):525-31 [11823664.001]
  • [Cites] Medicine (Baltimore). 2002 Mar;81(2):122-38 [11889412.001]
  • [Cites] Circulation. 2002 Mar 26;105(12):1407-11 [11914245.001]
  • [Cites] Qual Life Res. 2002 Mar;11(2):127-33 [12018736.001]
  • [Cites] Expert Opin Investig Drugs. 2002 Jun;11(6):851-8 [12036428.001]
  • [Cites] Qual Life Res. 2002 Jun;11(4):317-27 [12086117.001]
  • [Cites] J Soc Biol. 2002;196(2):161-73 [12360745.001]
  • [Cites] J Soc Biol. 2002;196(2):183-90 [12360747.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13777-82 [12370426.001]
  • [Cites] Expert Opin Investig Drugs. 2002 Oct;11(10):1467-76 [12387706.001]
  • [Cites] J Am Coll Cardiol. 2002 Nov 6;40(9):1668-74 [12427421.001]
  • [Cites] Clin Chem. 2004 Oct;50(10):1785-96 [15292070.001]
  • [Cites] Kidney Int. 2004 Oct;66(4):1589-95 [15458455.001]
  • [Cites] Biochim Biophys Acta. 2004 Nov 5;1690(3):250-7 [15511632.001]
  • [Cites] N Engl J Med. 1967 May 25;276(21):1163-7 [6023233.001]
  • [Cites] Nature. 1970 Sep 12;227(5263):1173 [5451124.001]
  • [Cites] Neurology. 1973 Aug;23(8):871-5 [4578349.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1973 Dec;36(6):1053-62 [4204059.001]
  • [Cites] Science. 1975 Jul 18;189(4198):186-94 [1138375.001]
  • [Cites] Pediatrics. 1976 Aug;58(2):259-63 [951142.001]
  • [Cites] Arch Dis Child. 1976 Nov;51(11):875-8 [1008594.001]
  • [Cites] Am Heart J. 1977 Jun;93(6):699-705 [140598.001]
  • [Cites] Arch Fr Pediatr. 1977 Oct;34(8):704-16 [412484.001]
  • [Cites] Kidney Int. 1978 Mar;13(3):223-35 [418264.001]
  • [Cites] Arch Ophthalmol. 1979 Apr;97(4):671-6 [106811.001]
  • [Cites] Am J Med. 1980 Jun;68(6):898-905 [6247911.001]
  • [Cites] Clin Chim Acta. 1981 May 5;112(2):247-51 [6263521.001]
  • [Cites] Am J Gastroenterol. 1981 Sep;76(3):246-51 [6274188.001]
  • [Cites] J Electrocardiol. 1982 Apr;15(2):153-6 [6461709.001]
  • [Cites] Neurology. 1982 May;32(5):498-502 [6803189.001]
  • [Cites] Annu Rev Biochem. 1991;60:257-80 [1883197.001]
  • [Cites] Acta Neurol Belg. 1992;92(1):36-40 [1546524.001]
  • [Cites] Br Heart J. 1992 Sep;68(3):323-5 [1389767.001]
  • [Cites] J Med Genet. 1993 Aug;30(8):658-63 [8411052.001]
  • [Cites] Neurology. 1993 Sep;43(9):1683-9 [8414012.001]
  • [Cites] Am J Hum Genet. 1993 Dec;53(6):1186-97 [7504405.001]
  • [Cites] Biochem Biophys Res Commun. 1993 Dec 30;197(3):1585-9 [7904161.001]
  • [Cites] Hum Mutat. 1994;3(2):103-11 [7911050.001]
  • [Cites] Hum Mol Genet. 1994 Mar;3(3):503-5 [8012363.001]
  • [Cites] N Engl J Med. 1995 Aug 3;333(5):288-93 [7596372.001]
  • [Cites] Pediatr Neurol. 1995 Apr;12(3):250-1 [7619194.001]
  • [Cites] Biochem Biophys Res Commun. 1995 Sep 25;214(3):1219-24 [7575533.001]
  • [Cites] Pediatr Dermatol. 1995 Sep;12(3):215-9 [7501549.001]
  • [Cites] Ann Neurol. 1996 Jul;40(1):8-17 [8687196.001]
  • [Cites] Biochem Mol Med. 1996 Apr;57(2):139-48 [8733892.001]
  • [Cites] Hum Mutat. 1996;8(1):38-43 [8807334.001]
  • [Cites] J Med Genet. 1996 Aug;33(8):682-8 [8863162.001]
  • [Cites] Eur J Hum Genet. 1996;4(4):219-24 [8875188.001]
  • [Cites] Hum Genet. 1996 Dec;98(6):719-26 [8931708.001]
  • [Cites] Urology. 1996 Dec;48(6):949-52 [8973687.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2540-4 [9122231.001]
  • [Cites] Am J Respir Crit Care Med. 1997 Mar;155(3):1004-10 [9116979.001]
  • [Cites] Mol Med. 1997 Mar;3(3):174-82 [9100224.001]
  • [Cites] Lancet Neurol. 2006 Sep;5(9):791-5 [16914407.001]
  • [Cites] Clin Nephrol. 2006 Aug;66(2):77-84 [16939062.001]
  • [Cites] Pediatrics. 2006 Sep;118(3):924-32 [16950982.001]
  • [Cites] J Inherit Metab Dis. 2006 Oct;29(5):653-9 [16972173.001]
  • [Cites] Genet Med. 2006 Sep;8(9):539-48 [16980809.001]
  • [Cites] Mol Genet Metab. 2006 Nov;89(3):239-44 [16765076.001]
  • [Cites] Eur J Med Genet. 2006 Sep-Oct;49(5):419-25 [16510324.001]
  • [Cites] Cardiovasc Hematol Agents Med Chem. 2006 Oct;4(4):289-97 [17073606.001]
  • [Cites] J Clin Endocrinol Metab. 2006 Nov;91(11):4319-25 [16926253.001]
  • [Cites] J Med Assoc Thai. 2006 Sep;89(9):1528-35 [17100396.001]
  • [Cites] Neurology. 2006 Dec 12;67(11):2045-7 [17159117.001]
  • [Cites] Brain. 2007 Jan;130(Pt 1):143-50 [17105746.001]
  • [Cites] Acta Paediatr. 2007 Jan;96(1):122-7 [17187618.001]
  • [Cites] Ann Intern Med. 2007 Jan 16;146(2):77-86 [17179052.001]
  • [Cites] J Inherit Metab Dis. 2007 Feb;30(1):106 [17171433.001]
  • [Cites] J Inherit Metab Dis. 2007 Feb;30(1):68-78 [17206462.001]
  • [Cites] Br J Ophthalmol. 2007 Feb;91(2):210-4 [16973664.001]
  • [Cites] J Inherit Metab Dis. 2007 Apr;30(2):184-92 [17347915.001]
  • [Cites] Clin Neurol Neurosurg. 2007 May;109(4):361-3 [17234336.001]
  • [Cites] Acta Paediatr Suppl. 2007 Apr;96(455):6-16 [17391432.001]
  • [Cites] Acta Paediatr Suppl. 2007 Apr;96(455):33-6 [17391437.001]
  • [Cites] Heart. 2007 Apr;93(4):528-35 [17401074.001]
  • [Cites] Lymphat Res Biol. 2003;1(3):185-9 [15624436.001]
  • [Cites] FASEB J. 2005 Jan;19(1):12-8 [15629890.001]
  • [Cites] Curr Opin Nephrol Hypertens. 2005 Mar;14(2):87-95 [15687833.001]
  • [Cites] Kidney Int. 2003 Sep;64(3):801-7 [12911529.001]
  • [Cites] Hum Mutat. 2003 Sep;22(3):258 [12938095.001]
  • [Cites] J Inherit Metab Dis. 2003;26(4):413-4 [12971431.001]
  • [Cites] Circulation. 2003 Sep 16;108(11):1299-301 [12952834.001]
  • [Cites] Mol Genet Metab. 2003 Nov;80(3):307-14 [14680977.001]
  • [Cites] Hum Pathol. 2003 Dec;34(12):1358; author reply 1358-9 [14691926.001]
  • [Cites] J Inherit Metab Dis. 2003;26(7):617-27 [14707510.001]
  • [Cites] Eur J Hum Genet. 2004 Feb;12(2):87-92 [14685153.001]
  • [Cites] Clin Genet. 2004 Feb;65(2):77-86 [14984463.001]
  • [Cites] Acta Paediatr Suppl. 2003 Dec;92(443):14-5; discussion 5 [14989460.001]
  • [Cites] Acta Paediatr Suppl. 2003 Dec;92(443):33-7; discussion 27 [14989464.001]
  • [Cites] J Mol Biol. 2004 Mar 19;337(2):319-35 [15003450.001]
  • [Cites] Rev Prat. 2003 Dec 31;53(20):2215-20 [15018073.001]
  • [Cites] Clin Genet. 2004 Apr;65(4):299-307 [15025723.001]
  • [Cites] Brain Dev. 2004 Sep;26(6):363-6 [15275696.001]
  • [Cites] Curr Opin Cardiol. 2004 Sep;19(5):452-7 [15316452.001]
  • [Cites] Nucl Med Commun. 1998 Sep;19(9):887-91 [10581595.001]
  • [Cites] Ann Neurol. 2000 Feb;47(2):229-33 [10665494.001]
  • [Cites] Pain. 2000 Feb;84(2-3):361-5 [10666542.001]
  • [Cites] Mol Med. 1999 Dec;5(12):806-11 [10666480.001]
  • [Cites] Am Heart J. 2000 Jun;139(6):1101-8 [10827394.001]
  • [Cites] Biochim Biophys Acta. 2000 Jun 15;1501(2-3):227-35 [10838196.001]
  • [Cites] J Clin Invest. 2000 Jun;105(11):1563-71 [10841515.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7515-20 [10840053.001]
  • [Cites] Transplantation. 2000 Jun 15;69(11):2337-9 [10868636.001]
  • [Cites] J Investig Med. 2000 Jul;48(4):227-35 [10916280.001]
  • [Cites] Clin Genet. 2000 Sep;58(3):228-33 [11076046.001]
  • [Cites] Rev Med Interne. 2000 Dec;21(12):1086-103 [11191676.001]
  • [Cites] Am J Hum Genet. 2001 Jan;68(1):14-25 [11115376.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2676-81 [11226298.001]
  • [Cites] Hum Mutat. 2001 Apr;17(4):353 [11295840.001]
  • [Cites] J Hum Genet. 2001;46(4):192-6 [11322659.001]
  • [Cites] JAMA. 2001 Jun 6;285(21):2743-9 [11386930.001]
  • [Cites] N Engl J Med. 2001 Jul 5;345(1):9-16 [11439963.001]
  • [Cites] N Engl J Med. 2001 Jul 5;345(1):25-32 [11439944.001]
  • [Cites] Clin Chim Acta. 2001 Jun;308(1-2):195-6 [11432396.001]
  • [Cites] Clin Genet. 2001 Jul;60(1):46-51 [11531969.001]
  • [Cites] Clin Genet. 2001 Jul;60(1):63-7 [11531972.001]
  • [Cites] J Med Genet. 2001 Sep;38(9):629-31 [11565551.001]
  • [Cites] Anal Bioanal Chem. 2005 Jul;382(5):1209-16 [15959771.001]
  • [Cites] J Pediatr. 2005 Jul;147(1):102-5 [16027705.001]
  • [Cites] Neurology. 2005 Aug 23;65(4):600-2 [16116124.001]
  • [Cites] J Inherit Metab Dis. 2005;28(5):715-22 [16151903.001]
  • [Cites] J Inherit Metab Dis. 2005;28(5):787-8 [16151910.001]
  • [Cites] J Inherit Metab Dis. 2005;28(5):803-5 [16151917.001]
  • [Cites] Am J Cardiol. 2005 Sep 15;96(6):842-6 [16169374.001]
  • [Cites] Clin Exp Nephrol. 2005 Sep;9(3):228-32 [16189631.001]
  • [Cites] Respiration. 2005 Sep-Oct;72(5):504-11 [16210890.001]
  • [Cites] Pacing Clin Electrophysiol. 2005 Oct;28(10):1142-3 [16221278.001]
  • [Cites] Clin Chem Lab Med. 2005;43(11):1276-7 [16232095.001]
  • [Cites] Lancet. 2005 Nov 19;366(9499):1794-6 [16298216.001]
  • [Cites] J Mass Spectrom. 2006 Jan;41(1):50-8 [16287034.001]
  • [Cites] Nephrol Dial Transplant. 2006 Feb;21(2):345-54 [16204287.001]
  • [Cites] Nephrol Dial Transplant. 2006 Feb;21(2):355-60 [16249196.001]
  • [Cites] Acta Paediatr. 2006 Jan;95(1):86-92 [16498740.001]
  • [Cites] Heart. 2006 Mar;92(3):357-60 [16085718.001]
  • [Cites] Virchows Arch. 2006 Mar;448(3):337-43 [16315019.001]
  • [Cites] Am J Physiol Cell Physiol. 2006 Apr;290(4):C1076-82 [16531566.001]
  • [Cites] Acta Neuropathol. 2006 Feb;111(2):178-85 [16463201.001]
  • [Cites] J Hum Genet. 2006;51(3):180-8 [16372133.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):839-44 [16469946.001]
  • [Cites] Kidney Int. 2002 Dec;62(6):1933-46 [12427118.001]
  • [Cites] Mol Med. 2002 Jun;8(6):306-12 [12428061.001]
  • [Cites] J Clin Neurophysiol. 2002 Dec;19(6):575-86 [12488789.001]
  • [Cites] J Am Geriatr Soc. 1985 Apr;33(4):278-85 [3989190.001]
  • [Cites] J Am Coll Cardiol. 1986 May;7(5):1157-61 [3082958.001]
  • [Cites] Proc Natl Acad Sci U S A. 1986 Jul;83(13):4859-63 [3014515.001]
  • [Cites] Postgrad Med J. 1986 Oct;62(732):969 [3095821.001]
  • [Cites] Br Heart J. 1987 Mar;57(3):296-9 [3105563.001]
  • [Cites] J Am Acad Dermatol. 1987 Nov;17(5 Pt 2):883-7 [3119682.001]
  • [Cites] Arch Neurol. 1988 Apr;45(4):468-72 [3128256.001]
  • [Cites] Neurology. 1989 Apr;39(4):598-600 [2494569.001]
  • [Cites] J Clin Invest. 1989 Apr;83(4):1390-9 [2539398.001]
  • [Cites] Nucleic Acids Res. 1989 Apr 25;17(8):3301-2 [2542896.001]
  • [Cites] Am J Obstet Gynecol. 1990 Feb;162(2):464-5 [2155532.001]
  • [Cites] J Lipid Res. 1990 Feb;31(2):335-40 [2157788.001]
  • [Cites] J Biol Chem. 1990 Jun 5;265(16):9319-26 [2160973.001]
  • [Cites] Am J Hum Genet. 1990 Nov;47(5):784-9 [2171331.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1990;417(5):449-55 [2173254.001]
  • [Cites] N Engl J Med. 1991 Feb 7;324(6):395-9 [1846223.001]
  • [Cites] Heart. 2008 Feb;94(2):153-8 [17483124.001]
  • [Cites] Mol Genet Metab. 2008 Feb;93(2):112-28 [18037317.001]
  • [Cites] Hum Mutat. 2008 Feb;29(2):331 [18205205.001]
  • [Cites] Mol Biotechnol. 2008 Feb;38(2):109-19 [18219591.001]
  • [Cites] J Genet Couns. 2008 Feb;17(1):79-83 [18172746.001]
  • [Cites] Mol Genet Metab. 2008 Mar;93(3):331-40 [18023222.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2812-7 [18287059.001]
  • [Cites] J Pediatr. 2008 Apr;152(4):563-70, 570.e1 [18346516.001]
  • [Cites] Acta Paediatr. 2008 Apr;97(4):463-9 [18363956.001]
  • [Cites] Nephrol Dial Transplant. 2008 May;23(5):1628-35 [18057066.001]
  • [Cites] Nephrol Dial Transplant. 2008 May;23(5):1600-7 [18175781.001]
  • [Cites] Am J Kidney Dis. 2008 May;51(5):767-76 [18436087.001]
  • [Cites] Kidney Int. 2008 May;73(10):1193-9 [18033242.001]
  • [Cites] Genet Med. 2008 May;10(5):353-8 [18496035.001]
  • [Cites] J Neurol. 2008 May;255(5):738-44 [18297328.001]
  • [Cites] Acta Paediatr Suppl. 2006 Apr;95(451):57-62 [16720467.001]
  • [Cites] Acta Paediatr Suppl. 2006 Apr;95(451):63-8 [16720468.001]
  • [Cites] J Cardiovasc Magn Reson. 2006;8(3):479-82 [16755835.001]
  • [Cites] N Engl J Med. 2006 Jun 8;354(23):2473-83 [16760447.001]
  • [Cites] J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):397-404 [16763908.001]
  • [Cites] Am J Hum Genet. 2006 Jul;79(1):31-40 [16773563.001]
  • [Cites] Genet Med. 2006 Jun;8(6):346-53 [16778596.001]
  • [Cites] Am J Hypertens. 2006 Aug;19(8):782-7 [16876675.001]
  • [Cites] Expert Opin Biol Ther. 2009 Feb;9(2):255-61 [19236256.001]
  • [Cites] Stroke. 2009 Mar;40(3):788-94 [19150871.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 2009 Apr;247(4):523-34 [18931853.001]
  • [Cites] J Am Soc Nephrol. 2009 Mar;20(3):629-37 [19158356.001]
  • [Cites] Mol Genet Metab. 2009 Apr;96(4):233-8 [19181556.001]
  • [Cites] Transpl Int. 2009 Apr;22(4):475-81 [19207191.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2009 Apr;296(4):H1133-40 [19202000.001]
  • [Cites] Pharmacol Ther. 2009 Apr;122(1):65-77 [19318041.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2009 May;144(1):92-3 [19233535.001]
  • [Cites] Genet Med. 2009 Apr;11(4):256-64 [19265719.001]
  • [Cites] Clin Chim Acta. 2009 May;403(1-2):159-62 [19245803.001]
  • [Cites] Expert Opin Biol Ther. 2009 May;9(5):631-9 [19368525.001]
  • [Cites] J Am Soc Nephrol. 2009 May;20(5):1132-9 [19357250.001]
  • [Cites] Ultrasound Med Biol. 2009 May;35(5):730-5 [19110366.001]
  • [Cites] Am J Nephrol. 2009;29(5):353-61 [18974635.001]
  • [Cites] Circulation. 2009 May 19;119(19):2561-7 [19414635.001]
  • [Cites] Pediatr Ann. 2009 Apr;38(4):190, 192 [19455947.001]
  • [Cites] J Inherit Metab Dis. 2009 Jun;32(3):424-40 [19387866.001]
  • [Cites] Genet Med. 2009 Jun;11(6):441-9 [19346951.001]
  • [Cites] Heart. 2009 Jul;95(13):1103-7 [19372091.001]
  • [Cites] Nephrol Dial Transplant. 2009 Jul;24(7):2102-11 [19218538.001]
  • [Cites] J Med Genet. 2009 Aug;46(8):548-52 [19473999.001]
  • [Cites] Eur J Hum Genet. 2007 May;15(5):535-42 [17327876.001]
  • [Cites] J Am Soc Nephrol. 2007 May;18(5):1576-83 [17409308.001]
  • [Cites] J Am Soc Nephrol. 2007 May;18(5):1547-57 [17409312.001]
  • [Cites] Clin Chim Acta. 2005 Mar;353(1-2):201-3 [15698608.001]
  • [Cites] J Inherit Metab Dis. 2005;28(1):35-48 [15702404.001]
  • [Cites] Eur J Clin Invest. 2004 Mar;34(3):236-42 [15025684.001]
  • [Cites] Br J Dermatol. 2004 Mar;150(3):575-7 [15030345.001]
  • [Cites] Can J Neurol Sci. 2004 Feb;31(1):112-4 [15038481.001]
  • [Cites] Neurology. 2004 Apr 13;62(7):1066-72 [15079003.001]
  • [Cites] J Am Soc Nephrol. 2004 May;15(5):1323-9 [15100373.001]
  • [Cites] Ophthalmologica. 2004 May-Jun;218(3):207-9 [15103218.001]
  • [Cites] Mol Genet Metab. 2004 May;82(1):93-7 [15110329.001]
  • [Cites] J Pediatr. 2004 May;144(5 Suppl):S20-6 [15126980.001]
  • [Cites] J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Jun 15;805(2):331-7 [15135109.001]
  • [Cites] J Inherit Metab Dis. 2004;27(2):229-40 [15159654.001]
  • [Cites] Am J Hum Genet. 2004 Jul;75(1):65-74 [15154115.001]
  • [Cites] J Neurol. 2004 May;251(5):564-70 [15164189.001]
  • [Cites] Expert Opin Biol Ther. 2004 Jul;4(7):1167-76 [15268683.001]
  • [Cites] Hum Mutat. 2005 Mar;25(3):299-305 [15712228.001]
  • [Cites] J Clin Pharmacol. 2007 Oct;47(10):1222-30 [17698592.001]
  • [Cites] J Inherit Metab Dis. 2007 Oct;30(5):790-9 [17619837.001]
  • [Cites] J Neurol. 2007 Oct;254(10):1433-42 [17934877.001]
  • [Cites] J Neurol. 2007 Oct;254(10):1447-9 [17940724.001]
  • [Cites] Clin Gastroenterol Hepatol. 2007 Dec;5(12):1447-53 [17919989.001]
  • [Cites] J Inherit Metab Dis. 2007 Nov;30(6):988 [17849232.001]
  • [Cites] J Inherit Metab Dis. 2007 Nov;30(6):943-51 [17994284.001]
  • [Cites] Genet Med. 2007 Dec;9(12):812-8 [18091430.001]
  • [Cites] J Am Coll Cardiol. 2007 Dec 18;50(25):2399-403 [18154965.001]
  • [Cites] Clin J Am Soc Nephrol. 2008 Jan;3(1):139-45 [18003767.001]
  • [Cites] Pediatrics. 2005 Mar;115(3):e344-55 [15713906.001]
  • [Cites] J Med Genet. 2005 Mar;42(3):247-52 [15744039.001]
  • [Cites] Am J Med Genet A. 2005 Apr 1;134A(1):84-7 [15712198.001]
  • [Cites] Clin Experiment Ophthalmol. 2005 Apr;33(2):164-8 [15807825.001]
  • [Cites] Kidney Int. 2005 May;67(5):1955-60 [15840043.001]
  • [Cites] Acta Paediatr Suppl. 2005 Mar;94(447):15-8; discussion 9-10 [15895706.001]
  • [Cites] Acta Paediatr Suppl. 2005 Mar;94(447):51-4; discussion 37-8 [15895713.001]
  • [Cites] Acta Paediatr Suppl. 2005 Mar;94(447):87-92; discussion 79 [15895718.001]
  • [Cites] J Inherit Metab Dis. 2005;28(4):563-73 [15902560.001]
  • [Cites] J Inherit Metab Dis. 2005;28(4):575-83 [15902561.001]
  • [Cites] Mod Pathol. 2005 May;18(5):733-8 [15605079.001]
  • [Cites] Eur Heart J. 2005 Jun;26(12):1221-7 [15728649.001]
  • [Cites] Clin Genet. 2005 Jul;68(1):93-5 [15952993.001]
  • [Cites] J Obstet Gynaecol Res. 2010 Apr;36(2):428-9 [20492401.001]
  • [Cites] J Sex Med. 2010 Apr;7(4 Pt 1):1588-91 [20102445.001]
  • [Cites] Mol Genet Metab. 2010 Jul;100(3):257-61 [20409739.001]
  • [Cites] Nephrol Dial Transplant. 2010 Jul;25(7):2168-77 [19833663.001]
  • [Cites] J Hypertens. 2010 Jul;28(7):1438-48 [20125036.001]
  • [Cites] J Biol Chem. 2010 Jul 9;285(28):21560-6 [20444686.001]
  • [Cites] Am J Med. 2010 Jul;123(7):658.e1-658.e10 [20609689.001]
  • [Cites] J Inherit Metab Dis. 2010 Aug;33(4):429-36 [20549363.001]
  • [Cites] Biochim Biophys Acta. 2010 Sep;1802(9):741-8 [20471476.001]
  • [Cites] QJM. 2010 Sep;103(9):641-59 [20660166.001]
  • [Cites] Clin Chim Acta. 2010 Dec 14;411(23-24):1906-14 [20716442.001]
  • [Cites] Int J Cardiol. 2010 Oct 8;144(2):337-9 [19344961.001]
  • [Cites] Heart. 2010 Dec;96(23):1915-9 [20965976.001]
  • [Cites] Genet Med. 2010 Nov;12(11):703-12 [20885332.001]
  • [Cites] Biochim Biophys Acta. 2011 Jan;1812(1):70-6 [20851180.001]
  • [Cites] Clin J Am Soc Nephrol. 2010 Dec;5(12):2220-8 [20813854.001]
  • [Cites] Heart. 2011 Jan;97(2):131-6 [21062768.001]
  • [Cites] Rev Med Interne. 2010 Dec;31 Suppl 2:S209-13 [21211665.001]
  • [Cites] Cardiovasc Res. 2011 Feb 1;89(2):290-9 [20971723.001]
  • [Cites] Nephrol Dial Transplant. 2011 Jun;26(6):1797-802 [20504837.001]
  • [Cites] J Inherit Metab Dis. 2008 Dec;31 Suppl 2:S369-74 [18937048.001]
  • [Cites] Autophagy. 2010 Jul;6(5):589-99 [20431343.001]
  • [Cites] J Med Genet. 2006 Apr;43(4):347-52 [16227523.001]
  • [Cites] Hum Genomics. 2006 Mar;2(5):297-309 [16595074.001]
  • [Cites] J Inherit Metab Dis. 2006 Feb;29(1):106-11 [16601876.001]
  • [Cites] Intern Med J. 2002 Dec;32(12):575-84 [12512750.001]
  • [Cites] Clin Genet. 2003 Jan;63(1):46-52 [12519371.001]
  • [Cites] J Am Soc Nephrol. 2003 Feb;14(2):298-302 [12538729.001]
  • [Cites] Acta Paediatr Suppl. 2002;91(439):57-61 [12572844.001]
  • [Cites] Acta Paediatr Suppl. 2002;91(439):62-6 [12572845.001]
  • [Cites] Ann Intern Med. 2003 Feb 18;138(4):338-46 [12585833.001]
  • [Cites] Am J Clin Dermatol. 2003;4(3):189-96 [12627994.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3450-4 [12624185.001]
  • [Cites] Glycobiology. 2003 Apr;13(4):305-13 [12626384.001]
  • [Cites] Circulation. 2003 Apr 22;107(15):1978-84 [12668521.001]
  • [Cites] J Genet Couns. 2002 Apr;11(2):121-46 [12735292.001]
  • [Cites] AJNR Am J Neuroradiol. 2003 May;24(5):916-21 [12748094.001]
  • [Cites] AJNR Am J Neuroradiol. 2003 Jun-Jul;24(6):1096-101 [12812932.001]
  • [Cites] Am J Hum Genet. 2003 Jul;73(1):162-73 [12796853.001]
  • [Cites] Ophthalmic Genet. 2003 Sep;24(3):129-39 [12868031.001]
  • [Cites] Nephrol Dial Transplant. 2003 Aug;18(8):1581-4 [12897098.001]
  • [Cites] Clin Chem. 2008 Oct;54(10):1725-8 [18719200.001]
  • [Cites] Clin Genet. 2008 Sep;74(3):260-6 [18445046.001]
  • [Cites] Neuropathology. 2008 Oct;28(5):532-40 [18410273.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2008 Nov;79(11):1249-54 [18535022.001]
  • [Cites] Lancet. 2008 Oct 18;372(9647):1427-35 [18940466.001]
  • [Cites] Mol Genet Metab. 2008 Nov;95(3):163-8 [18707907.001]
  • [Cites] Pediatr Res. 2008 Nov;64(5):550-5 [18596579.001]
  • [Cites] J Am Soc Nephrol. 2008 Nov;19(11):2052-9 [18448583.001]
  • [Cites] Kidney Int. 2008 Nov;74(10):1366 [18974770.001]
  • [Cites] J Am Soc Echocardiogr. 2008 Nov;21(11):1265-8 [18835697.001]
  • [Cites] Int J Cardiol. 2008 Nov 28;130(3):367-73 [18572264.001]
  • [Cites] BMC Neurol. 2008;8:41 [18990229.001]
  • [Cites] Kidney Int Suppl. 2008 Dec;(111):S29-32 [19039306.001]
  • [Cites] Pain Med. 2008 Nov;9(8):1217-23 [18565003.001]
  • [Cites] Mol Genet Metab. 2009 Jan;96(1):4-12 [19022694.001]
  • [Cites] Neurology. 2009 Jan 6;72(1):63-8 [19122032.001]
  • [Cites] Transplantation. 2009 Jan 27;87(2):280-5 [19155985.001]
  • [Cites] Kidney Int. 2009 Feb;75(4):399-407 [19037253.001]
  • [Cites] Kidney Int. 2009 Feb;75(4):351-3 [19180148.001]
  • [Cites] Circulation. 2009 Feb 3;119(4):524-9 [19153271.001]
  • [Cites] Mol Genet Metab. 2009 Mar;96(3):83-4 [19083254.001]
  • [Cites] Transpl Int. 2009 Mar;22(3):287-92 [18954370.001]
  • [Cites] J Pharmacol Exp Ther. 2009 Mar;328(3):723-31 [19106170.001]
  • [Cites] J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S73-81 [20087663.001]
  • [Cites] J Inherit Metab Dis. 2006 Feb;29(1):112-8 [16601877.001]
  • [Cites] Kidney Int. 2006 Apr;69(7):1216-21 [16609685.001]
  • [Cites] Circulation. 2006 Apr 25;113(16):e720-1 [16636179.001]
  • [Cites] Am J Cardiol. 2006 May 15;97(10):1515-8 [16679096.001]
  • [Cites] Rev Neurol (Paris). 2006 May;162(5):569-80 [16710123.001]
  • [Cites] Acta Paediatr Suppl. 2006 Apr;95(451):30-8 [16720462.001]
  • [Cites] Virchows Arch. 2008 Jun;452(6):651-65 [18351385.001]
  • [Cites] J Cardiol. 2008 Feb;51(1):50-9 [18522775.001]
  • [Cites] Mol Genet Metab. 2008 Jul;94(3):319-25 [18424138.001]
  • [Cites] Mol Genet Metab. 2008 Jul;94(3):313-8 [18456533.001]
  • [Cites] Mol Genet Metab. 2008 Jul;94(3):382-5 [18472290.001]
  • [Cites] Br J Nurs. 2008 May 22-Jun 11;17(10):653-7 [18563007.001]
  • [Cites] J Inherit Metab Dis. 2008 Jun;31(3):432-41 [18509742.001]
  • [Cites] Intern Med J. 2008 Jun;38(6):407-14 [18613897.001]
  • [Cites] Virchows Arch. 2008 Sep;453(3):291-300 [18762974.001]
  • [Cites] Mol Genet Metab. 2008 Sep-Oct;95(1-2):114-5 [18701330.001]
  • [Cites] J Inherit Metab Dis. 2009 Aug;32(4):481-7 [19495571.001]
  • [Cites] Pain. 2009 Sep;145(1-2):10-1 [19665844.001]
  • [Cites] J Am Soc Nephrol. 2009 Sep;20(9):1975-85 [19628671.001]
  • [Cites] Eur Heart J. 2007 May;28(10):1228-35 [17483538.001]
  • [Cites] Clin Neurol Neurosurg. 2007 Jul;109(6):479-84 [17509753.001]
  • [Cites] Presse Med. 2007 Mar;36 Spec No 1:1S3-6 [17546760.001]
  • [Cites] Presse Med. 2007 Mar;36 Spec No 1:1S14-9 [17546762.001]
  • [Cites] Presse Med. 2007 Mar;36 Spec No 1:1S36-42 [17546766.001]
  • [Cites] Clin J Pain. 2007 Jul-Aug;23(6):535-42 [17575495.001]
  • [Cites] Clin Ther. 2007;29 Suppl A:S17-8 [17580237.001]
  • [Cites] Fertil Steril. 2007 Jul;88(1):212.e15-8 [17261284.001]
  • [Cites] PLoS One. 2007;2(7):e598 [17622343.001]
  • [Cites] Br J Dermatol. 2007 Aug;157(2):331-7 [17573884.001]
  • [Cites] Prenat Diagn. 2007 Aug;27(8):693-4 [17533632.001]
  • [Cites] Biochem J. 2007 Sep 1;406(2):285-95 [17555407.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2007 Sep;78(9):1007 [17702786.001]
  • [Cites] J Am Soc Nephrol. 2007 Sep;18(9):2426-8 [17699807.001]
  • [Cites] J Am Soc Nephrol. 2007 Sep;18(9):2609-17 [17656478.001]
  • [Cites] FEBS J. 2007 Oct;274(19):4962-71 [17894781.001]
  • [Cites] Eur J Pediatr. 2009 Nov;168(11):1355-63 [19242721.001]
  • [Cites] Hum Mutat. 2009 Oct;30(10):1397-405 [19621417.001]
  • [Cites] Auris Nasus Larynx. 2009 Dec;36(6):627-32 [19261412.001]
  • [Cites] Am J Hum Genet. 2009 Nov;85(5):569-80 [19853240.001]
  • [Cites] Adv Clin Chem. 2009;49:57-71 [19947355.001]
  • [Cites] Lancet. 2009 Dec 12;374(9706):1986-96 [19959221.001]
  • [Cites] Circ Cardiovasc Genet. 2009 Oct;2(5):450-6 [20031620.001]
  • [Cites] Stroke. 2010 Jan;41(1):78-81 [20007919.001]
  • [Cites] Int J Clin Pharmacol Ther. 2009;47 Suppl 1:S111-7 [20040321.001]
  • [Cites] Eur Heart J. 2010 Jan;31(1):67-76 [19773225.001]
  • [Cites] J Inherit Metab Dis. 2009 Dec;32(6):739-44 [19876760.001]
  • [Cites] J Inherit Metab Dis. 2009 Dec;32(6):745-53 [19924564.001]
  • [Cites] J Biol Chem. 2010 Feb 5;285(6):3625-32 [19940122.001]
  • [Cites] Clin J Am Soc Nephrol. 2010 Feb;5(2):359 [20019119.001]
  • [Cites] Clin J Am Soc Nephrol. 2010 Feb;5(2):365-70 [20056758.001]
  • [Cites] Mol Genet Metab. 2010 Mar;99(3):283-90 [19951842.001]
  • [Cites] Nephrol Dial Transplant. 2010 Mar;25(3):769-75 [19846394.001]
  • [Cites] Mol Genet Metab. 2010 Apr;99(4):367-73 [20022777.001]
  • [Cites] J Pediatr. 2010 May;156(5):832-7, 837.e1 [20097359.001]
  • [Cites] Eur J Med Genet. 2010 Mar-Apr;53(2):111-2 [20045092.001]
  • [Cites] Nephrol Dial Transplant. 2010 May;25(5):1507-13 [20038520.001]
  • [Cites] Stroke. 2010 May;41(5):863-8 [20360539.001]
  • [Cites] Lancet. 2010 May 1;375(9725):1523; author reply 1523-4 [20435225.001]
  • (PMID = 21092187.001).
  • [ISSN] 1750-1172
  • [Journal-full-title] Orphanet journal of rare diseases
  • [ISO-abbreviation] Orphanet J Rare Dis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] EC 3.2.1.22 / alpha-Galactosidase
  • [Other-IDs] NLM/ PMC3009617
  •  go-up   go-down


64. Busse PJ, Schofield B, Birmingham N, Yang N, Wen MC, Zhang T, Srivastava K, Li XM: The traditional Chinese herbal formula ASHMI inhibits allergic lung inflammation in antigen-sensitized and antigen-challenged aged mice. Ann Allergy Asthma Immunol; 2010 Mar;104(3):236-46
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Although asthma is typically characterized as a childhood disease, it can develop later in life.
  • The control groups were untreated, age-matched, ovalbumin-sensitized and ovalbumin-challenged mice (ovalbumin mice) and naive mice.

  • MedlinePlus Health Information. consumer health - Asthma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Exp Allergy. 2007 Sep;37(9):1392-403 [17845421.001]
  • [Cites] J Investig Allergol Clin Immunol. 1998 Jan-Feb;8(1):35-41 [9555618.001]
  • [Cites] Thorax. 1998 Nov;53(11):992-8 [10193402.001]
  • [Cites] J Immunol. 2001 Sep 1;167(5):2798-807 [11509625.001]
  • [Cites] Curr Med Res Opin. 2007 Oct;23(10):2379-86 [17711616.001]
  • [Cites] J Allergy Clin Immunol. 1974 Mar;53(3):127-38 [4813888.001]
  • [Cites] Ann Allergy Asthma Immunol. 2007 Feb;98(2):118-27 [17304877.001]
  • [Cites] J Allergy Clin Immunol. 2000 Oct;106(4):660-8 [11031336.001]
  • [Cites] J Altern Complement Med. 2009 Jul;15(7):735-43 [19586409.001]
  • [Cites] Br J Dis Chest. 1987 Jan;81(1):23-9 [3663486.001]
  • [Cites] Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1308-13 [11029336.001]
  • [Cites] Age Ageing. 1988 Jul;17(4):275-8 [3177088.001]
  • [Cites] Am J Respir Cell Mol Biol. 2002 Feb;26(2):202-8 [11804871.001]
  • [Cites] Drugs Aging. 2009;26(1):1-22 [19102511.001]
  • [Cites] J Allergy Clin Immunol. 2004 Jan;113(1):101-8 [14713914.001]
  • [Cites] Am J Respir Crit Care Med. 2002 Sep 1;166(5):686-90 [12204866.001]
  • [Cites] Am J Respir Crit Care Med. 2009 May 15;179(10):894-902 [19234104.001]
  • [Cites] Phytother Res. 2010 Jul;24(7):1047-55 [19998324.001]
  • [Cites] Respiration. 1998;65(5):347-53 [9782216.001]
  • [Cites] J Pharm Pharmacol. 2001 May;53(5):601-7 [11370699.001]
  • [Cites] J Allergy Clin Immunol. 2005 Sep;116(3):517-24 [16159618.001]
  • [Cites] Eur Respir J. 2005 May;25(5):879-84 [15863646.001]
  • [Cites] J Clin Invest. 2003 Oct;112(7):1029-36 [14523040.001]
  • [Cites] Age Ageing. 2003 May;32(3):299-302 [12720616.001]
  • [Cites] J Allergy Clin Immunol. 2005 Dec;116(6):1256-63 [16337454.001]
  • [Cites] Drugs. 1996 Mar;51(3):415-23 [8882379.001]
  • [Cites] Drug Saf. 2001;24(14):1065-80 [11735662.001]
  • [Cites] Chest. 2008 Feb;133(2):412-9 [18252914.001]
  • [Cites] Drugs. 2008;68(12):1741-70 [18681495.001]
  • [Cites] Clin Sci (Lond). 2005 Jun;108(6):463-77 [15896192.001]
  • [Cites] Am J Respir Cell Mol Biol. 2000 Mar;22(3):253-60 [10696060.001]
  • [Cites] Phytomedicine. 2009 Mar;16(2-3):97-110 [19211237.001]
  • (PMID = 20377113.001).
  • [ISSN] 1081-1206
  • [Journal-full-title] Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
  • [ISO-abbreviation] Ann. Allergy Asthma Immunol.
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / K08 AI063932; United States / NIAID NIH HHS / AI / K08 AI063932-01A2; United States / NCCIH NIH HHS / AT / P01 AT002647
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Asthmatic Agents; 0 / Antigens; 0 / Drugs, Chinese Herbal; 9006-59-1 / Ovalbumin
  • [Other-IDs] NLM/ NIHMS245951; NLM/ PMC4608683
  •  go-up   go-down


65. Arya LS, Dinand V, Thavaraj V, Bakhshi S, Dawar R, Rath GK, Singh R, Vats TS: Hodgkin's disease in Indian children: outcome with chemotherapy alone. Pediatr Blood Cancer; 2006 Jan;46(1):26-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: To assess the efficacy of chemotherapy alone, using four cycles of COPP alternating with four cycles of ABVD in all stages of childhood Hodgkin's disease (HD).
  • PROCEDURE: Between January 1991 and February 2001, 148 previously untreated patients were investigated, treated, and analyzed for remission and survival.
  • CONCLUSIONS: Chemotherapy alone with alternating COPP/ABVD, without additional radiotherapy, provides high rates of durable remission and is an effective therapy in childhood HD, even in case of large mediastinal mass and peripheral or abdominal bulky disease.

  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • Hazardous Substances Data Bank. BLEOMYCIN .
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. DACARBAZINE .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • Hazardous Substances Data Bank. PROCARBAZINE .
  • Hazardous Substances Data Bank. VINBLASTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16161019.001).
  • [ISSN] 1545-5009
  • [Journal-full-title] Pediatric blood & cancer
  • [ISO-abbreviation] Pediatr Blood Cancer
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 11056-06-7 / Bleomycin; 35S93Y190K / Procarbazine; 5J49Q6B70F / Vincristine; 5V9KLZ54CY / Vinblastine; 7GR28W0FJI / Dacarbazine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; ABVD protocol; COPP protocol
  •  go-up   go-down


66. Sun XF, Zhen ZJ, Liu DG, Xia ZJ, Huang HQ, Zhang L, Zhou ZM, Li YH, Xia Y, Ling JY, Guan ZZ: [Modified BFM-90 regimen greatly improves treatment outcomes of chinese childhood and adolescent lymphoblastic lymphoma]. Zhonghua Zhong Liu Za Zhi; 2007 Jan;29(1):58-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Modified BFM-90 regimen greatly improves treatment outcomes of chinese childhood and adolescent lymphoblastic lymphoma].
  • OBJECTIVE: This study was designed to evaluate the efficacy and toxicity of modified BFM-90 regimen originated from Germany authors in the treatment of Chinese childhood and adolescent lymphoblastic lymphoma.
  • METHODS: Thirty-six untreated lymphoblastic lymphoma patients aged from 3 to 18 years were included, with 1 patient in stage II , 9 in stage III and 26 in stage IV.
  • CONCLUSION: Modified BFM-90 protocol can improve the efficacy and survival of Chinese childhood and adolescent lymphoblastic lymphoma with tolerable toxicity.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy

  • Genetic Alliance. consumer health - Lymphoblastic lymphoma.
  • Hazardous Substances Data Bank. CYTARABINE .
  • Hazardous Substances Data Bank. DAUNORUBICIN .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. MERCAPTOPURINE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • Hazardous Substances Data Bank. METHOTREXATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17575697.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] Clinical Trial; English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 04079A1RDZ / Cytarabine; 5J49Q6B70F / Vincristine; 8N3DW7272P / Cyclophosphamide; E7WED276I5 / 6-Mercaptopurine; EC 3.5.1.1 / Asparaginase; VB0R961HZT / Prednisone; YL5FZ2Y5U1 / Methotrexate; ZS7284E0ZP / Daunorubicin; AIEOP acute lymphoblastic leukemia protocol
  •  go-up   go-down


67. Schmitz SA, O'Regan DP, Fitzpatrick J, Neuwirth C, Potter E, Tosi I, Hajnal JV, Naoumova RP: MRI at 3 Tesla detects no evidence for ischemic brain damage in intensively treated patients with homozygous familial hypercholesterolemia. Neuroradiology; 2007 Nov;49(11):927-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Patients with untreated homozygous FH have a markedly increased risk for premature atherosclerosis.
  • All patients had been on maximal lipid-lowering medication since early childhood, and four of them were also on treatment with low-density lipoprotein (LDL) apheresis at bi-weekly intervals.


68. Sondhi D, Peterson DA, Edelstein AM, del Fierro K, Hackett NR, Crystal RG: Survival advantage of neonatal CNS gene transfer for late infantile neuronal ceroid lipofuscinosis. Exp Neurol; 2008 Sep;213(1):18-27
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Late infantile neuronal ceroid lipofuscinosis (LINCL), a fatal autosomal recessive neurodegenerative lysosomal storage disorder of childhood, is caused by mutations in the CLN2 gene, resulting in deficiency of the protein tripeptidyl peptidase I (TPP-I).
  • Using behavioral markers, 2 day-treated mice demonstrate marked improvement over 3 wk, 7 wk or untreated mice.
  • Finally, neonatal administration of AAVrh.10hCLN2 was associated with markedly enhanced survival, with a median time of death 376 days for neonatal treated mice, 277 days for 3 wk-treated mice, 168 days for 7 wk-treated mice, and 121 days for untreated mice.
  • These data suggest that neonatal treatment offers many unique advantages, and that early detection and treatment may be essential for maximal gene therapy for childhood lysosomal storage disorders affecting the CNS.

  • MedlinePlus Health Information. consumer health - Genes and Gene Therapy.
  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Exp Physiol. 2005 Jan;90(1):53-9 [15542619.001]
  • [Cites] Stem Cells Dev. 2007 Jun;16(3):429-38 [17610373.001]
  • [Cites] Arch Neurol. 2001 Nov;58(11):1793-8 [11708986.001]
  • [Cites] J Virol. 2001 Dec;75(24):12382-92 [11711628.001]
  • [Cites] Exp Neurol. 2002 Jan;173(1):1-21 [11771935.001]
  • [Cites] Hum Gene Ther. 2002 Mar 20;13(5):579-604 [11916483.001]
  • [Cites] Am J Med Genet. 2002 Nov 1;112(4):347-54 [12376936.001]
  • [Cites] Methods. 2002 Oct;28(2):203-7 [12413418.001]
  • [Cites] J Neuropathol Exp Neurol. 2003 Jan;62(1):1-13 [12528813.001]
  • [Cites] J Virol. 2003 Jun;77(12):7034-40 [12768022.001]
  • [Cites] Gene Ther. 2004 Oct;11 Suppl 1:S92-7 [15454963.001]
  • [Cites] J Neurosci. 2004 Oct 13;24(41):9117-26 [15483130.001]
  • [Cites] Annu Rev Biochem. 1991;60:257-80 [1883197.001]
  • [Cites] Exp Neurol. 1993 Jul;122(1):155-64 [8339785.001]
  • [Cites] J Virol. 1996 Jul;70(7):4646-54 [8676491.001]
  • [Cites] J Neurochem. 1996 Aug;67(2):677-83 [8764595.001]
  • [Cites] Neuroscience. 1997 Jul;79(1):57-78 [9178865.001]
  • [Cites] FASEB J. 1997 Jul;11(8):635-9 [9240965.001]
  • [Cites] Science. 1997 Sep 19;277(5333):1802-5 [9295267.001]
  • [Cites] Neuroscience. 1998 Jun;84(4):1013-23 [9578392.001]
  • [Cites] J Neurosurg. 1999 Feb;90(2):315-20 [9950503.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2296-300 [10051635.001]
  • [Cites] Hum Gene Ther. 2004 Nov;15(11):1131-54 [15610613.001]
  • [Cites] Br J Haematol. 2005 Feb;128(4):413-31 [15686451.001]
  • [Cites] Hum Gene Ther. 2005 Jan;16(1):49-56 [15703488.001]
  • [Cites] Mol Ther. 2005 May;11(5):734-44 [15851012.001]
  • [Cites] J Gene Med. 2005 May;7(5):530-9 [15651039.001]
  • [Cites] N Engl J Med. 2005 May 19;352(20):2069-81 [15901860.001]
  • [Cites] Hum Gene Ther. 2005 Jul;16(7):781-91 [16000060.001]
  • [Cites] Annu Rev Neurosci. 2005;28:223-50 [16022595.001]
  • [Cites] Nat Rev Neurosci. 2005 Sep;6(9):713-25 [16049428.001]
  • [Cites] Neuropediatrics. 2005 Oct;36(5):285-9 [16217702.001]
  • [Cites] Hum Gene Ther. 2005 Dec;16(12):1484-503 [16390279.001]
  • [Cites] Annu Rev Med. 2006;57:283-96 [16409150.001]
  • [Cites] J Neurosci. 2006 Feb 1;26(5):1334-42 [16452657.001]
  • [Cites] Neuroscience. 2006;138(2):501-10 [16414198.001]
  • [Cites] Mol Ther. 2006 Mar;13(3):538-47 [16364693.001]
  • [Cites] Neurology. 2007 Aug 7;69(6):521-35 [17679671.001]
  • [Cites] J Inherit Metab Dis. 2007 Aug;30(4):447-65 [17643194.001]
  • [Cites] Mol Ther. 2007 Oct;15(10):1782-8 [17637720.001]
  • [Cites] Pediatrics. 2007 Nov;120(5):e1327-34 [17974725.001]
  • [Cites] Gene Ther. 2007 Nov;14(22):1605-9 [17898796.001]
  • [Cites] Mol Ther. 2006 Mar;13(3):463-83 [16412695.001]
  • [Cites] Mol Ther. 2006 Mar;13(3):528-37 [16413228.001]
  • [Cites] J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):405-8 [16763909.001]
  • [Cites] Mol Genet Metab. 2006 Aug;88(4):307-14 [16600651.001]
  • [Cites] Hum Gene Ther. 2006 Aug;17(8):807-20 [16942441.001]
  • [Cites] Mol Ther. 2007 Jan;15(1):30-7 [17164772.001]
  • [Cites] Hum Genet. 2007 Mar;121(1):1-22 [17089160.001]
  • [Cites] Mol Ther. 2007 Mar;15(3):481-91 [17180118.001]
  • [Cites] Brain Res. 2007 Apr 6;1140:195-204 [17289003.001]
  • [Cites] Curr Opin Neurol. 2007 Apr;20(2):151-8 [17351484.001]
  • [Cites] J Inherit Metab Dis. 2007 Apr;30(2):129-33 [17342450.001]
  • [Cites] Hum Gene Ther. 2007 Mar;18(3):195-206 [17343566.001]
  • [Cites] Clin Genet. 2007 May;71(5):446-50 [17489850.001]
  • [Cites] Gene Ther. 2001 Jul;8(14):1081-7 [11526455.001]
  • (PMID = 18639872.001).
  • [ISSN] 1090-2430
  • [Journal-full-title] Experimental neurology
  • [ISO-abbreviation] Exp. Neurol.
  • [Language] ENG
  • [Grant] United States / NINDS NIH HHS / NS / NS047458-01A1; United States / NINDS NIH HHS / NS / U01 NS047458; United States / NINDS NIH HHS / NS / U01 NS047458-01A1
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 3.4.- / Endopeptidases; EC 3.4.- / Serine Proteases; EC 3.4.11.- / Aminopeptidases; EC 3.4.14.- / Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; EC 3.4.14.9 / tripeptidyl-peptidase 1
  • [Other-IDs] NLM/ NIHMS91788; NLM/ PMC2702175
  •  go-up   go-down


69. Sun XF, Liu DG, Zhen ZJ, Chen XQ, Xia Y, Wang ZH, He YJ, Guan ZG: [Efficacy of short-term and intensive chemotherapy for the treatment of childhood and adolescent B cell non-Hodgkin's lymphoma]. Zhonghua Xue Ye Xue Za Zhi; 2005 Oct;26(10):581-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Efficacy of short-term and intensive chemotherapy for the treatment of childhood and adolescent B cell non-Hodgkin's lymphoma].
  • OBJECTIVES: To evaluate the efficacy and toxicity of the B-NHL-BFM-90 protocol in the treatment of Chinese childhood and adolescent B-cell non-Hodgkin's lymphomas (B-NHL).
  • METHODS: Forty-two untreated childhood and adolescent B-NHL were enrolled in the present study.
  • CONCLUSION: Short term and intensive chemotherapy can improves the efficacy and survival rate of childhood and adolescent B-NHL, especially for advanced stage patients.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16532964.001).
  • [ISSN] 0253-2727
  • [Journal-full-title] Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • [ISO-abbreviation] Zhonghua Xue Ye Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


70. Hudgins LC, Kleinman B, Scheuer A, White S, Gordon BR: Long-term safety and efficacy of low-density lipoprotein apheresis in childhood for homozygous familial hypercholesterolemia. Am J Cardiol; 2008 Nov 1;102(9):1199-204
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term safety and efficacy of low-density lipoprotein apheresis in childhood for homozygous familial hypercholesterolemia.
  • Untreated pediatric patients with homozygous familial hypercholesterolemia usually have myocardial infarctions, heart failure, or death by the teenage years.
  • In conclusion, LDL apheresis is well tolerated for decades by even very young pediatric patients with homozygous familial hypercholesterolemia.

  • Genetic Alliance. consumer health - Familial Hypercholesterolemia.
  • Genetic Alliance. consumer health - Hypercholesterolemia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18940291.001).
  • [ISSN] 1879-1913
  • [Journal-full-title] The American journal of cardiology
  • [ISO-abbreviation] Am. J. Cardiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cholesterol, LDL
  •  go-up   go-down


71. Wooditch AC, Aronoff SC: Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children. Pediatrics; 2005 Oct;116(4):989-95
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: Kawasaki disease is an acute vasculitis of infancy and childhood.
  • When untreated, 15% to 25% of patients develop coronary artery aneurysms.


72. Al-Qahtani FS: Congenital amegakaryocytic thrombocytopenia: a brief review of the literature. Clin Med Insights Pathol; 2010 Jun 04;3:25-30
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Prognosis of CAMT patients is poor, because all develop in childhood a tri-linear marrow aplasia that is always fatal when untreated.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21151552.001).
  • [ISSN] 1179-5557
  • [Journal-full-title] Clinical medicine insights. Pathology
  • [ISO-abbreviation] Clin Med Insights Pathol
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2999995
  • [Keywords] NOTNLM ; amegakaryocytic / congenital / inherited / thrombocytopenia
  •  go-up   go-down


73. Zadik Z, Sinai T, Borondukov E, Zung A, Yaniv I, Reifen R: Longitudinal monitoring of bone accretion measured by quantitative multi-site ultrasound (QUS) of bones in patients with delayed puberty (a pilot study). Osteoporos Int; 2005 Sep;16(9):1036-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Proper bone development during childhood is the key factor in achieving higher peak bone mass during middle age, which may not be achievable in CGDP children, and thereby osteoporosis may appear at an earlier age then expected.
  • Despite the fact that QUS remained in the normative range in all patients, a clear deterioration was demonstrated in untreated CGDP patients.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. OXANDROLONE .
  • Hazardous Substances Data Bank. TESTOSTERONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Bone Miner Res. 1999 Nov;14 (11):1952-62 [10571696.001]
  • [Cites] J Clin Endocrinol Metab. 1990 May;70(5):1330-3 [2335574.001]
  • [Cites] BMJ. 1994 Apr 9;308(6934):939-41 [8173399.001]
  • [Cites] J Clin Endocrinol Metab. 1996 Oct;81(10):3460-4 [8855785.001]
  • [Cites] Am J Public Health. 1994 Aug;84(8):1319-22 [8059895.001]
  • [Cites] J Clin Densitom. 2001 Fall;4(3):239-48 [11740066.001]
  • [Cites] Clin Orthop Relat Res. 1983 Sep;(178):292-6 [6883863.001]
  • [Cites] J Bone Miner Res. 1999 Apr;14 (4):644-51 [10234587.001]
  • [Cites] J Clin Endocrinol Metab. 1992 Oct;75(4):1060-5 [1400871.001]
  • [Cites] Endocrinology. 1988 Jan;122(1):254-60 [3335207.001]
  • [Cites] Acta Paediatr. 1995 Jun;84(6):627-30 [7670243.001]
  • [Cites] Osteoporos Int. 2001;12 (6):456-64 [11446561.001]
  • [Cites] J Bone Miner Res. 1998 Jan;13(1):143-8 [9443800.001]
  • [Cites] Am J Clin Nutr. 1989 Mar;49(3):534-41 [2923086.001]
  • [Cites] Osteoporos Int. 2003 Oct;14 (10 ):857-62 [12915957.001]
  • [Cites] J Clin Endocrinol Metab. 1999 Dec;84(12):4489-96 [10599707.001]
  • [Cites] J Nutr. 1979 Sep;109(9):1652-60 [573313.001]
  • [Cites] J Pediatr. 1994 Aug;125(2):201-7 [8040762.001]
  • [Cites] Osteoporos Int. 2000;11(8):688-96 [11095172.001]
  • [Cites] Pediatrics. 1995 Dec;96(6):1095-100 [7491227.001]
  • [Cites] J Pediatr Endocrinol Metab. 2001 Jul;14 Suppl 2:953-7 [11529401.001]
  • [Cites] N Engl J Med. 1992 Feb 27;326(9):600-4 [1734250.001]
  • [Cites] J Clin Endocrinol Metab. 1999 Dec;84(12):4349-54 [10599687.001]
  • [Cites] J Clin Endocrinol Metab. 1999 Dec;84(12):4355-61 [10599688.001]
  • [Cites] Annu Rev Nutr. 1983;3:213-21 [6357235.001]
  • [Cites] J Clin Endocrinol Metab. 1991 Sep;73(3):555-63 [1874933.001]
  • [Cites] Am J Clin Nutr. 1979 Mar;32(3):540-9 [420146.001]
  • [Cites] J Clin Densitom. 2000 Spring;3(1):1-7 [10745297.001]
  • [Cites] J Clin Endocrinol Metab. 1996 Mar;81(3):1152-5 [8772591.001]
  • [Cites] Endocrinol Metab Clin North Am. 1989 Dec;18(4):903-18 [2691242.001]
  • [Cites] Osteoporos Int. 2000;11(5):411-6 [10912843.001]
  • [Cites] J Clin Invest. 1999 Sep;104(6):795-804 [10491415.001]
  • [Cites] Bone. 1995 Jan;16(1):5-7 [7742083.001]
  • [Cites] J Pediatr. 1993 Dec;123(6):863-70 [8229518.001]
  • [Cites] J Clin Endocrinol Metab. 1998 Dec;83(12):4280-3 [9851764.001]
  • (PMID = 15616757.001).
  • [ISSN] 0937-941X
  • [Journal-full-title] Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
  • [ISO-abbreviation] Osteoporos Int
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Randomized Controlled Trial
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anabolic Agents; 3XMK78S47O / Testosterone; 7H6TM3CT4L / Oxandrolone
  •  go-up   go-down


74. Ertekin V, Selimoğlu MA, Turgut A, Bakan N: Fecal calprotectin concentration in celiac disease. J Clin Gastroenterol; 2010 Sep;44(8):544-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: As FC is regarded as a marker of inflammation in the gastrointestinal tract, we hypothesized that it might be increased in untreated CD.
  • FC concentration under GFD was 4.6+/-2.7 mg/L and there was a significant statistical difference between untreated patients and those under GFD for 1 year (P=0.001).
  • CONCLUSIONS: It was found that FC concentration is increased in childhood CD, related to the severity of histopathologic findings and responsive to GFD.

  • Genetic Alliance. consumer health - Celiac Disease.
  • MedlinePlus Health Information. consumer health - Bowel Movement.
  • MedlinePlus Health Information. consumer health - Celiac Disease.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20054281.001).
  • [ISSN] 1539-2031
  • [Journal-full-title] Journal of clinical gastroenterology
  • [ISO-abbreviation] J. Clin. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Leukocyte L1 Antigen Complex
  •  go-up   go-down


75. Szilágyi A, Barta C, Boór K, Székely A, Demetrovics Z, Csorba J, Kalász H, Sasvári-Székely M: [The potential role of childhood ADHD in the development of heroin dependence at a young age]. Neuropsychopharmacol Hung; 2007 Jun;9(2):69-75
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The potential role of childhood ADHD in the development of heroin dependence at a young age].
  • The ADHD Rating Scale (ADHD-RS) completed by parents is a tool for diagnosing ADHD in childhood.
  • We adapted this questionnaire for a self-report retrospective scale to estimate the presence of childhood ADHD symptoms in adults.
  • Besides, mean score of both scales were higher in the clinical population as a higher portion of substance abusers reported symptoms of childhood ADHD than controls.
  • These results support the hypothesis that untreated childhood ADHD could be a risk factor for developing substance use disorder.

  • MedlinePlus Health Information. consumer health - Attention Deficit Hyperactivity Disorder.
  • MedlinePlus Health Information. consumer health - Heroin.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17970529.001).
  • [ISSN] 1419-8711
  • [Journal-full-title] Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakológiai Egyesület lapja = official journal of the Hungarian Association of Psychopharmacology
  • [ISO-abbreviation] Neuropsychopharmacol Hung
  • [Language] hun
  • [Publication-type] English Abstract; Evaluation Studies; Journal Article; Validation Studies
  • [Publication-country] Hungary
  •  go-up   go-down


76. Cybulla M, Walter K, Neumann HP, Widmer U, Schärer M, Sunder-Plassmann G, Jansen T, Rolfs A, Beck M: [Fabry disease: demographic data since introduction of enzyme replacement therapy]. Dtsch Med Wochenschr; 2007 Jul 5;132(28-29):1505-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The disease not only markedly impairs the quality of life but also shortens life expectancy if untreated.
  • RESULTS: Typical symptoms - acroparesthesias, joint pain, hypohidrosis, fever and angiokeratoma - have their onset in childhood (mean age nine years).


77. Zeng WQ, Al-Yamani E, Acierno JS Jr, Slaugenhaupt S, Gillis T, MacDonald ME, Ozand PT, Gusella JF: Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3. Am J Hum Genet; 2005 Jul;77(1):16-26
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Biotin-responsive basal ganglia disease (BBGD) is a recessive disorder with childhood onset that presents as a subacute encephalopathy, with confusion, dysarthria, and dysphagia, and that progresses to severe cogwheel rigidity, dystonia, quadriparesis, and eventual death, if left untreated.


78. Aminorroaya A, Kelleher S, Conway AJ, Ly LP, Handelsman DJ: Adequacy of androgen replacement influences bone density response to testosterone in androgen-deficient men. Eur J Endocrinol; 2005 Jun;152(6):881-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Patients were classified as having a congenital, childhood, or post-pubertal onset, as well as according to the adequacy of treatment prior to their first DEXA scan as untreated, partially treated or well treated.
  • In cross-sectional analysis at the time of the first DEXA scan untreated men (n = 24) had significantly reduced age-adjusted BMD at all four sites (L1-L4, femoral neck, Ward's triangle and trochanter).
  • Well-treated men (n = 77) had significantly better age-adjusted BMD at all four sites compared with those who were partially treated (n = 66) or untreated (n = 24) with their age-adjusted BMD being normalized.
  • In a longitudinal assessment of men (n = 60) who had two or more serial DEXA scans, at the second DEXA scan after a median of 3 years, men who were previously partially treated (n = 19) or untreated (n = 11) had proportionately greater improvements in BMD, significantly for Ward's triangle (P = 0.025) and the trochanter (P = 0.044) compared with men (n = 30) previously well treated.
  • The greatest BMD gains are made by those who have been either untreated or partially treated, and optimal treatment over time (median 3 years) normalizes BMD to the level expected for healthy men of the same age.

  • MedlinePlus Health Information. consumer health - Bone Density.
  • MedlinePlus Health Information. consumer health - Hormone Replacement Therapy.
  • Hazardous Substances Data Bank. TESTOSTERONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15941928.001).
  • [ISSN] 0804-4643
  • [Journal-full-title] European journal of endocrinology
  • [ISO-abbreviation] Eur. J. Endocrinol.
  • [Language] ENG
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Androgens; 3XMK78S47O / Testosterone
  •  go-up   go-down


79. Taddio A, Chambers CT, Halperin SA, Ipp M, Lockett D, Rieder MJ, Shah V: Inadequate pain management during routine childhood immunizations: the nerve of it. Clin Ther; 2009;31 Suppl 2:S152-67
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inadequate pain management during routine childhood immunizations: the nerve of it.
  • Recently, increasing attention has been paid to the pain resulting from routine childhood immunizations.
  • (1) the epidemiology of childhood immunization pain;.
  • RESULTS: Vaccine injections are the most common iatrogenic procedure performed in childhood and a major source of distress for children (of all ages), their parents, and the participating health care professionals, as well as a direct cause of vaccine nonadherence.
  • Treating pain during childhood immunization has the potential to reduce distress during the procedure and greatly improve satisfaction with the immunization experience through more positive experiences for children and their families.
  • Other potential benefits include improved adherence to immunization schedules and reduced sequelae of untreated pain.


80. Dinand V, Dawar R, Arya LS, Unni R, Mohanty B, Singh R: Hodgkin's lymphoma in Indian children: prevalence and significance of Epstein-Barr virus detection in Hodgkin's and Reed-Sternberg cells. Eur J Cancer; 2007 Jan;43(1):161-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: 145 previously untreated children diagnosed with HL from 1991 to 2003 were included.
  • CONCLUSION: EBV detection in 96.6% of childhood HL in a population with almost universal EBV seroconversion, and in none of the control lymph nodes, suggests a causative role of EBV in most cases of Indian childhood HL.

  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17113770.001).
  • [ISSN] 0959-8049
  • [Journal-full-title] European journal of cancer (Oxford, England : 1990)
  • [ISO-abbreviation] Eur. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


81. Mejia C, Ruiz-Azuara L: Casiopeinas IIgly and IIIia induce apoptosis in medulloblastoma cells. Pathol Oncol Res; 2008 Dec;14(4):467-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The medulloblastoma is a tumor of the central nervous system that is expressed in childhood.
  • In all cases medulloblastoma cells treated with Casiopeinas showed more apoptotic features than untreated cells.

  • Genetic Alliance. consumer health - Medulloblastoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 1996 Feb 1;56(3):538-43 [8564968.001]
  • [Cites] J Natl Cancer Inst. 1990 Jul 4;82(13):1107-12 [2359136.001]
  • [Cites] Neoplasia. 2005 Jun;7(6):563-74 [16036107.001]
  • [Cites] Nat Cell Biol. 2001 Apr;3(4):339-45 [11283606.001]
  • [Cites] J Biol Chem. 1998 Oct 9;273(41):26900-7 [9756937.001]
  • [Cites] Biochem Pharmacol. 2003 Jun 15;65(12):1979-89 [12787878.001]
  • [Cites] J Biol Chem. 1985 Nov 5;260(25):13844-50 [4055760.001]
  • [Cites] Chem Res Toxicol. 1997 Dec;10(12):1338-44 [9437523.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1982 Nov;8(11):2023-7 [6759487.001]
  • [Cites] Oncogene. 2004 Apr 12;23(16):2757-65 [15077139.001]
  • [Cites] J Cell Sci. 2006 Jun 1;119(Pt 11):2362-74 [16723742.001]
  • [Cites] Nature. 2005 May 19;435(7040):365-9 [15902261.001]
  • [Cites] Cancer Res. 1992 Feb 15;52(4):997-1005 [1737363.001]
  • [Cites] Int J Oncol. 1998 Jan;12(1):141-52 [9454898.001]
  • [Cites] Semin Oncol. 1986 Mar;13(1):110-22 [3513315.001]
  • [Cites] Biochem Biophys Res Commun. 2003 May 9;304(3):487-97 [12729583.001]
  • [Cites] J Chromatogr B Analyt Technol Biomed Life Sci. 2002 May 25;772(1):115-21 [12016022.001]
  • (PMID = 18521723.001).
  • [ISSN] 1219-4956
  • [Journal-full-title] Pathology oncology research : POR
  • [ISO-abbreviation] Pathol. Oncol. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / (4,4-dimethyl-2,2-bipyridine)(acetylacetonate)copper(II); 0 / Antineoplastic Agents; 0 / Organometallic Compounds; 0 / casiopeina II-glycine
  •  go-up   go-down


82. An Q, Xue TY, Xu W, Gao JZ, Wu Y, Xu CP: [Effect of N-tosyl-L-phenylalnylchloromethyl ketone and dexamethasone on expression of nuclear transcription factor-kappaB in childhood acute lymphoblastic leukemia and its significance]. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr;15(2):399-403
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Effect of N-tosyl-L-phenylalnylchloromethyl ketone and dexamethasone on expression of nuclear transcription factor-kappaB in childhood acute lymphoblastic leukemia and its significance].
  • In order to investigate the effect of N-tosyl-L-phenylalnylchloromethyl ketone (TPCK) and dexamethasone (Dex) on expression of nuclear transcription factor-kappaB (NF-kappaB) in childhood acute lymphoblastic leukemia (ALL) and its significance, so as to provide the experimental basis for corresponding clinical treatment of ALL, in which NF-kappaB is taken as a target.
  • The biotin-streptavidin method was used to detect the expression of NF-kappaB P65 protein and the effects of TPCK and Dex at clinically relevant dosage on activity of NF-kappaB P65 protein in 20 childhood ALL patients.
  • The positive expression was (25.0 +/- 3.0)%, there was significant difference, as compared with untreated ALL cells (T=55, P<0.01).
  • Inhibition of NF-kappaB conduction pathway may have a significant value in childhood ALL treatment.

  • Genetic Alliance. consumer health - Acute Lymphoblastic Leukemia.
  • Genetic Alliance. consumer health - Acute Lymphoblastic Leukemia, Childhood.
  • Hazardous Substances Data Bank. DEXAMETHASONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17493356.001).
  • [ISSN] 1009-2137
  • [Journal-full-title] Zhongguo shi yan xue ye xue za zhi
  • [ISO-abbreviation] Zhongguo Shi Yan Xue Ye Xue Za Zhi
  • [Language] CHI
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / NF-kappa B; 0 / Protein Synthesis Inhibitors; 402-71-1 / Tosylphenylalanyl Chloromethyl Ketone; 7S5I7G3JQL / Dexamethasone
  •  go-up   go-down


83. Erdoğan HB, Bozbuğa N, Kayalar N, Erentuğ V, Omeroğlu SN, Kirali K, Ipek G, Akinci E, Yakut C: Long-term outcome after total correction of tetralogy of Fallot in adolescent and adult age. J Card Surg; 2005 Mar-Apr;20(2):119-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although most patients with tetralogy of Fallot (TOF) undergo radical repair during infancy and childhood, patients remaining undiagnosed and untreated until adulthood can still be treated.
  • Corrective procedures in adult patients with TOF can be performed successfully compared to patients who underwent operation during infancy and childhood.

  • Genetic Alliance. consumer health - Fallot Tetralogy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15725134.001).
  • [ISSN] 0886-0440
  • [Journal-full-title] Journal of cardiac surgery
  • [ISO-abbreviation] J Card Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


84. Hanley WB: Finding the fertile woman with phenylketonuria. Eur J Obstet Gynecol Reprod Biol; 2008 Apr;137(2):131-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The world literature is reviewed, including that published from the International MPKU Collaborative Study (MPKUCS) and evidence is presented to support our hypothesis that at least 10% of subjects with untreated "classical PKU" will have relatively normal intellectual function and that a significantly higher percentage of the less severe "variants" (who make up approximately 50% of the total) will have IQ's measured within the normal range.
  • However, the offspring of the mildest variant (untreated) "non-PKU mild hyperphenylalaninemia (MHP)" - blood phenylalanine 200-600 micromol/L - appear to be unaffected.
  • Others, whose diet was discontinued in childhood, may not remember why they were on special diets.

  • Genetic Alliance. consumer health - Phenylketonuria.
  • MedlinePlus Health Information. consumer health - Genetic Testing.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18262326.001).
  • [ISSN] 0301-2115
  • [Journal-full-title] European journal of obstetrics, gynecology, and reproductive biology
  • [ISO-abbreviation] Eur. J. Obstet. Gynecol. Reprod. Biol.
  • [Language] eng
  • [Grant] United States / NICHD NIH HHS / HD / N01-HD-2-3148; United States / NICHD NIH HHS / HD / N01-HD-2-3149; United States / NICHD NIH HHS / HD / N01-HD-2-3155; United States / NICHD NIH HHS / HD / N01-HD-3156
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Review
  • [Publication-country] Ireland
  • [Chemical-registry-number] EC 1.14.16.1 / Phenylalanine Hydroxylase
  • [Number-of-references] 42
  •  go-up   go-down


85. Cohen RT, Raby BA, Van Steen K, Fuhlbrigge AL, Celedón JC, Rosner BA, Strunk RC, Zeiger RS, Weiss ST, Childhood Asthma Management Program Research Group: In utero smoke exposure and impaired response to inhaled corticosteroids in children with asthma. J Allergy Clin Immunol; 2010 Sep;126(3):491-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: To assess the impact of parent-reported IUS exposure on airway responsiveness in childhood asthma, we performed a repeated-measures analysis of methacholine PC(20) data from the Childhood Asthma Management Program, a 4-year, multicenter, randomized, double-masked, placebo-controlled trial of 1041 children age 5 to 12 years comparing the long-term efficacy of ICS with mast cell stabilizing agents or placebo.
  • Moreover, while children who were not exposed to IUS who received budesonide experienced substantial improvement in PC(20) compared with untreated children (1.25-fold increase; 95% CI, 1.03-1.50; P = .02), the beneficial effects of budesonide were attenuated among children with a history of IUS exposure (1.04-fold increase, 95% CI, 0.65-1.68; P = .88).

  • Genetic Alliance. consumer health - Asthma.
  • MedlinePlus Health Information. consumer health - Asthma.
  • MedlinePlus Health Information. consumer health - Asthma in Children.
  • MedlinePlus Health Information. consumer health - Secondhand Smoke.
  • MedlinePlus Health Information. consumer health - Steroids.
  • COS Scholar Universe. author profiles.
  • Pharmacogenomics Knowledge Base. meta-databases - Pharmacogenomic Annotation 827859669 for PMID:20673983 [PharmGKB] .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
  • [Cites] Paediatr Perinat Epidemiol. 2001 Apr;15(2):140-3 [11383579.001]
  • [Cites] Eur Respir J. 2004 Jun;23(6):906-15 [15219006.001]
  • [Cites] J Allergy Clin Immunol. 2002 Mar;109(3):410-8 [11897984.001]
  • [Cites] Am Rev Respir Dis. 1985 Oct;132(4):894-900 [4051324.001]
  • [Cites] Am J Public Health. 1992 Jan;82(1):33-6 [1536331.001]
  • [Cites] Am Rev Respir Dis. 1992 May;145(5):1129-35 [1586058.001]
  • [Cites] Lancet. 1996 Oct 19;348(9034):1060-4 [8874457.001]
  • [Cites] Eur Respir J. 1997 Aug;10(8):1774-9 [9272918.001]
  • [Cites] J Expo Anal Environ Epidemiol. 1998 Jul-Sep;8(3):347-57 [9679216.001]
  • [Cites] Am J Respir Crit Care Med. 1998 Sep;158(3):802-6 [9731008.001]
  • [Cites] Control Clin Trials. 1999 Feb;20(1):91-120 [10027502.001]
  • [Cites] J Clin Invest. 1999 Mar;103(5):637-47 [10074480.001]
  • [Cites] J Allergy Clin Immunol. 2005 Apr;115(4):668-74; quiz 675 [15805982.001]
  • [Cites] Am J Respir Crit Care Med. 2005 Jul 1;172(1):61-6 [15805186.001]
  • [Cites] Paediatr Perinat Epidemiol. 2005 Sep;19(5):368-76 [16115289.001]
  • [Cites] Am J Respir Crit Care Med. 2005 Sep 1;172(5):552-8 [15937295.001]
  • [Cites] J Allergy Clin Immunol. 2006 Jan;117(1):45-52 [16387583.001]
  • [Cites] Respir Res. 2006;7:3 [16396689.001]
  • [Cites] Matern Child Health J. 2005 Dec;9(4):385-92 [16249943.001]
  • [Cites] Am J Respir Crit Care Med. 2006 Jun 1;173(11):1255-63 [16484675.001]
  • [Cites] Respir Res. 2006;7:48 [16569224.001]
  • [Cites] Tob Control. 2006 Aug;15(4):294-301 [16885578.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L611-8 [17545491.001]
  • [Cites] Nicotine Tob Res. 2007 Oct;9(10):1005-13 [17852766.001]
  • [Cites] J Allergy Clin Immunol. 2007 Nov;120(5 Suppl):S94-138 [17983880.001]
  • [Cites] Thorax. 2000 Apr;55(4):271-6 [10722765.001]
  • [Cites] Am J Respir Crit Care Med. 2000 Jul;162(1):50-6 [10903219.001]
  • [Cites] N Engl J Med. 2000 Oct 12;343(15):1054-63 [11027739.001]
  • [Cites] Am J Respir Crit Care Med. 2001 Feb;163(2):429-36 [11179118.001]
  • [Cites] Respir Res. 2002;3 Suppl 1:S21-5 [12119054.001]
  • [Cites] Am J Respir Crit Care Med. 2003 Jan 1;167(1):45-9 [12502475.001]
  • [Cites] Am J Respir Crit Care Med. 2003 Mar 15;167(6):917-24 [12480608.001]
  • [Cites] Am J Respir Crit Care Med. 2003 Aug 1;168(3):342-7 [12791581.001]
  • [Cites] Arch Dis Child. 2003 Dec;88(12):1086-90 [14670776.001]
  • [Cites] Paediatr Perinat Epidemiol. 2004 Jan;18(1):73-9 [14738549.001]
  • [Cites] Pediatrics. 2004 Apr;113(4 Suppl):1007-15 [15060193.001]
  • [Cites] Hum Mol Genet. 2004 Jul 1;13(13):1353-9 [15128701.001]
  • [Cites] Am J Respir Crit Care Med. 2001 Sep 15;164(6):989-94 [11587984.001]
  • (PMID = 20673983.001).
  • [ISSN] 1097-6825
  • [Journal-full-title] The Journal of allergy and clinical immunology
  • [ISO-abbreviation] J. Allergy Clin. Immunol.
  • [Language] ENG
  • [Grant] United States / PHS HHS / / 16048; United States / NHLBI NIH HHS / HL / HL074193-01; United States / PHS HHS / / 16050; United States / NCRR NIH HHS / RR / RR00036; United States / PHS HHS / / 16052; United States / NCRR NIH HHS / RR / M01 RR002719; United States / NCRR NIH HHS / RR / M01 RR002719-14; United States / NHLBI NIH HHS / HR / N01-HR-16044; United States / NCRR NIH HHS / RR / M01 RR000036-371243; United States / NCRR NIH HHS / RR / M01 RR000036; United States / NCRR NIH HHS / RR / RR000036-371243; United States / NCRR NIH HHS / RR / RR002719-14; United States / PHS HHS / / 16049; United States / NCRR NIH HHS / RR / RR000051-41; United States / NCRR NIH HHS / RR / M01 RR000036-39; United States / NCRR NIH HHS / RR / M01RR02719-14; United States / PHS HHS / / 16045; United States / NCRR NIH HHS / RR / M01 RR000051; United States / PHS HHS / / 16046; United States / NHLBI NIH HHS / HL / K08 HL074193; United States / NHLBI NIH HHS / HL / K08 HL074193-01; United States / NCRR NIH HHS / RR / M01 RR000051-41; United States / PHS HHS / / 16047; United States / NHLBI NIH HHS / HL / N01HR16044; United States / PHS HHS / / 16051; United States / NCRR NIH HHS / RR / M01RR00051; United States / NCRR NIH HHS / RR / M01RR0099718-24
  • [Publication-type] Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Adrenal Cortex Hormones; 0 / Tobacco Smoke Pollution; 51333-22-3 / Budesonide
  • [Other-IDs] NLM/ NIHMS218236; NLM/ PMC2937829
  • [Investigator] Shapiro GG; DuHamel TR; Lasley MV; Chinn T; Hinatsu M; Furukawa CT; Altman LC; Virant FS; Williams PV; Kennedy MS; Becker JW; White G; Bierman CW; Crawford D; Eliassen H; Hammond B; Minotti DA; Reagan C; Sharpe M; Wighton TG; Weiss S; Fuhlbrigge A; Plunkett A; Madden N; Barrant P; Darcy C; Thompson K; Torda W; Tata M; Babigian S; Benson L; Caicedo J; Calder T; DeFilippo A; Dorsainvil C; Erickson J; Fulton P; Grace M; Gilbert J; Greineder D; Haynes S; Higham M; Jakubowski D; Kelleher S; Koslof J; Mandel D; Martin P; Martinez A; McAuliffe J; Nakamoto E; Pacella P; Parks P; Sagarin J; Seligsohn K; Swords S; Syring M; Traylor J; Van Horn M; Wells C; Whitman A; MacLusky I; Reisman J; Levison H; Hall A; Chay J; Miki M; Sananes R; Benedet Y; Carpenter S; Collinson M; Finlayson-Kulchin J; Gore K; Holmes N; Klassen S; Quenneville J; Wasson C; Adkinson F Jr; Eggleston P; Aylward EH; Huss K; Plotnick L; Pulsifer M; Rand C; Bollers N; Bull D; Hamilton R; Hyatt K; Limb S; Pessaro M; Philips S; Wheeler B; Szefler S; Nelson HS; Bender B; Covar R; Liu A; Spahn J; Sundström D; Phillips M; White MP; Brelsford K; Bridges J; Ciacco J; Eltz M; Feeley J; Flynn M; Gleason M; Junk-Blanchard T; Hassell J; Hefner M; Hendrickson C; Hettleman D; Irvin CG; Jacobs J; Kamada A; Nimmagadda S; Kamada A; Sandoval K; Sheridan J; Washington T; Willcutt E; Carel K; Jain N; Leo H; Macomber B; Mjaanes C; Stewart L; Song B; Zeiger RS; Friedman N; Mellon MH; Schatz M; Harden K; Jenson EM; Panzlau S; Rodriguez E; Easton JG; Feinberg M; Galbreath LL; Gulczynski J; Hansen E; Jalowayski A; Lincoln A; Kaufman J; King S; Lopez B; Magiari-Ene M; Mostafa K; Moscona A; Nelle CA; Powers J; Sandoval K; Wilson NW; Kelly HW; Jacobs A; Spicher M; Raissy HH; Annett R; Archibeque T; Bashir N; Selda Bereket H; Braun M; Bush S; Clayton M; Colon-Semidey A; Devault S; Grad R; Hunt D; Larsson J; McClelland S; McWilliams B; Montoya E; Moreshead M; Murphy S; Ortega B; Weers D; Zayas J; Strunk RC; Bacharier L; Bloomberg GR; Corry JM; Rodgers D; Kertz L; Morgan V; Oliver-Welker T; White DK; Cherniack R; Tonascia J; Meinert C; Belt P; Collins K; Collison B; Colvin R; Dodge J; Donithan M; Harle J; Jackson R; Livingston H; Meinert J; Owens K; Smith M; Sternberg A; Van Natta M; Wild M; Wilson L; Wise R; Yates K; Taggart V; Eggers L; Kiley J; Zheng G; Albert P; Hurd S; Parker S; Randall P; Wu M; Eigen H; Cloutier M; Connett J; Cuttler L; Evans D; Kattan M; Menendez R; Simons FE; Davis CE; Leikin S; Strunk R; Szefler S; Taggart V; Tonascia J; Meinert C; Cherniack R; Strunk R; Adkinson NF; Annett R; Bender B; Caesar M; DuHamel TR; Kelly HW; Levison H; Lincoln A; MacLusky I; McWilliams B; Meinert CL; Parker S; Reisman J; Rodgers D; Seligsohn K; Shapiro GG; Sharpe M; Sundström D; Szefler S; Taggart V; Tata M; Tonascia J; Weiss S; Wheeler B; Wise R; Zeiger R
  •  go-up   go-down


86. Sun XF, Zhen ZJ, Lui DG, Xia Y, He YJ, Wang ZH, Lin JY, Guan ZZ: Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol. Eur J Haematol; 2006 Nov;77(5):365-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: From September 1997 to August 2005, 55 untreated patients (age less than 20 yr) from a single institution were enrolled.
  • CONCLUSIONS: This modified NHL-BFM-90 protocol is very effective for Chinese children and adolescents with BKL and large cell lymphomas, and represented an increase in the cure rates in childhood NHL in China.

  • Genetic Alliance. consumer health - Lymphoma, large-cell.
  • Genetic Alliance. consumer health - Burkitt's Lymphoma.
  • Hazardous Substances Data Bank. DAUNORUBICIN .
  • Hazardous Substances Data Bank. PREDNISONE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16879606.001).
  • [ISSN] 0902-4441
  • [Journal-full-title] European journal of haematology
  • [ISO-abbreviation] Eur. J. Haematol.
  • [Language] eng
  • [Publication-type] Clinical Trial; Comparative Study; Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 5J49Q6B70F / Vincristine; EC 3.5.1.1 / Asparaginase; VB0R961HZT / Prednisone; ZS7284E0ZP / Daunorubicin; PVDA protocol
  •  go-up   go-down


87. Baker JD: Twenty-year follow-up of surgery for intermittent exotropia. J AAPOS; 2008 Jun;12(3):227-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Of 66 adults presenting with exotropia, 9% had a previous history of exotropia surgery, and 32% had a history of an untreated exodeviation in childhood.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18455937.001).
  • [ISSN] 1528-3933
  • [Journal-full-title] Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
  • [ISO-abbreviation] J AAPOS
  • [Language] ENG
  • [Publication-type] Lectures; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


88. Iorio R, Giannattasio A, Sepe A, Terracciano LM, Vecchione R, Vegnente A: Chronic hepatitis C in childhood: an 18-year experience. Clin Infect Dis; 2005 Nov 15;41(10):1431-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chronic hepatitis C in childhood: an 18-year experience.
  • BACKGROUND: The long-term outcome of chronic hepatitis C (CHC) has not been well studied, both for untreated and interferon-treated children.
  • Sustained clearance of viremia was achieved in 38% of the patients treated with interferon, compared with 12% of untreated children (P<.05).

  • Genetic Alliance. consumer health - Hepatitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16231253.001).
  • [ISSN] 1537-6591
  • [Journal-full-title] Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • [ISO-abbreviation] Clin. Infect. Dis.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antiviral Agents; 0 / Hepatitis C Antibodies; 0 / Interferon-alpha; 0 / Recombinant Proteins; 76543-88-9 / interferon alfa-2a; 99210-65-8 / interferon alfa-2b
  •  go-up   go-down


89. Modesto-Lowe V, Danforth JS, Neering C, Easton C: Can we prevent smoking in children with ADHD: a review of the literature. Conn Med; 2010 Apr;74(4):229-36
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This article reviews the link between ADHD and smoking across various developmental stages with an emphasis on factors that interact with ADHD (e.g., comorbidity with conduct disorder) to modify risk for nicotine dependence from childhood through adulthood.
  • RESULTS: Childhood, adolescent and adult ADHD all increase risk for smoking.
  • Childhood ADHD increases risk for early smoking during adolescence, particularly if untreated and in combination with conduct disorder (CD).

  • MedlinePlus Health Information. consumer health - Attention Deficit Hyperactivity Disorder.
  • MedlinePlus Health Information. consumer health - Smoking.
  • MedlinePlus Health Information. consumer health - Smoking and Youth.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20441004.001).
  • [ISSN] 0010-6178
  • [Journal-full-title] Connecticut medicine
  • [ISO-abbreviation] Conn Med
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Central Nervous System Stimulants
  • [Number-of-references] 40
  •  go-up   go-down


90. Connock M, Burls A, Frew E, Fry-Smith A, Juarez-Garcia A, McCabe C, Wailoo A, Abrams K, Cooper N, Sutton A, O'Hagan A, Moore D: The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review. Health Technol Assess; 2006 Jul;10(24):iii-iv, ix-136